Page last updated: 2024-11-05

oleanolic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Oleanolic acid is a pentacyclic triterpenoid compound found in a wide variety of plants, including olive oil, rosemary, and licorice. It has been studied extensively for its various pharmacological properties, including anti-inflammatory, anti-cancer, and antiviral activities. Oleanolic acid exhibits its effects through multiple mechanisms, such as inhibiting the production of inflammatory mediators, inducing apoptosis in cancer cells, and interfering with viral replication. It is naturally produced in plants through the mevalonate pathway, and can also be synthesized in the laboratory. Its importance lies in its potential as a therapeutic agent for various diseases. The study of oleanolic acid focuses on understanding its mechanisms of action, developing new therapeutic strategies based on its properties, and exploring its potential as a safe and effective alternative or complementary treatment for various conditions.'

Cross-References

ID SourceID
PubMed CID10494
CHEMBL ID168
CHEBI ID37659
SCHEMBL ID71070
MeSH IDM0015248

Synonyms (91)

Synonym
MLS002207133
einecs 208-081-6
olean-12-en-28-oic acid, 3beta-hydroxy-
(3-beta)-3-hydroxyolean-12-en-28-oic acid
nsc 114945
olean-12-en-28-oic acid, 3-beta-hydroxy-
ccris 6493
olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-
olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-
3-beta-hydroxyolean-12-en-28-oic acid
(4as,5s,6as,6br,8r,8ar,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2h-picene-4a-carboxylic acid
(4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
508-02-1
giganteumgenin c
nsc114945 ,
oleanolic acid ,
virgaureagenin b
caryophyllin
astrantiagenin c
nsc-114945
oleanic acid
3beta-hydroxyolean-12-en-28-oic acid
CHEBI:37659 ,
smr000445561
MLS000697656
oleanol
oleonolic acid
oleanolic acid, >=97%
C7EE6ACC-7175-4947-B524-FF8479525DA1
CHEMBL168 ,
C17148
gledigenin 1
LMPR0106150004
(2s,5s,10s,18s,1r,14r,15r,20r)-18-hydroxy-1,2,8,8,15,19,19-heptamethylpentacyc lo[12.8.0.0<2,11>.0<5,10>.0<15,20>]docos-11-ene-5-carboxylic acid
oleanolic_acid
oleanolic acid (oa)(compound 1)
bdbm50346601
AKOS015951416
HMS2232D15
unii-6smk8r7tgj
6smk8r7tgj ,
oleanolic acid [inci]
oleanolic acid [usp-rs]
oleanolic acid (constituent of holy basil leaf) [dsc]
oleanolic acid (constituent of banaba leaf) [dsc]
oleanolic acid [mi]
(3.beta.)-3-hydroxyolean-12-en-28-oic acid
3.beta.-hydroxyolean-12-en-28-oic acid
oleanolic acid [who-dd]
gtpl3306
CCG-208530
SCHEMBL71070
CS-3800
Q-100572
oleanolic acid, united states pharmacopeia (usp) reference standard
(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2h)-carboxylic acid
HY-N0156
(3?)-3-hydroxyolean-12-en-28-oic acid
oleanoic acid hydrate
DTXSID50858790 ,
AC-8026
oleanolic acid, analytical standard
oleanolic acid, primary pharmaceutical reference standard
3beta-hydroxy-olean-12-en-28-oic acid
3-beta-hydroxyolean-12-en-28-oate
3beta-hydroxy-olean-12-en-28-oate
(3.beta.)-3-beta-hydroxy-olean-12-en-28-oate
(3.beta.)-3-beta-hydroxy-olean-12-en-28-oic acid
(3.beta.)-3-hydroxy-olean-12-en-28-oate
(3.beta.)-3-hydroxy-olean-12-en-28-oic acid
3.beta.-hydroxy-olean-12-en-28-oate
oleanolic acid, european pharmacopoeia (ep) reference standard
(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid
MIJYXULNPSFWEK-GTOFXWBISA-N
Q418628
oleanolsa currencyure
AS-35338
(3-beta)-3-hydroxyolean-12-en-28-oate
3.beta.-hydroxy-olean-12-en-28-oic acid
olean-12-en-28-oic acid, 3-hydroxy-, (3b)-
oleanolic-acid
(4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylicacid
EX-A1991
NCGC00017222-10
BP-25410
EN300-342251
oleanolic acid (constituent of banaba leaf)
(3beta)-3-hydroxyolean-12-en-28-oic acid
dtxcid701474453
oleanolic acid (constituent of holy basil leaf)
oleanolic acid (usp-rs)

Research Excerpts

Overview

Oleanolic acid (OA) is a widely used triterpenoid from plants. It has strong antioxidant activities, hepatoprotective, anti-inflammatory and anti-cancer activities. Oleanolic Acid is a promising drug for treating gliomas.

ExcerptReferenceRelevance
"Oleanolic acid (OA) is a natural, biologically active pentacyclic triterpenoid found in "( Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
An, HJ; Cheon, SY; Jin, BR; Kim, HJ, 2020
)
3.44
"Oleanolic acid is a widely used triterpenoid from plants, which has strong antioxidant activities, hepatoprotective, anti-inflammatory and anti-cancer activities."( Oleanolic acid reduces oxidative stress and neuronal apoptosis after experimental subarachnoid hemorrhage by regulating Nrf2/HO-1 pathway.
Han, Y; Li, X; Liang, G; Wang, C, 2022
)
2.89
"Oleanolic acid (OA) is a pentacyclic triterpenoid class of natural products that possess a broad range of biological activities, specifically anticancer activities. "( A Review on Recent Developments in the Anticancer Potential of Oleanolic Acid and its Analogs (2017-2020).
Gupta, N, 2022
)
2.4
"Oleanolic acid (OA) is a pentacyclic triterpenoid widely found in the Oleaceae family, and it represents 3.5% of the dry weight of olive leaves. "( Solubility and Permeability Enhancement of Oleanolic Acid by Solid Dispersion in Poloxamers and γ-CD.
Albonetti, L; Bergonzi, MC; Bilia, AR; De Stefani, C; Lodovichi, J; Quintela, JC; Salvatici, MC, 2022
)
2.43
"Oleanolic acid (OA) is a triterpenoid compound with anti-cholestatic effects."( Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis.
Huang, C; Liu, F; Liu, J; Meng, C; Xia, C, 2022
)
2.89
"Oleanolic acid is a promising drug for treating gliomas, but its underlying mechanism is unclear. "( Exploring the underlying mechanism of oleanolic acid treating glioma by transcriptome and molecular docking.
Huang, J; Lin, S; Xu, L; Zhu, F, 2022
)
2.44
"Oleanolic acid (OA) is a five-ring triterpenoid compound, which is widely present in plants. "( Anticancer activity of oleanolic acid and its derivatives modified at A-ring and C-28 position.
Chen, HF; Gao, CX; Hu, Y; Liu, ML; Liu, QW; Peng, YL; Tang, CH; Wu, TJ; Yang, ZH; Zheng, X, 2023
)
2.66
"Oleanolic acid (OA) is a natural triterpenoid that possesses multiple pharmacological properties including anti-oxidation, anti-inflammatory and hypoglycemia."( Renoprotective effects of oleanolic acid and its possible mechanisms in rats with diabetic kidney disease.
Chen, X; Hu, Z; Kang, L; Liu, B; Liu, Y; Niu, K; Xing, H, 2022
)
1.74
"Oleanolic acid (OA) is a pentacyclic triterpenoid with favourable physiological activity. "( Effects of oleanolic acid on hair growth in mouse dorsal skin mediated via regulation of inflammatory cytokines.
Ai, Y; He, J; He, T; Luo, J; Rong, B; Zhang, B; Zhang, L; Zhang, W; Zheng, X; Zhu, S, 2023
)
2.74
"Oleanolic acid (OA) is a pentacyclic triterpenoid compound used clinically for acute and chronic hepatitis. "( Suppression of SIRT1/FXR signaling pathway contributes to oleanolic acid-induced liver injury.
Fu, X; Huang, J; Liao, S; Lu, Y; Wang, Y; Zhou, S, 2023
)
2.6
"Oleanolic acid (OA) is a naturally occurring triterpenoid compound derived from plants, which can activate TGR5."( Oleanolic acid promotes skeletal muscle fiber type transformation by activating TGR5-mediated CaN signaling pathway.
Chen, D; Chen, X; He, J; Huang, Z; Liu, S; Luo, Y; Yu, B; Zheng, P, 2024
)
3.61
"Oleanolic acid is an analogue of pentacyclic triterpenoids. "( New Applications of Oleanolic Acid and its Derivatives as Cardioprotective Agents: A Review of their Therapeutic Perspectives.
Chen, WH; Chen, X; Hou, N; Li, D; Lu, YJ; Sun, N; Wong, WL; Wu, P, 2019
)
2.28
"Oleanolic acid (OA) is a triterpenoid, widely found in plants and possesses antitumor activity in many cancer lines. "( P-glycoprotein modulates oleanolic acid effects in hepatocytes cancer cells and zebrafish embryos.
Greige-Gerges, H; Hamade, A; Kayouka, M; Landy, D; Najjar, F; Saliba, E, 2020
)
2.3
"Oleanolic acid (OA) is an active compound found in a variety of medicinal herbs and plants. "( Oleanolic acid protects against mast cell-mediated allergic responses by suppressing Akt/NF-κB and STAT1 activation.
An, HJ; Kang, YM; Lee, M, 2021
)
3.51
"Oleanolic acid (OA) is a naturally occurring pentacyclic triterpenoid with multifarious actions. "( Peripheral Anti-nociceptive and Anti-inflammatory Effect of Oleanolic Acid in a Rat Model of Osteoarthritis.
Fakhoury, M; Fouani, M; Lawand, N; Salman, I, 2021
)
2.31
"Oleanolic acid is an oleanane triterpene found in many plant species all over the world. "( Growth and Oleanolic Acid Accumulation of Polyscias fruticosa Cell Suspension Cultures.
An, LTB; Chung, NT; Huan, LVT; Kim, PTA; Loc, NH; Thu, LTA; Truong, NT, 2021
)
2.45
"Oleanolic acid is a pentacyclic triterpenoid compound that exists widely in medicinal herbs and other plants. "( Development and Evaluation of Oleanolic Acid Dosage Forms and Its Derivatives.
Bo, F; Feng, A; Li, L; Sun, Y; Yang, S; Zhang, L, 2020
)
2.29
"Oleanolic acid is a natural pentacyclic triterpenoid compound with strong anti-inflammatory activity."( Oleanolic acid exerts neuroprotective effects in subarachnoid hemorrhage rats through SIRT1-mediated HMGB1 deacetylation.
Han, Y; Li, X; Liang, G; Tong, Z; Wang, C, 2021
)
2.79
"Oleanolic acid (OA) is a substance that occurs naturally in the leaves, fruits, and rhizomes of plants and has anti-cancer activity."( Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway.
Kai, Z; Miao, S; Mingqing, S; Qinhua, X; Shuang, Z; Xiaofei, J; Yizhen, Y, 2021
)
2.79
"Oleanolic acid (OA) is a well-known natural product possessing many important pharmacological activities; however, its weak bioactivities significantly restrict the potential application in drug development. "( The in vitro and in vivo study of oleanolic acid indole derivatives as novel anti-inflammatory agents: Synthesis, biological evaluation, and mechanistic analysis.
Gan, L; He, H; Jin, J; Li, D; Lu, Y; Wong, WL; Wu, P; Wu, R; Zhang, K; Zhang, X, 2021
)
2.34
"Oleanolic acid (OA) is a pentacyclic triterpenoid compound that is present at high levels in olive oil and has several promising pharmacological effects, such as liver protection and anti-inflammatory, antioxidant, and anticancer effects. "( Oleanolic acid reshapes the gut microbiota and alters immune-related gene expression of intestinal epithelial cells.
Dong, N; Li, Y; Lv, H; Shan, A; Shi, B; Wang, Y; Xue, C; Zhou, J, 2022
)
3.61
"Oleanolic acid (OA) is an important triterpenic compound found in olive oil, however little is known about its concentrations in human plasma. "( Determination of oleanolic acid in human plasma and its association with olive oil intake in healthy Spanish adults within the EPIC Spain cohort study.
Agudo, A; Amiano, P; Ardanaz, E; Barricarte, A; Buckland, G; Chirlaque, MD; de la Torre, R; Dorronsoro, M; Gonzalez, CA; Huerta, JM; Lujan-Barroso, L; Molinuevo, A; Navarro, C; Pastor, A; Quirós, JR; Rodríguez-Barranco, M; Sánchez, MJ; Travier, N, 2017
)
2.24
"Oleanolic acid (OA) is a bioactive triterpenoid in medicinal plants. "( Oleanolic acid (OA) regulates inflammation and cellular dedifferentiation of chondrocytes via MAPK signaling pathways.
Eo, SH; Kim, SJ; Phull, AR, 2017
)
3.34
"Oleanolic acid (OA) is a natural pentacyclic triterpenoid with free radical scavenging, cardioprotective, and P450-mediated cyclooxygenase-upregulating properties."( Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma.
Afzal, A; Bashir, S; Khan, MW; Ma, X; Madni, A; Raza, SM; Sarfraz, M; Xiang, G, 2017
)
1.49
"Oleanolic acid (OA) is a triterpenoid contained in many herbal medicines. "( Oeanolic acid protects against the hepatotoxicity of D-galactosame plus endotoxin in mice.
Liu, J; Lu, YF; Wan, XL; Wu, Q; Xu, SF, 2017
)
1.9
"Oleanolic acid is a triterpenoid compound which is important in arterial injury."( Oleanolic acid alleviates diabetic rat carotid artery injury through the inhibition of NLRP3 inflammasome signaling pathways.
An, Q; Cui, W; Ding, Y; Hu, Q; Wang, B; Wu, F, 2017
)
2.62
"Oleanolic acid (OA) is a natural pentacyclic triterpenoic acid compound that present in various herbal medicines."( Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
Niu, G; Pei, Y; Sun, L; Wang, D, 2018
)
2.64
"Oleanolic acid is a pentacyclic triterpenoid widely found in plants, including fruits and vegetables with different techniques and chromatography platforms being employed in its extraction and isolation."( Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.
Ayeleso, TB; Matumba, MG; Mukwevho, E, 2017
)
2.62
"Oleanolic acid (OA) is a triterpenoid with reported bone anti-resorption activities. "( Oleanolic Acid Exerts Osteoprotective Effects and Modulates Vitamin D Metabolism.
Cao, S; Dong, XL; Ho, MX; Wong, KC; Wong, MS; Yao, XS; Yu, WX, 2018
)
3.37
"Oleanolic acid (OA) is a known natural compound with many important biological activities. "( Synthesis of Oleanolic Acid Analogues and Their Cytotoxic Effects on 3T3 Cell Line.
Guler, EM; Kocyigit, A; Ocal, N; Secen, H; Senol, H; Topcu, G; Tuncay, S, 2018
)
2.29
"Oleanolic acid is a plant-derived pentacyclic triterpenoid compound with various biological activities. "( Enhancing oleanolic acid production in engineered Saccharomyces cerevisiae.
Fan, J; Feng, X; Li, C; Wang, C; Zhao, Y, 2018
)
2.33
"Oleanolic acid (OA) is a promising anti-inflammatory therapeutic agent that can ameliorate cerebral damage in ischemic environments, but its role in AD remains poorly elucidated."( Oleanolic acid protects against cognitive decline and neuroinflammation-mediated neurotoxicity by blocking secretory phospholipase A2 IIA-activated calcium signals.
Jia, J; Li, K; Li, Y; Wang, L; Xia, R; Zhang, J; Zhang, L, 2018
)
2.64
"Oleanolic acid (OA) is a bioactive nature product which exists in various plants and herbs."( Oleanolic acid protects against pathogenesis of atherosclerosis, possibly via FXR-mediated angiotensin (Ang)-(1-7) upregulation.
Chen, J; Chen, Y; Huang, H; Jia, Y; Pan, Y; Shen, Y; Song, Z; Zhou, F, 2018
)
2.64
"Oleanolic acid (OA) is a pentacyclic triterpenoid compound extracted from olea europaeal, a traditional Chinese medicine herb. "( Lipid-lowering effects of oleanolic acid in hyperlipidemic patients.
Chen, CP; Lin, C; Liu, J; Luo, HQ; Ma, X; Ouyang, Q; Shen, J; Sun, HB; Xuan, CX, 2018
)
2.22
"Oleanolic acid (OA) is a triterpenoid that exists widely in fruits, vegetables and medicinal herbs. "( Oleanolic acid reprograms the liver to protect against hepatotoxicants, but is hepatotoxic at high doses.
Klaassen, CD; Liu, J; Lu, YF; Shi, FG; Wu, Q; Xu, SF, 2019
)
3.4
"Oleanolic acid (OA) is a natural pentacyclic triterpenoid with various biological functions."( Role of Oleanolic acid in maintaining BBB integrity by targeting p38MAPK/VEGF/Src signaling pathway in rat model of subarachnoid hemorrhage.
Han, YW; Li, XM; Liu, XJ; Zhao, Y, 2018
)
1.64
"Oleanolic acid (OA) is a naturally occurring triterpenoid found in many plants."( Oleanolic Acid Inhibits Liver X Receptor Alpha and Pregnane X Receptor to Attenuate Ligand-Induced Lipogenesis.
Chang, HY; Chen, CJ; Chu, FY; Lim, YP; Lin, YN; Shen, HY; Wang, CCN, 2018
)
2.64
"Oleanolic acid (OA) is a natural triterpenoid and an aglycone of many saponins possessing anti-diabetic, antioxidant, hypolipidemic and anti-inflammatory activities."( Nano-oleanolic acid alleviates metabolic dysfunctions in rats with high fat and fructose diet.
Du, LB; Hai, CX; Jin, L; Li, WL; Liao, N; Pauluhn, J; Peng, J; Wang, S; Wang, X; Wang, Z; Zhang, JL; Zhao, YY, 2018
)
1.72
"Oleanolic acid (OA) is an anti-osteoporosis natural product, but molecular mechanisms of therapeutic effect are not still well known."( High-throughput metabolomics investigates anti-osteoporosis activity of oleanolic acid via regulating metabolic networks using ultra-performance liquid chromatography coupled with mass spectrometry.
Chen, S; Qiao, J; Sun, G; Xu, Y; Yu, T, 2018
)
1.43
"Oleanolic acid (OA) is a naturally occurring triterpenoid that possesses antitumor activity against several tumor cell lines. "( Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A.
Duan, L; Guo, X; Jiang, X; Yang, Z; Zhang, J, 2019
)
3.4
"Oleanolic acid (OA) is a natural anti-inflammatory and antioxidant compound."( The protective effect of oleanolic acid on NMDA-induced MLE-12 cells apoptosis and lung injury in mice by activating SIRT1 and reducing NF-κB acetylation.
Huang, XT; Li, XH; Li, Y; Luo, ZQ; Peng, XP, 2019
)
1.54
"Oleanolic acid (OA) is a hydroxyl pentacyclic triterpene acid (HTAs) used in various ailments. "( Zinc and iron complexes of oleanolic acid, (OA) attenuate allergic airway inflammation in rats.
Ayub, F; Jehangir, A; Shahid, K; Shahzad, M; Waheed, A, 2019
)
2.25
"Oleanolic acid (OA) is a natural triterpenoid that possesses numerous beneficial health effects such as antioxidant, anti-inflammatory and anti-apoptotic activities. "( Oleanolic acid attenuates cisplatin-induced nephrotoxicity in mice and chemosensitizes human cervical cancer cells to cisplatin cytotoxicity.
Domitrović, R; Potočnjak, I; Šimić, L; Vukelić, I, 2019
)
3.4
"Oleanolic acid (OA) is a natural compound with antioxidant and anti-inflammatory activity that has been used to treat liver disorders in clinical practice for several years."( Alleviation of Hepatic Ischemia Reperfusion Injury by Oleanolic Acid Pretreating via Reducing HMGB1 Release and Inhibiting Apoptosis and Autophagy.
Chen, J; Chen, K; Dai, W; Fan, X; Feng, J; Guo, C; Ji, J; Li, J; Li, S; Liu, T; Mao, Y; Wang, F; Wang, W; Wu, J; Wu, L; Yu, Q; Zhang, J; Zhou, Y, 2019
)
1.48
"Oleanolic acid (OA) is a triterpenoid and a fantastic molecule with many beneficial effects. "( Repeated oral administration of oleanolic acid produces cholestatic liver injury in mice.
Liu, J; Lu, YF; Wan, XL; Xu, Y, 2013
)
2.12
"Oleanolic acid (OA) is a natural pentacyclic triterpenoid that has been used in traditional medicine as an anticancer and anti-inflammatory agent. "( Radiosensitizing effect of oleanolic acid on tumor cells through the inhibition of GSH synthesis in vitro.
Jin, W; Wang, J; Xiao, L; Xu, S; Yi, Q; Yu, M, 2013
)
2.13
"Oleanolic acid (OA) is a triterpenoids that exists widely in plants. "( Oleanolic acid alters bile acid metabolism and produces cholestatic liver injury in mice.
Fan, F; Klaassen, CD; Liu, J; Lu, YF; Wu, KC; Zhang, Y, 2013
)
3.28
"Oleanolic acid is a poorly water-soluble drug with low oral bioavailability. "( Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation.
Dou, J; Huang, X; Su, L; Yang, R; Zhai, G, 2013
)
2.06
"Oleanolic acid (OA) is a natural plant-derived triterpenoid with potent anti-inflammatory properties. "( Synergism of a natural plant product, oleanolic acid with calcineurin inhibitor in prolonging islet allograft survival.
Angaswamy, N; Banan, B; Benshoff, N; Chapman, W; Mohanakumar, T; Tiriveedhi, V, 2013
)
2.1
"Oleanolic acid is a triterpene widely distributed throughout the plant kingdom and present in virgin olive oil at a concentration of 57 mg/kg. "( Dietary oleanolic acid mediates circadian clock gene expression in liver independently of diet and animal model but requires apolipoprotein A1.
Arnal, C; Gabás-Rivera, C; Martínez-Beamonte, R; Navarro, MA; Osada, J; Ríos, JL; Rodríguez-Yoldi, MJ; Surra, JC, 2013
)
2.27
"Oleanolic acid is a pentacyclic triterpenoid naturally present in foods and medicinal plants with anticancer, antioxidant, and antiaging properties. "( Blockade of visfatin induction by oleanolic acid via disturbing IL-6-TRAF6-NF-κB signaling of adipocytes.
Han, SJ; Han, SY; Kang, MK; Kang, YH; Kim, HS; Park, SH; Sung, HY, 2014
)
2.12
"Oleanolic acid (OA) is a natural triterpenoid and has been demonstrated to protect against varieties of hepatotoxicants. "( Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins.
Bi, H; Chen, P; Deng, R; Fan, X; Huang, M; Wang, Y; Xu, C; Zeng, H; Zhou, X, 2014
)
2.22
"Oleanolic acid (OA) is a nutritional component widely distributed in various vegetables. "( p38 MAPK signaling mediates mitochondrial apoptosis in cancer cells induced by oleanolic acid.
Lin, XK; Liu, G; Liu, J; Ma, LN; Wu, N; Zheng, LH; Zhong, JT, 2014
)
2.07
"Oleanolic acid is a plant-derived pentacyclic terpenoid that is known to exhibit anti-oxidative and anti-inflammatory activities."( Oleanolic acid attenuates MK-801-induced schizophrenia-like behaviors in mice.
Cheong, JH; Kim, B; Ko, SY; Lee, HE; Lee, Y; Oh, HK; Park, SJ; Ryu, JH; Shin, CY, 2014
)
2.57
"Oleanolic acid (OA) is a natural triterpenoid, has many important biological actions, including antitumor effect, but its poor solubility often leads to poor pharmacodynamics."( A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
Bao, X; Chu, QC; Gao, M; Guan, X; Jiang, N; Liu, KX; Tian, Y; Xu, H; Zhang, CH, 2015
)
1.57
"Oleanolic acid is a triterpenoid that has shown in vitro cytotoxic activity against human tumour cells and is known to be present in many higher plants."( Semi-synthesis of nitrogen derivatives of oleanolic acid and effect on breast carcinoma MCF-7 cells.
Gwebu, ET; Hill, GM; Oyedeji, AO; Oyedeji, OO; Setzer, WN; Shode, FO; Songca, SP, 2014
)
2.11
"Oleanolic acid (OA) is a natural compound from plants with anti-tumor activities. "( Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122/Cyclin G1/MEF2D axis.
Li, D; Liu, M; Zhao, X, 2015
)
3.3
"Oleanolic acid (OA) is a natural triterpenoid with anticancer properties, but its hydrophobic nature and poor aqueous solubility pose challenges in pharmaceutical formulation development. "( Oleanolic Acid Loaded PEGylated PLA and PLGA Nanoparticles with Enhanced Cytotoxic Activity against Cancer Cells.
Bonacucina, G; Casettari, L; Cespi, M; Kwok, PC; Lam, JK; Leung, GP; Man, DK; Palmieri, GF; Sze, SC, 2015
)
3.3
"Oleanolic acid is a triterpenoid that has been shown to possess antioxidant properties. "( Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration.
Daniels, WM; Mabandla, MV; Nyoka, M, 2015
)
2.23
"Oleanolic acid (OA) is a natural pentacyclic triterpenoic acid and a principal active compound in many medicinal herbs that have long been used to clinically treat various types of human malignancies."( Oleanolic acid modulates multiple intracellular targets to inhibit colorectal cancer growth.
Chu, J; Li, L; Lin, J; Peng, J; Shen, A; Wei, L, 2015
)
2.58
"Oleanolic acid (OA) is a bioactive pentacyclic triterpenoid. "( Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid.
Han, Y; Han, Z; Jiang, Q; Wang, C; Wang, D; Zhong, W, 2015
)
2.08
"Oleanolic acid (OA) is an active ingredient in natural plants. "( Oleanolic acid activates daf-16 to increase lifespan in Caenorhabditis elegans.
Lu, L; Zhang, J; Zhou, L, 2015
)
3.3
"Oleanolic acid (OA) is a typical BCS IV drug with low water-solubility and poor permeability, metabolized by cytochrome P450 (CYP) isozymes in the intestinal tract, such as CYP3A. "( Dual strategies to improve oral bioavailability of oleanolic acid: Enhancing water-solubility, permeability and inhibiting cytochrome P450 isozymes.
Du, P; Jiang, Q; Yang, X; Zhang, H; Zhang, T, 2016
)
2.13
"Oleanolic acid (OA) is a naturally occurring pentacyclic triterpenoid and possesses diverse pharmacological activities, including anti-cancer effects that have been confirmed in multiple types of human cancers. "( Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
Chen, L; Li, X; Song, Y; Xiao, Y; Xing, Y; Zhang, P; Zhu, H, 2016
)
3.32
"Oleanolic acid (OA) is a natural triterpenoid that is widely distributed in edible and medicinal plants. "( ERK inhibition sensitizes cancer cells to oleanolic acid-induced apoptosis through ERK/Nrf2/ROS pathway.
Chen, X; Gong, Y; Liang, H; Liu, J; Ma, A; Ma, L; Wang, J; Yu, T; Zheng, L, 2016
)
2.14
"Oleanolic acid (OA) is a pentacyclic triterpenoid widely distributed throughout the Plantae kingdom that displays several pharmacological activities."( Oleanolic acid (OA) as an antileishmanial agent: Biological evaluation and in silico mechanistic insights.
Braden, H; Cunha, MR; Delorenzi, JC; Ferreira, C; Gattass, CR; Melo, TS; Parise-Filho, R; Saraiva, E; Soares, DC; Tavares, MT, 2016
)
2.6
"Oleanolic acid (OA) is a well-known pentacyclic triterpenoid compound, which has been used as a dietary supplement and is supplied as an over-the-counter drug for the treatment of human liver diseases. "( Pharmacokinetics in Vitro and in Vivo of Two Novel Prodrugs of Oleanolic Acid in Rats and Its Hepatoprotective Effects against Liver Injury Induced by CCl4.
Jiang, T; Li, G; Peng, W; Sun, W; Yu, R; Yu, Z, 2016
)
2.12
"Oleanolic acid (OA) is a natural product, which possesses antioxidant, anti‑inflammatory, and anti‑apoptotic activities."( Attenuation of renal ischemia/reperfusion injury by oleanolic acid preconditioning via its antioxidant, anti‑inflammatory, and anti‑apoptotic activities.
Li, X; Long, C; Wang, G; Yang, H; Yang, J, 2016
)
1.41
"Oleanolic acid (OA) is an active compound present in various herbal medicines, which have been used historically for the clinical treatment of various types of human malignancies, including colorectal cancer (CRC)."( Oleanolic acid inhibits colorectal cancer angiogenesis in vivo and in vitro via suppression of STAT3 and Hedgehog pathways.
Li, L; Lin, J; Peng, J; Shen, A; Sun, G; Wei, L; Zhang, M, 2016
)
2.6
"Oleanolic acid is a pentacyclic triterpenoid compound widely found in plants and well known for its medicinal properties. "( Semisynthesis of Derivatives of Oleanolic Acid from Syzygium aromaticum and Their Antinociceptive and Anti-Inflammatory Properties.
Aremu, OO; Nkeh-Chungag, BN; Oyedeji, AO; Oyedeji, OO; Rali, S, 2016
)
2.16
"Oleanolic acid is a naturally occurring triterpenoid and is widely present in food and medicinal plants. "( Oleanolic acid ameliorates cognitive dysfunction caused by cholinergic blockade via TrkB-dependent BDNF signaling.
Gwon, Y; Jeon, SJ; Kim, DH; Kim, H; Lee, HE; Lee, HJ; Park, SJ; Ryu, JH; Shin, CY; Zhang, J, 2017
)
3.34
"Oleanolic acid (OA) is a pentacyclic triterpenoid acid of natural abundance in plants which possesses important biological activities. "( Solid inclusion complexes of oleanolic acid with amino-appended β-cyclodextrins (ACDs): Preparation, characterization, water solubility and anticancer activity.
Gao, K; Liao, X; Liu, Y; Niu, R; Ren, Y; Yang, B; Yang, Z; Zhang, J, 2016
)
2.17
"Oleanolic acid (OA) is a triterpenoid found in various fruits and vegetables and used in traditional Chinese medicine. "( Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment.
Huang, H; Jia, X; Ke, Z; Song, J; Wu, H; Xia, Z; Zhang, Z; Zhong, Q; Zhong, R,
)
1.82
"Oleanolic acid (OA) is a natural triterpenoid and an aglycone of many saponins."( NOX2-ROS-HIF-1α signaling is critical for the inhibitory effect of oleanolic acid on rectal cancer cell proliferation.
Cai, L; Guo, Y; Han, B; Luo, K; Ren, Z; Sun, L, 2017
)
1.41
"Oleanolic acid (OA) is a plant-derived triterpenoid that is frequently used in Chinese medicine as a safe but slow-acting treatment in many liver disorders."( A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes.
Fussenegger, M; Shao, J; Wang, Y; Xie, M; Xue, S; Yang, L; Ye, H; Yin, J; Yu, Y, 2017
)
1.18
"Oleanolic acid (OA) is a natural triperpenoid that protects against a variety of hepatotoxicants such as carbon tetrachloride, cadmium, acetaminophen, and bromobenzene. "( New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction.
Liu, J; Lu, YF; Pi, J; Wu, Q, 2008
)
2.03
"Oleanolic acid is a plant-derived triterpenoid, which protects against various hepatotoxicants in rodents. "( Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes.
Aleksunes, LM; Klaassen, CD; Reisman, SA, 2009
)
3.24
"Oleanolic acid is a molecule of current therapeutic interest. "( Protective effect of oleanolic acid on gentamicin induced nephrotoxicity in rats.
Jadhav, RB; Mundada, S; Patil, CR; Patil, PR; Singh, PK, 2010
)
2.12
"Oleanolic acid (OA) is an ingredient found in some Traditional Chinese Medicine remedies for treating liver ailments. "( Oleanolic acid is a selective farnesoid X receptor modulator.
Liu, W; Wong, C, 2010
)
3.25
"Oleanolic acid (OA) is a natural triterpenoid, which has been used in Chinese medicine for the treatment of liver disorders for many years. "( Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases.
Bai, H; Chen, HL; Hai, CX; Li, WL; Liang, X; Liu, R; Wang, X; Wang, Z; Ye, XL; Zhang, XD, 2010
)
2.1
"Oleanolic acid is a triterpenoid compound that is widely present in vegetables, medicinal herbs, and other plants and has potent antioxidant and antiinflammatory properties. "( Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes.
Gong, JH; Han, SJ; Kang, SW; Kang, YH; Kim, JL; Lee, ES; Li, J; Sung, HY, 2010
)
3.25
"Oleanolic acid (OA) is a plant triterpenoid steroid with potentially antiatherogenic properties. "( Antiatherogenic effects of oleanolic acid in apolipoprotein E knockout mice.
Andersen, MR; Buus, NH; Hansson, NC; Rodriguez-Rodriguez, R; Simonsen, U; Stankevicius, E, 2011
)
2.11
"Oleanolic acid is a pentacyclic triterpene present in many fruits and vegetables, and has received much attention on account of its biological properties. "( Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.
Gao, D; Tang, S; Tong, Q, 2012
)
3.26
"Oleanolic acid (OA) is a triterpenoid known for its anti-inflammatory and anti-cancer properties; however, the anti-inflammatory effects of OA on lipopolysaccharide (LPS)-mediated pro-inflammatory responses have not been studied. "( Anti-inflammatory effects of oleanolic acid on LPS-induced inflammation in vitro and in vivo.
Bae, JS; Ku, SK; Lee, W; Song, KS; Yang, EJ, 2013
)
2.12
"Oleanolic acid (OA) is a naturally occurring triterpenoid in food materials and is a component of the leaves and roots of Olea europaea, Viscum album L., Aralia chinensis L. "( Apoptosis-induced cell death due to oleanolic acid in HaCaT keratinocyte cells--a proof-of-principle approach for chemopreventive drug development.
George, VC; Kumar, DR; Kumar, RA; Suresh, PK, 2012
)
2.1
"Oleanolic Acid is a natural chemical which has wide-ranging function and abundant source. "( [Survey of pharmacology of oleanolic acid].
Du, NS; Ma, L; Tian, LT, 2002
)
2.05
"Oleanolic acid is a naturally derived triterpene used clinically in the treatment of hepatitis in China, but its poor solubility often leads to poor bioavailability. "( Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect.
Chen, Y; Liu, J; Xu, H; Yang, X; Zhao, X, 2005
)
3.21
"Oleanolic acid is a naturally occurring compound used clinically in China for the treatment of hepatitis B. "( Physical characterization of oleanolic acid nonsolvate and solvates prepared by solvent recrystallization.
Chan, CK; Chow, AH; Tong, HH; Wu, HB; Xi, J; Zheng, Y, 2008
)
2.08
"Oleanolic acid is a triterpenoid that may contribute to the cardio-protective effects of olive oil. "( Oleanolic acid induces prostacyclin release in human vascular smooth muscle cells through a cyclooxygenase-2-dependent mechanism.
Badimon, L; González-Díez, M; Herrera, MD; Martínez-González, J; Rodríguez, C; Rodríguez-Rodríguez, R; Ruiz-Gutierrez, V, 2008
)
3.23
"Oleanolic acid is a naturally occurring compound, isolated from Luffa cylindrica, which inhibits the in-vitro immunohaemolysis of antibody-coated sheep erythrocytes by guinea-pig serum. "( Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway.
Kapil, A; Sharma, S, 1994
)
2.03
"Oleanolic acid (OA) is a triterpenoid compound that has been shown to protect against some hepatotoxicants and is used in China to treat hepatitis. "( Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
Choudhuri, S; Klaassen, CD; Kreppel, H; Liu, J; Liu, Y, 1993
)
3.17
"Oleanolic acid (OA) is a triterpenoid compound that has been shown to protect against a number of hepatotoxicants, and is used in China to treat hepatitis. "( Protective effects of oleanolic acid on acetaminophen-induced hepatotoxicity in mice.
Klaassen, CD; Liu, J; Liu, Y; Madhu, C, 1993
)
2.04
"Oleanolic acid is a triterpenoid compound that has been shown to protect against liver injury produced by some hepatotoxicants. "( Protection against carbon tetrachloride hepatotoxicity by oleanolic acid is not mediated through metallothionein.
Hartley, DP; Liu, J; Liu, Y, 1998
)
1.99
"Oleanolic acid is a triterpenoid which is quite common in nature in the form either of free acid or in triterpenoid saponin glycosides. "( In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells.
Battinelli, L; Lichtner, M; Marzi, M; Mastroianni, CM; Mazzanti, G; Mengoni, F; Vullo, V, 2002
)
2.05
"Oleanolic acid may prove to be a promising antifertility agent devoid of undesirable side effects."( Antifertility effect in male rats of oleanolic acid, a triterpene from Eugenia jambolana flowers.
Bapna, JS; Lakshmanan, S; Panchanadam, M; Rajasekaran, M; Ramachandran Nair, AG; Veliath, AJ, 1988
)
1.27

Effects

Oleanolic acid (OA) has been reported to prevent bone loss in ovariectomized (OVX) rats by stimulating osteoblastogenesis. The sapogenin extract obtained - analyzed by this method - showed an error of 10.7% in relation to its gas chromatography determination.

ExcerptReferenceRelevance
"Oleanolic acid (OA) has been shown to be useful for the treatment of mental disorders."( Oleanolic Acid Attenuates Morphine Withdrawal Symptoms in Rodents: Association with Regulation of Dopamine Function.
Li, S; Pan, S; Shi, Z; Wang, L, 2021
)
3.51
"Oleanolic acid (OA) has multiple pharmaceutical applications including anti-inflammatory activity, but low permeability of the molecule limits its widespread use."( Topical gel based nanoparticles for the controlled release of oleanolic acid: design and in vivo characterization of a cubic liquid crystalline anti-inflammatory drug.
Li, S; Pan, S; Shi, Z; Wang, L, 2021
)
2.3
"Oleanolic acid (OA) has been widely used in the clinic for hepatoprotection in Chinese medicine."( Oleanolic acid-loaded nanoparticles attenuate activation of hepatic stellate cells via suppressing TGF-β1 and oxidative stress in PM2.5-exposed hepatocytes.
Leilei, L; Lianbao, Y; Ming, L; Sihang, L; Weiqiang, C; Wenke, Q; Xue, S; Yan, L; Ying, W; Yuyuan, L, 2022
)
2.89
"Oleanolic acid (OA) has been proven to be an inhibitor of PTP1B, and its anti-cardiac remodeling effects have been validated in different mouse models."( Oleanolic acid derivative alleviates cardiac fibrosis through inhibiting PTP1B activity and regulating AMPK/TGF-β/Smads pathway.
Bahetibike, S; Huang, LT; Lu, YQ; Ma, HY; Mei, S; Qi, R; Wang, AH; Xiao, SL; Yang, RY; Yi, YL; Yu, ZW; Zhu, J; Zhu, SJ, 2023
)
3.07
"Oleanolic acid (OA) has neurotrophic effects on neurons, although its use as a neurological drug requires further research. "( Oleanolic Acid Promotes Neuronal Differentiation and Histone Deacetylase 5 Phosphorylation in Rat Hippocampal Neurons.
Jo, HR; Kim, YS; Lee, CH; Son, H; Wang, SE, 2017
)
3.34
"Oleanolic acid (OA) has been reported to possess anti-diabetic effects in type 1 diabetic rats."( The Effects of Plant-Derived Oleanolic Acid on Selected Parameters of Glucose Homeostasis in a Diet-Induced Pre-Diabetic Rat Model.
Gamede, M; Khathi, A; Mabuza, L; Ngubane, P, 2018
)
1.49
"Oleanolic acid (OA) has been reported to prevent bone loss in ovariectomized (OVX) rats by stimulating osteoblastogenesis."( Oleanolic acid exerts bone protective effects in ovariectomized mice by inhibiting osteoclastogenesis.
Chen, Y; Dong, Y; Feng, X; Li, C; Li, X; Liu, S; Lu, S; Qiao, P; Shi, Q; Shu, B; Tang, D; Wang, J; Wang, Y; Xue, C; Zhang, Y; Zhao, D; Zhao, Y, 2018
)
2.64
"Oleanolic acid (OA) has recently become a research hotspot in the treatment of many human diseases, especially osteoporosis and arthritis. "( Oleanolic acid inhibits RANKL-induced osteoclastogenesis via ER alpha/miR-503/RANK signaling pathway in RAW264.7 cells.
Gan, GX; Jia, LJ; Li, JP; Liu, W; Shi, LY; Tang, SY; Xie, BP; Zeng, Y; Zhang, J, 2019
)
3.4
"Oleanolic acid (OA) has been well demonstrated to suppress survival, growth and angiogenesis of glioma cells."( Oleanolic acid suppresses migration and invasion of malignant glioma cells by inactivating MAPK/ERK signaling pathway.
Bo, Y; Guo, G; Yao, W; Zhang, Q, 2013
)
2.55
"Oleanolic acid (OA) has been reported to have anticancer effects, but the extent of its cytotoxicity, its ability to interact with nuclear DNA, its action against skin melanoma, as well as the molecular mechanism of its action against cell proliferation and in support of cell death are still unexplored. "( Oleanolic acid isolated from ethanolic extract of Phytolacca decandra induces apoptosis in A375 skin melanoma cells: drug-DNA interaction and signaling cascade.
Bishayee, K; Ghosh, S; Khuda-Bukhsh, AR, 2014
)
3.29
"Oleanolic acid (OA) has been used to treat liver disorders, but whether it can attenuate hepatic ischemia-reperfusion- (IR-) associated liver dysfunction remains unexplored. "( Protective effects of pretreatment with oleanolic acid in rats in the acute phase of hepatic ischemia-reperfusion injury: role of the PI3K/Akt pathway.
Chen, J; Gui, B; Hua, F; Qian, Y; Sun, H; Xu, Z, 2014
)
2.11
"Oleanolic acid (OA) has been widely studied because of its pleiotropic therapeutic and preventive effect on various diseases. "( Oleanolic acid inhibits proliferation and invasiveness of Kras-transformed cells via autophagy.
Lin, X; Liu, G; Liu, J; Ma, L; Wang, B; Wu, N; Zhao, Y; Zheng, L, 2014
)
3.29
"Oleanolic acid has significant pharmacological activities, such as anti-tumor, regulating blood sugar level and liver protection, which are more effective compared with free aglyconeoleanolic acid. "( Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling.
Guo, HQ; Li, JY; Mu, DW; Su, B; Zhou, GB, 2015
)
3.3
"Oleanolic acid (OA) has low aqueous solubility and low permeability, which results poor bioavailability. "( Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis.
Bera, T; Ghosh, S; Kar, N, 2016
)
3.32
"Oleanolic acid has been considered a good start molecule for synthetic exploitation. "( Oleanane derivatives for pharmaceutical use: a patent review (2000-2016).
Masullo, M; Piacente, S; Pizza, C, 2017
)
1.9
"Oleanolic acid has been isolated from chloroform extract of Olea ferruginea Royle after removal of organic bases and free acids. "( Oleanolic acid and related derivatives as medicinally important compounds.
Ata, A; Sultana, N, 2008
)
3.23
"Oleanolic acid has been marketed in China as an oral drug for human liver disorders."( Pharmacology of oleanolic acid and ursolic acid.
Liu, J, 1995
)
1.36
"Oleanolic acid (OA) has been shown to inhibit mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate (TPA). "( Inhibitory effect of oleanolic acid on 12-O-tetradecanoylphorbol-13-acetate-induced gene expression in mouse skin.
Klaassen, CD; Liu, J; Oguro, T; Yoshida, T, 1998
)
2.06
"The oleanolic acid percentage has been determined (0.269 +/- 0.025) in quinoa, and the content of saponins estimated using a conversion factor found by gas chromatography and expressed in the following relationship: % Saponin = (8.5204) x (% oleanolic acid) The sapogenin extract obtained - analyzed by this method - showed an error of 10.7% in relation to its gas chromatography determination."( [Spectrophotometric determination of oleanolic acid and saponins from quinoa (Chenopodium quinoa Willd, Kancolla variety)].
Díaz Villar, L; Peñafiel, CC, 1988
)
1.03

Actions

Oleanolic acid can inhibit edema and exhibit obvious inhibitory activity to inflammatory by activating of the pituitary-adrenal cortical system. Oleanolic Acid failed to increase calcium in HUVECs, but increased time-dependently phosphorylation of Akt kinase at Serine(473) (Akt-Ser(473)) and eNOS at serine(1177)

ExcerptReferenceRelevance
"Oleanolic acid can inhibit edema and exhibit obvious inhibitory activity to inflammatory by activating of the pituitary-adrenal cortical system, inhibiting the synthesis or release of PGs, inhibiting endotoxin-mediated release of HMGB1 by endothelial cells or regulating MAPK, PI3K/Akt/NF- κB/ICAM-1/JAK/STAT signaling pathways, etc. "( Advances on the Anti-Inflammatory Activity of Oleanolic Acid and Derivatives.
Luan, M; Meng, Q; Wang, H; Xu, Y; Zhang, X; Zhao, F, 2021
)
2.32
"Oleanolic acid failed to increase calcium in HUVECs, but increased time-dependently phosphorylation of Akt kinase at Serine(473) (Akt-Ser(473)) and eNOS at Serine(1177) (eNOS-Ser(1177)), which was attenuated by inhibitors of phosphoinositide-3-kinase."( Oleanolic acid induces relaxation and calcium-independent release of endothelium-derived nitric oxide.
Andersen, MR; Herrera, MD; Ostergaard, L; Rodriguez-Rodriguez, R; Ruiz-Gutierrez, V; Simonsen, U; Stankevicius, E, 2008
)
2.51

Treatment

Oleanolic acid treatment altered the expression of 12 genes involved in the Kyoto Encyclopedia of Genes and Genomes. Treatment also resulted in fragmentation of nuclear DNA in a dose‑dependent manner, producing the typical features of DNA laddering on an agarose gel.

ExcerptReferenceRelevance
"Oleanolic acid treatment also altered the expression of 12 genes involved in the Kyoto Encyclopedia of Genes and Genomes(KEGG)pathways of complement and coagulation cascades, hematopoietic cell lineage, and leukocyte transendothelial migration in intestinal epithelial cells to improve gut immunity."( Oleanolic acid reshapes the gut microbiota and alters immune-related gene expression of intestinal epithelial cells.
Dong, N; Li, Y; Lv, H; Shan, A; Shi, B; Wang, Y; Xue, C; Zhou, J, 2022
)
2.89
"Oleanolic acid treatment also resulted in fragmentation of nuclear DNA in a dose‑dependent manner, producing the typical features of DNA laddering on an agarose gel."( Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells.
Huang, HY; Wu, YL; Zhu, YY, 2015
)
1.41
"Oleanolic acid-treated wild-type mice had increased hepatic mRNA expression of the Nrf2 target genes NAD(P)H:quinone oxidoreductase 1 (Nqo1); glutamate-cysteine ligase, catalytic subunit (Gclc); heme oxygenase-1 (Ho-1); as well as Nrf2 itself."( Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes.
Aleksunes, LM; Klaassen, CD; Reisman, SA, 2009
)
2.52
"Oleanolic acid pretreatment (100-400 micromol/kg, s.c.) protected Sprague-Dawley rats and mice from carbon tetrachloride-induced liver injury in a dose- and time-dependent manner, as evidenced by serum alanine aminotransferase and sorbitol dehydrogenase activities, as well as by histopathology."( Protection against carbon tetrachloride hepatotoxicity by oleanolic acid is not mediated through metallothionein.
Hartley, DP; Liu, J; Liu, Y, 1998
)
1.27
"Pretreatment with oleanolic acid also led to an increase in antioxidant enzyme activity (CAT and AChE) and levels (GSH and SOD) in the brain."( Oleanolic acid suppresses pentylenetetrazole-induced seizure in vivo.
Akünal Türel, C; Yunusoğlu, O, 2023
)
2.68
"Pretreatment of oleanolic acid alleviated MCAO-induced ischemia-reperfusion injury as indicated by the significant decreases in cerebral infarction area and neurological symptom score at 24 h post injury, Evans blue leakage, expression of matrix metalloproteinase 9 (MMP9) and occludin, dihydroethidium fluorescence, and block malonaldehyde generation. "( Neuroprotective effects of oleanolic acid against cerebral ischemia-reperfusion injury in mice.
Gu, JH; Ji, X; Shi, R; Shi, YJ; Sun, LL; Xu, F, 2021
)
1.26
"Treatment with oleanolic acid derivatives decreased the levels of β-catenin in both the cytoplasm and the nucleus."( Oleanolic acid derivatives inhibit the Wnt/β-catenin signaling pathway by promoting the phosphorylation of β-catenin in human SMMC-7721 cells.
Du, H; Duan, Z; Fan, X; Jiang, J; Lei, H; Li, H; Sun, Y; Wang, P; Wang, Z, 2016
)
2.22
"Pre-treatment with oleanolic acid significantly reduced nociceptive behavior associated with acute pain."( Oleanolic acid promotes orofacial antinociception in adult zebrafish (Danio rerio) through TRPV1 receptors.
Alves, YA; Campos, AR; Coelho, RF; Magalhaes, FEA; Santos, SAAR; Soares, ICR; Tavares, KCS; Vieira-Neto, AE, 2019
)
2.28
"Rats treated with oleanolic acid 7 days pre- and 1 day post-lesion had more dopamine in the striatum than the non-treated or the 7 days after lesion rats."( Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration.
Daniels, WM; Mabandla, MV; Nyoka, M, 2015
)
1.11
"Pretreatment with oleanolic acid prior to the administration of carbon tetrachloride significantly prevented the increase in serum alanine aminotransferase and lactate dehydrogenase activity and liver lipid peroxidation in a dose-dependent manner."( Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury.
Jeong, HG, 1999
)
0.88

Toxicity

ExcerptReferenceRelevance
"Liver injury occurred after sheep were injected intravenously with the triperpene acid lantadene A, the toxic principle of the tropical plant Lantana camara."( Lantadene A toxicity in sheep. A model for cholestasis.
Heath, TJ; Lamberton, JA; Pass, MA; Seawright, AA, 1979
)
0.26
" One of the mechanisms for this protection appears to be the decreased AA toxic activation via P-450, as well as increased detoxication via glucuronidation of AA."( Protective effects of fulvotomentosides on acetaminophen-induced hepatotoxicity.
Jia, XS; Klaassen, CD; Liu, J; Liu, YP; Madhu, C; Mao, Q, 1992
)
0.28
" Momordin Ic and oleanolic acid obtained from KF appear to contribute to alleviating the adverse effects of CCl4 treatment by enhancing the hepatic antioxidant defense system."( Momordin Ic and oleanolic acid from Kochiae Fructus reduce carbon tetrachloride-induced hepatotoxicity in rats.
Cho, SY; Choi, JW; Kim, NY; Kim, SH; Kim, SJ; Lee, JS; Lee, MK; Park, HJ; Park, MJ, 2005
)
1.01
" Finally, strong data exist to suggest that NG440 is a safe formula for human consumption."( Clinical safety and efficacy of NG440: a novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditions.
Bland, JS; Carroll, B; Darland, G; Hall, A; Katke, J; Lamb, J; Lerman, RH; Minich, DM; Tripp, M, 2007
)
0.55
" Coordinated regulation of detoxification enzymes and drug transporters and suppression of inflammation by Nrf2 during cisplatin nephrotoxicity are probable defense mechanisms to eliminate toxic mediators and promote proximal tubule recovery."( Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.
Aleksunes, LM; Goedken, MJ; Klaassen, CD; Manautou, JE; Rockwell, CE; Thomale, J, 2010
)
0.36
" Due to its toxic effects on the eyes, lungs, and skin, and the relative ease with which it may be synthesized, mustard gas remains a potential chemical threat to the present day."( Protection against 2-chloroethyl ethyl sulfide (CEES)-induced cytotoxicity in human keratinocytes by an inducer of the glutathione detoxification pathway.
Abel, EL; Andreeff, M; Bubel, JD; DiGiovanni, J; MacLeod, MC; McClellan, SA; Powell, L; Simper, MS, 2011
)
0.37
" However, increases in albuminuria, serum transaminase, and frequency of adverse events were noted."( Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects.
Abbate, M; Benigni, A; Carrara, F; Corna, D; Gaspari, F; Locatelli, M; Nava, V; Remuzzi, G; Sangalli, F; Zoja, C, 2013
)
0.39
" Our current study was to examine the toxic effect of SSD on human hepatocyte LO2 cells and explore the possible mechanism."( Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity.
Chen, L; Chen, W; Kong, D; Wang, A; Zhang, F; Zheng, S; Zhu, X, 2013
)
0.39
" Single dose administration of 20, 60, and 80 mg bardoxolone methyl was safe and well-tolerated in healthy volunteers."( A food effect study and dose proportionality study to assess the pharmacokinetics and safety of bardoxolone methyl in healthy volunteers.
Awni, WM; Dumas, EO; Kelley, RJ; Klein, CE; Meyer, CJ; Teuscher, NS, 2014
)
0.4
" Baking herb with vinegar is believed to attenuate the adverse responses."( Content decline of SERCA inhibitors saikosaponin a and d attenuates cardiotoxicity and hepatotoxicity of vinegar-baked Radix bupleuri.
Li, S; Peng, S; Qiao, Y; Shen, C; Wang, S; Wu, Q; Yang, W; Yu, Y; Zhang, M; Zhang, Q; Zhang, Y, 2017
)
0.46
" The current study provides experimental evidence for clinical safe use of RB, and also new insights into understanding the mechanism by which SS and RB induced liver injury."( Saikosaponins induced hepatotoxicity in mice via lipid metabolism dysregulation and oxidative stress: a proteomic study.
Huang, Y; Li, X; Liu, R; Lu, J; Luan, Y; Lv, L; Sun, R, 2017
)
0.46
" These data demonstrate that OA inhibited the transactivation of PXR and CAR, reduced the expression and function of CYP3A4 and CYP2B6, and may therefore serve as an effective agent for reducing probability adverse interactions between transcriptional inducers of CYP450 and therapeutic drugs."( Oleanolic Acid-Mediated Inhibition of Pregnane X Receptor and Constitutive Androstane Receptor Attenuates Rifampin-Isoniazid Cytotoxicity.
Chang, HY; Chen, CJ; Chen, JJ; Cheng, WK; Lee, YR; Lim, YP; Lin, YN, 2017
)
1.9
"Currently, no effective and safe medicines are available to treat diabetic nephropathy (DN)."( Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy.
Chen, C; Huang, Z; Lai, Y; Li, P; Mou, Y; Peng, S; Tian, J; Xu, X; Xu, Y; Zhang, Y; Zhao, D, 2017
)
0.46
"Methylmercury (MeHg) is one of the most toxic environmental pollutants, presenting a serious health hazard worldwide."( Oleanolic acid 3-glucoside, a synthetic oleanane-type saponin, alleviates methylmercury toxicity in vitro and in vivo.
Kiyono, M; Kobayashi, Y; Konishi, N; Nakamura, R; Shirahata, T; Sone, Y; Takanezawa, Y; Uraguchi, S, 2019
)
1.96
"Dose-dependent cardiotoxicity is the leading adverse reaction seen in cancer patients treated with doxorubicin."( Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathway.
Bentley, RA; Colley, HE; Copple, IM; Cross, MJ; Lu, ZQ; Murdoch, C; Sharma, P; Tomlinson, L; Webb, SD, 2019
)
0.51
" Saponins are the main pharmacodynamic and toxic components of Bupleuri Radix."( [Study on liver protection and hepatotoxicity of saikosaponin a based on zebrafish model].
Gao, JJ; Han, LW; He, QX; Liu, KC; Tu, PF; Xia, Q; Zhang, SS; Zhang, Y, 2019
)
0.51
" In-vivo toxicity study demonstrated no adverse effects on body weight and vital organs in the treatment group compared with the control group."( Targeted delivery of ursolic acid and oleanolic acid to lungs in the form of an inhaler for the management of tuberculosis: Pharmacokinetic and toxicity assessment.
Debnath, SK; Dighe, V; Maske, P; Saini, V; Srivastava, R, 2022
)
0.99

Pharmacokinetics

Oleanolic acid and other ingredients present in QYDT could affect the pharmacokinetic behaviour of swertiamarin.

ExcerptReferenceRelevance
" Following oral administration of oleanolic acid at doses of 10, 25 and 50 mg/kg, Tmax, t1/2, dose-normalized Cmax (66-74 ng/ml based on 25 mg/kg) and dose-normalized AUC (5."( Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats.
Choi, WR; Han, CK; Jeong, DW; Ji, HY; Kim, HH; Kim, YH; Lee, HS; Lee, SM; Yoo, SD, 2007
)
0.9
" In these studies, the pharmacodynamic activity of CDDO-Im is characterized in two distinct lines of ARE reporter mice and by measuring increases in Nqo1 transcript levels as a marker of cytoprotective gene induction."( Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes.
Burton, NC; Flanders, KC; Gribble, GW; Guilarte, TR; Honda, T; Johnson, DA; Johnson, JA; Katsuoka, F; Kensler, TW; Liby, KT; Sporn, MB; Tauchi, M; Yamamoto, M; Yates, MS, 2007
)
0.34
" This developed method was subsequently successfully applied to pharmacokinetic profiles of the four saponins in rats."( Liquid chromatography-mass spectrometry analysis of macranthoidin B, macranthoidin A, dipsacoside B, and macranthoside B in rat plasma for the pharmacokinetic investigation.
Chen, CY; Li, P; Qi, LW; Wen, XD; Yi, L, 2009
)
0.35
" Based on animal data, human pharmacokinetic parameters of Cl, V ( ss ) and t (1/2) were predicted by simple allometry."( Interspecies scaling of oleanolic acid in mice, rats, rabbits and dogs and prediction of human pharmacokinetics.
Jeong, DW; Ji, HY; Lee, HS; Park, EJ; Park, ES; Shin, BS; Yoo, SD, 2009
)
0.66
"To estimate the pharmacologically active dose range of a new investigational compound S-0139, a selective endothelin A (ET(A)) receptor antagonist, in man, and to examine the duration of its pharmacodynamic effect."( Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET) antagonist, in the human forearm blood flow model.
Albala, B; Francis-Lang, A; Laurijssens, BE; Lunnon, MW; Maltby, K; Mistry, P; Nagafuji, T; Palmer, JE; Wallace, SM; Wilkinson, IB, 2010
)
0.36
"7 microg kg(-1) min(-1)) to explore the duration of the pharmacodynamic effect."( Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET) antagonist, in the human forearm blood flow model.
Albala, B; Francis-Lang, A; Laurijssens, BE; Lunnon, MW; Maltby, K; Mistry, P; Nagafuji, T; Palmer, JE; Wallace, SM; Wilkinson, IB, 2010
)
0.36
"S-0139 dose-dependently blocks ET-1-mediated vasoconstriction in the forearm and has a prolonged duration of effect beyond that expected from its pharmacokinetic profile."( Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET) antagonist, in the human forearm blood flow model.
Albala, B; Francis-Lang, A; Laurijssens, BE; Lunnon, MW; Maltby, K; Mistry, P; Nagafuji, T; Palmer, JE; Wallace, SM; Wilkinson, IB, 2010
)
0.36
" This quantitative measurement was successfully applied to a pharmacokinetic study of Yi-Qi-Fu-Mai injection."( An LC-MS method for simultaneous determination of nine ginsenosides in rat plasma and its application in pharmacokinetic study.
Lin, R; Tong, L; Wan, M; Wang, G; Wang, Z; Ye, Z; Zhou, D, 2011
)
0.37
" The pharmacokinetic profiles of α- and β-amyrins in rats were subsequently investigated in Sprague-Dawley rats."( Quantification of α- and β-amyrin in rat plasma by gas chromatography-mass spectrometry: application to preclinical pharmacokinetic study.
Ching, J; Koh, HL; Lin, HS; Tan, CH, 2011
)
0.37
" However, the metabolism and pharmacokinetic characteristics of ardipusilloside I remain unknown."( Metabolism and pharmacokinetic study of ardipusilloside I in rats.
Cui, H; Gan, HQ; Gu, Y; Huan, ML; Teng, ZH; Wang, R; Wang, XJ; Zhang, BL; Zhang, WD; Zhou, SY, 2012
)
0.38
" This proposed method was successfully applied to a pharmacokinetic study on clematichinenoside AR in rats after oral administration."( Validated LC-MS/MS assay for the quantitative determination of clematichinenoside AR in rat plasma and its application to a pharmacokinetic study.
Li, F; Li, P; Liu, L; Liu, X; Wang, D; Xu, P; Zhang, J; Zhou, L, 2012
)
0.38
" The method has been successfully applied to a pharmacokinetic study of Oldenlandia diffusa extract after oral administration in rats."( Simultaneous determination of oleanolic acid, p-coumaric acid, ferulic acid, kaemperol and quercetin in rat plasma by LC-MS-MS and application to a pharmacokinetic study of Oldenlandia diffusa extract in rats.
Chen, H; He, S; Huang, X; Li, N; Li, Y; Liu, C; Mi, S; Wang, N; Xu, X; Zheng, X,
)
0.42
" The developed method was suitable for the quantification of EsA and successfully applied to the pharmacokinetic study of EsA after an oral administration to beagle dogs."( Determination of esculentoside A in dog plasma by LC-MS/MS method: application to pre-clinical pharmacokinetics.
Chang, H; Chen, X; Fan, G; Guan, X; Sun, F; Zhang, W, 2013
)
0.39
" According to the permeability and affinity, 7a and 9b were selected in the pharmacokinetic studies in rats."( Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao, F; Fang, L; Gao, Y; Ping, Q; Wang, M, 2013
)
0.63
" The method has been successfully translated to the pharmacokinetic study of RA in rats after intravenous and intraperitoneal administration (0."( Determination of Raddeanin A in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
Chen, HZ; Fang, C; Guan, YY; Liu, YR; Lu, Q; Luan, X; Qi, H; Tang, YB; Wang, C; Wang, XL; Yu, DH; Zhao, M, 2013
)
0.39
" However, information regarding its pharmacokinetic properties remains limited."( Pharmacokinetics of hederacoside C, an active ingredient in AG NPP709, in rats.
Choi, HD; Han, CK; Jung, JW; Kang, HE; Kim, JM; Lee, HS; Shin, YJ; Yoon, JN, 2013
)
0.39
"The results showed that the pharmacokinetic parameters Cmax, AUC0-∞, Vz/F and CLz/F were significantly different (P<0."( Comparative pharmacokinetics of swertiamarin in rats after oral administration of swertiamarin alone, Qing Ye Dan tablets and co-administration of swertiamarin and oleanolic acid.
Feng, EF; He, JC; Li, HL; Liu, CX; Liu, YQ; Shi, PP; Xu, GL, 2013
)
0.59
"The data indicate that oleanolic acid and the other ingredients present in QYDT could affect the pharmacokinetic behaviour of swertiamarin in rats."( Comparative pharmacokinetics of swertiamarin in rats after oral administration of swertiamarin alone, Qing Ye Dan tablets and co-administration of swertiamarin and oleanolic acid.
Feng, EF; He, JC; Li, HL; Liu, CX; Liu, YQ; Shi, PP; Xu, GL, 2013
)
0.9
" The method was validated and successfully applied to the preliminary pharmacokinetic study of chikusetsusaponin V and chikusetsusaponin IV in rat plasma after oral administration of saponins extracted from Rhizoma Panacis Japonici."( Determination of chikusetsusaponin V and chikusetsusaponin IV in rat plasma by liquid chromatography-mass spectrometry and its application to a preliminary pharmacokinetic study.
Chen, J; Li, F; Qi, D; Shi, X; Yang, X; Yang, Z; Zhang, C, 2013
)
0.39
" In the pharmacokinetic (PK) study, beagle dogs were given oral doses of calenduloside E (1."( Pharmacokinetic study of calenduloside E and its active metabolite oleanolic acid in beagle dog using liquid chromatography-tandem mass spectrometry.
Cheng, L; Fawcett, JP; Gu, J; Shi, M; Sun, X; Sun, Y; Xu, H; Yang, Y; Zhao, S, 2014
)
0.64
" Consequently, the validated method could be successfully and precisely applied to the pharmacokinetic study of asperosaponin VI and its metabolites."( Pharmacokinetics study of asperosaponin VI and its metabolites cauloside A, HN saponin F and hederagenin.
Chang, YX; Gao, XM; Han, LF; Huo, Y; Liu, EW; Wang, JL; Wang, L; Wang, T, 2014
)
0.4
" In a Phase I trial in cancer patients, CDDO-Me was found to have a slow and saturable oral absorption, a relatively long terminal phase half-life (39 hours at 900 mg/day), nonlinearity (dose-dependent) at high doses (600-1,300 mg/day), and high interpatient variability."( Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.
He, ZX; Wang, YY; Yang, YX; Zhe, H; Zhou, SF, 2014
)
0.4
" To date, no information is available about analytical method and pharmacokinetic studies of phytolaccagenin."( Development and validation of a HPLC-MS/MS method for the determination of phytolaccagenin in rat plasma and application to a pharmacokinetic study.
Derendorf, H; Fueth, M; Okunieff, P; Singh, RS; Swarts, S; Wei, F, 2015
)
0.42
" The pharmacokinetic behaviors of oral dosage of QingGanSanJie decoctions were then studied in rats following the developed approach."( Simultaneous Determination of Oleanolic and Ursolic Acids in Rat Plasma by HPLC-MS: Application to a Pharmacokinetic Study After Oral Administration of Different Combinations of QingGanSanJie Decoction Extracts.
Chai, Y; Li, W; Li, Y; Lv, L; Wang, X; Xu, H; Zhang, G; Zhao, L, 2015
)
0.42
" The developed method was successfully applied to the pharmacokinetic study of shionone and epi-friedelinol after oral administration of Aster tataricus extract to rats."( Development and validation of an LC/MS/MS method for simultaneous determination of shionone and epi-friedelinol in rat plasma for pharmacokinetic study after oral administration of Aster tataricus extract.
Deng, J; Hu, L; Liu, JT; Liu, Y; Wang, SP; Xiong, Y; Yin, DF; Zhong, W; Zhou, K, 2016
)
0.43
" This method was successfully applied in the pharmacokinetic study of CHS-IVa in rats."( Determination and validation of chikusetsusaponin IVa in rat plasma by UPLC-MS/MS and its application to pharmacokinetic study.
Guo, MH; Liu, SP; Wang, Y; Wang, Z, 2016
)
0.43
" The validated method was successfully applied into a pharmacokinetic study of orally administered BDP in rats."( UFLC-MS/MS determination and pharmacokinetic studies of six Saikosaponins in rat plasma after oral administration of Bupleurum Dropping Pills.
Chu, Y; Guan, X; Li, S; Li, W; Liu, C; Ma, X; Sun, H; Wang, X; Yan, K; Yan, X; Zhou, S, 2016
)
0.43
" Blood samples for pharmacokinetic analysis were taken over 120 hours following dose administration."( A food effect study and dose proportionality study to assess the pharmacokinetics and safety of bardoxolone methyl in healthy volunteers.
Awni, WM; Dumas, EO; Kelley, RJ; Klein, CE; Meyer, CJ; Teuscher, NS, 2014
)
0.4
" The assay was successfully applied to study the pharmacokinetic behavior of the three analytes in rats after oral and intravenous administration of a mixture of saponins (hederacoside C, hederacoside D, and ɑ-hederin)."( Pharmacokinetic parameters of three active ingredients hederacoside C, hederacoside D, and ɑ-hederin in Hedera helix in rats.
Li, L; Liu, J; Xing, Y; Xu, H; Yu, M; Yu, Z; Zhao, Y, 2016
)
0.43
" The pharmacokinetic parameters of PVPOALs in rats were determined by UPLC-MS/MS following oral administration."( Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes.
Gao, N; Liu, X; Liu, Y; Luo, X; Xu, X, 2017
)
0.68
" Main pharmacokinetic parameters were as follows: tmax (0."( [Pharmacokinetics and tissue distribution of α-hederin sodium salt in rats].
Feng, YL; He, MZ; Li, Y; Li, ZF; Liu, Z; Ouyang, H; Yang, SL, 2016
)
0.43
" Pharmacokinetic tests were used to evaluate the effects of SSd on serum Dox disposition."( The effect of saikosaponin D on doxorubicin pharmacokinetics and its MDR reversal in MCF-7/adr cell xenografts.
Feng, LJ; Gai, XD; Li, C; Wang, ML; Wang, P; Xue, HG, 2017
)
0.46
" There was no significant difference between the Dox pharmacokinetic parameters obtained in the mice that received Dox only and Dox combined with SSd, indicating that SSd did not alter the pharmacokinetic profiles of Dox."( The effect of saikosaponin D on doxorubicin pharmacokinetics and its MDR reversal in MCF-7/adr cell xenografts.
Feng, LJ; Gai, XD; Li, C; Wang, ML; Wang, P; Xue, HG, 2017
)
0.46
" The concentration of the SSa in mice plasma and brain was determined by UPLC-MS/MS, and the pharmacokinetic parameters, bioavailability, the brain targeting coefficient (Re) and the brain drug targeting index (DTI) were calculated with Kinetica software."( [Comparison of different administration routes of saikosaponin in plasma pharmacokinetics and brain pharmacokinetics].
Chen, XL; Dai, YJ; Deng, XY; Tang, HY; Xie, L, 2017
)
0.46
" The method has been successfully applied to a preclinical pharmacokinetic study in rats after a single intravenous (2 mg/kg) or oral (50 mg/kg) administration."( A rapid and sensitive UHPLC-MS/MS method for the determination of celosin A in rat plasma with application to pharmacokinetic study.
Cao, X; Shen, J; Song, J; Zhou, W, 2019
)
0.51
" The validated LC-MS/MS method was successfully applied to the pharmacokinetic analysis of hesperidin, emodin, polydatin and naringin of SGZT in rat plasma after administration."( Metabolite profiling of Shuganzhi tablets in rats and pharmacokinetics study of four bioactive compounds with liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Guan, H; Han, H; Ju, Z; Li, G; Lin, J; Shi, M; Tang, J; Xu, Y; Zhang, T, 2021
)
0.62
" The pharmacokinetic parameters of the representative components absorbed into the blood were compared between XJP&B and XJP&W by the pharmacokinetics study method, in order to determine the dynamic changes of the representative components in rats."( Analysis of the pharmacodynamic difference between Xiaojin Pills taken with Chinese Baijiu and water based on serum pharmacochemistry and pharmacokinetics.
Deng, X; Han, L; Liao, W; Lin, J; Song, J; Xu, R; Zhang, D, 2023
)
0.91
" The pharmacokinetic study results of representative components demonstrated that the mean plasma concentration-time profile and pharmacokinetic parameters of muscone, aconitine, and 3-acetyl-11-keto-β-boswellic acid were significantly different between XJP&B and XJP&W."( Analysis of the pharmacodynamic difference between Xiaojin Pills taken with Chinese Baijiu and water based on serum pharmacochemistry and pharmacokinetics.
Deng, X; Han, L; Liao, W; Lin, J; Song, J; Xu, R; Zhang, D, 2023
)
0.91
" With prior approval of IAEC, a pharmacokinetic and acute inhalation toxicity study was conducted using MDI on Wistar rats."( Targeted delivery of ursolic acid and oleanolic acid to lungs in the form of an inhaler for the management of tuberculosis: Pharmacokinetic and toxicity assessment.
Debnath, SK; Dighe, V; Maske, P; Saini, V; Srivastava, R, 2022
)
0.99
"The pharmacokinetic study showed an increased biological half-life of UA (9."( Targeted delivery of ursolic acid and oleanolic acid to lungs in the form of an inhaler for the management of tuberculosis: Pharmacokinetic and toxicity assessment.
Debnath, SK; Dighe, V; Maske, P; Saini, V; Srivastava, R, 2022
)
0.99

Compound-Compound Interactions

Heparin sodium (HS)-loaded polylactic-co-glycolic acid-D-α-tocopheryl polyethylene glycol 1000 succinate (PLGA-TPGS) nanoparticles (HPTNs) were prepared. They were combined with oleanolic acid (OA)-loaded PLGA- TPGS nanoparticles to form a combination therapy system for the treatment of liver cancer.

ExcerptReferenceRelevance
"An efficient system to produce saikosaponins (saikosaponin-a and -d) in Bupleurum falcatum adventitious root fragments combined with signal transducers was developed."( Efficient production of saikosaponins in Bupleurum falcatum root fragments combined with signal transducers.
Aoyagi, H; Kobayashi, Y; Kusakari, K; Tanaka, H; Yamada, K; Yokoyama, M, 2001
)
0.31
"A method based on accelerated solvent extraction combined with rapid-resolution LC-MS for efficient extraction, rapid separation, online identification and accurate determination of the saikosaponins (SSs) in Radix bupleuri (RB) was developed."( Identification and determination of the saikosaponins in Radix bupleuri by accelerated solvent extraction combined with rapid-resolution LC-MS.
Chen, JX; Fan, CL; Guo, PR; Luo, HT; Tang, YZ; Yang, YY, 2010
)
0.36
"To observe the effects of interferon-alpha combined with saikosaponin on serum T lymphocyte subgroups and hepatic cytokines in mice with immune hepatic injury."( [Effects of interferon-alpha combined with saikosaponin on serum T lymphocyte subgroups and hepatic cytokines in mice with immune hepatic injury].
Chen, YY; Liu, GW; Xue, DY, 2012
)
0.38
"The aim of this study was to investigate the effects of Saikosaponin-d (SSd) combined with radiotherapy on SMMC-7721 hepatoma cell lines and its mechanism."( Effects of SSd combined with radiation on inhibiting SMMC-7721 hepatoma cell growth.
Bai, MH; Lin, S; Ma, HB; Min, WL; Song, LQ; Wang, BF; Wang, M; Wang, XJ; Yang, P, 2014
)
0.4
" Radiation caused ultrastructural damage to cells, and the damage was enhanced in combination with SSd."( Effects of SSd combined with radiation on inhibiting SMMC-7721 hepatoma cell growth.
Bai, MH; Lin, S; Ma, HB; Min, WL; Song, LQ; Wang, BF; Wang, M; Wang, XJ; Yang, P, 2014
)
0.4
"1 ml/kg CCl4 in combination with 5% ethanol with glucose 3 times a week for 6 weeks."( Hepatoprotective properties of betulonic acid amide and heptral in toxic liver injury induced by carbon tetrachloride in combination with ethanol.
Baiev, DS; Biryukova, MS; Ivanova, EP; Nepomnyashchikh, GI; Semenov, DE; Sorokina, IV; Tolstikova, TG; Zhukova, NA, 2015
)
0.42
"Heparin sodium (HS)-loaded polylactic-co-glycolic acid-D-α-tocopheryl polyethylene glycol 1000 succinate (PLGA-TPGS) nanoparticles (HPTNs) were prepared as sustained and targeted delivery carriers and combined with oleanolic acid (OA)-loaded PLGA-TPGS nanoparticles (OPTNs) that had been investigated in our previous work to form a combination therapy system for the treatment of liver cancer."( Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancer.
Bao, X; Deng, S; Gao, D; Gao, M; Guan, X; Liu, H; Lv, L; Tian, Y; Wang, C; Xu, H; Zhang, C, 2016
)
2.06
" The apoptosis of HepG2 cells induced by OPTNs combined with HPTNs was determined by Annexin V-FITC staining and PI labelling."( Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancer.
Bao, X; Deng, S; Gao, D; Gao, M; Guan, X; Liu, H; Lv, L; Tian, Y; Wang, C; Xu, H; Zhang, C, 2016
)
1.88
" The cell apoptosis results indicated that OPTNs combined with HPTNs could induce HepG2 cell apoptosis and exert synergistic effects."( Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancer.
Bao, X; Deng, S; Gao, D; Gao, M; Guan, X; Liu, H; Lv, L; Tian, Y; Wang, C; Xu, H; Zhang, C, 2016
)
1.88
" It also inhibited daclatasvir-resistant mutant strains of HCV, especially in combination with daclatasvir."( Antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus.
Hou, MC; Huang, YH; Lan, KH; Lan, KL; Lee, WP; Liao, SX, 2019
)
0.51
" Cell viability and wound healing assays demonstrated that SSd combined with NRP-1 knockdown could significantly enhance the damage of HepG2."( Untargeted Metabolomics Study of the In Vitro Anti-Hepatoma Effect of Saikosaponin d in Combination with NRP-1 Knockdown.
Chen, Y; Hou, X; Li, R; Lv, Y; Sun, R; Tian, Y; Xu, F; Xu, L; Zhang, Q; Zhang, Z, 2019
)
0.51
" A UHPLC system couple with a quadrupole combined with time of flight mass spectrometer was used for qualitatively analyzing of the composition of SGZT and its metabolites in serum, urine, bile and feces of rats."( Metabolite profiling of Shuganzhi tablets in rats and pharmacokinetics study of four bioactive compounds with liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Guan, H; Han, H; Ju, Z; Li, G; Lin, J; Shi, M; Tang, J; Xu, Y; Zhang, T, 2021
)
0.62
" This study simulates the disease situation, establishes a high-fat and high-fructose-induced model induced by tert-butyl hydroperoxide (tBHP), and adopts nano-sized oleanolic acid combined with lipid-lowering ketones to explore improvement in the IR mechanism."( Effect of Nano-Oleanolic Acid Combined With Lipid-Lowering Ketones on Insulin Resistance in Rats with Gestational Diabetes.
Gu, J; Min, Z; Wang, R; Wang, S; Yan, Y, 2022
)
1.27

Bioavailability

A self-microemulsifying drug delivery system (SMEDDS) has been developed to enhance the solubility and oral bioavailability of oleanolic acid. The absorption rate constants of o Leanolic acid microemulsion and micelle were 0.15% in stomach.

ExcerptReferenceRelevance
" A-44, are essential for the appearance of 2 and 3 in the rat plasma and cumulative feces, since orally administered 1 was poorly absorbed from the gastrointestinal tract."( Metabolism and pharmacokinetics of orally administered saikosaponin b1 in conventional, germ-free and Eubacterium sp. A-44-infected gnotobiote rats.
Akao, T; Hattori, M; Kida, H; Meselhy, MR, 1998
)
0.3
"A human study was conducted to evaluate soyasaponin bioavailability in humans."( Soyasaponin I and sapongenol B have limited absorption by Caco-2 intestinal cells and limited bioavailability in women.
Hendrich, S; Hu, J; Murphy, PA; Reddy, MB, 2004
)
0.32
" Furthermore, the drug bioavailability was 181."( Preparation of enteric microsphere of oleanolic acid dihemiphthalate sodium by salting-out action using spherical crystallization technique.
Cui, FD; Fan, YL; Ji, YB; Yang, MS, 2005
)
0.6
" These studies, for the first time, demonstrate that a non-toxic hydrophilic lysinated derivative of betulonic acid and its solubility in a biocompatible aqueous medium has enhanced the bioavailability of the drug and has thus unleashed its full anti-prostate cancer activity."( Boc-lysinated-betulonic acid: a potent, anti-prostate cancer agent.
Bomshteyn, A; Hao, M; Katdare, M; Kisilis, E; Oktem, O; Rathnam, P; Saxena, BB; Zhu, L, 2006
)
0.33
"This study aims to formulate and evaluate bioavailability of a self-nanoemulsified drug delivery system (SNEDDS) of a poorly water-soluble herbal active component oleanolic acid (OA) for oral delivery."( Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid.
Chan, CK; Chang, Q; Meng, ZY; Sun, JB; Tong, HH; Wang, GN; Wang, YT; Xi, J; Zheng, Y, 2009
)
0.76
" Nitric oxide (NO) bioavailability is reduced by altered endothelial signal transduction or increased formation of radical oxygen species reacting with NO."( Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation.
Buus, NH; Dalsgaard, T; Rodriguez-Rodriguez, R; Simonsen, U; Stankevicius, E,
)
0.13
" Lancemaside A has a low bioavailability (1."( Murine metabolism and absorption of lancemaside A, an active compound in the roots of Codonopsis lanceolata.
Hayama, M; Ichikawa, M; Kodera, Y; Komoto, N; Kuroyanagi, M; Nakano, D; Nishihama, T; Ohta, S; Sekita, S; Shirota, O; Ushijima, M, 2010
)
0.36
" The bioavailability of the decoction and certain fractions, and the mode of cell death induced by these mixtures, were also investigated."( Cytotoxicity and bioavailability studies on a decoction of Oldenlandia diffusa and its fractions separated by HPLC.
Barker, J; Carew, M; Ganbold, M; Jones, L; Ma, R, 2010
)
0.36
" Relative to the SC-free formulation, the presence of SC in the formulation resulted in a significant increase in the in vivo absorption rate of OA while exerting no apparent impact on the extent of OA absorption."( Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.
Chan, HM; Chang, Q; Chow, AH; Du, Z; Lai, LC; Tong, HH; Wang, GN; Zheng, Y, 2011
)
0.58
"Preparing OA as SE-stabilized NS particles provides a novel method to enhance saturation solubility, in vitro dissolution rate, bioefficacy and in vivo bioavailability of free OA and/or other potentially useful hydrophobic drugs."( Formulation, biological and pharmacokinetic studies of sucrose ester-stabilized nanosuspensions of oleanolic Acid.
Das, S; Heng, PW; Li, W; Ng, KY, 2011
)
0.59
" The absolute oral bioavailability of β-amyrin in the crude plant extract was about fourfold higher than that in the suspension of pure form (3."( Quantification of α- and β-amyrin in rat plasma by gas chromatography-mass spectrometry: application to preclinical pharmacokinetic study.
Ching, J; Koh, HL; Lin, HS; Tan, CH, 2011
)
0.37
" Compounds that alter transport by one or both of these OATPs could potentially be used to target drugs to hepatocytes or improve the bioavailability of drugs that are cleared by the liver."( Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
Araya, JJ; Hagenbuch, B; Roth, M; Timmermann, BN, 2011
)
0.37
"The purposes of this study were to expand the structure of parent drugs selected for peptide transporter 1 (PepT1)-targeted ester prodrug design and to improve oral bioavailability of oleanolic acid (OA), a Biopharmaceutics Classification System (BCS) class IV drug."( Ethylene glycol-linked amino acid diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability and pharmacokinetics.
Cao, F; Gao, Y; Jia, J; Lai, Y; Ping, Q; Sha, L; Yin, Z; Zhang, Y, 2012
)
0.82
" Bardoxolone methyl is a potent, orally bioavailable Nrf-2 agonist."( A preliminary evaluation of bardoxolone methyl for the treatment of diabetic nephropathy.
Thomas, M, 2012
)
0.38
" However, its poor solubility and low bioavailability limit its use."( Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.
Gao, D; Tang, S; Tong, Q, 2012
)
1.82
" In this study, propylene glycol was used as a linker to further compare the effect of the type of linker on the stability, permeability, affinity, and bioavailability of the prodrugs of OA."( Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao, F; Fang, L; Gao, Y; Ping, Q; Wang, M, 2013
)
0.63
" For water-insoluble drugs, various formulation approaches are employed to enhance the solubility and bioavailability of lead compounds."( Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept.
Cai, Z; Cao, S; Hou, P; Lei, H; Ni, J; Tan, Q; Yu, F; Zhang, T, 2013
)
0.39
" A self-microemulsifying drug delivery system (SMEDDS) has been developed to enhance the solubility and oral bioavailability of oleanolic acid."( Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation.
Dou, J; Huang, X; Su, L; Yang, R; Zhai, G, 2013
)
0.82
" Oral bioavailability of T-OA microemulsion and oleic acid solution were checked by using rat model."( In-vitro and in-vivo comparison of T-OA microemulsions and solid dispersions based on EPDC.
Cai, Z; Cao, S; Hou, P; Lei, H; Liu, J; Liu, Y; Ni, J; Wang, P; Wang, Y; Zhang, T, 2015
)
0.42
"The bioavailability and absorption of soyasaponins and soyasapogenols remain unclear; therefore, the aim of this study was to evaluate plasma soyasaponin and soyasapogenol concentrations and absorption characteristics."( Comparison of bioavailability (I) between soyasaponins and soyasapogenols, and (II) between group A and B soyasaponins.
Kamo, S; Sato, T; Suzuki, S, 2014
)
0.4
"These results suggest that bioavailability of soyasapogenols is better than that of corresponding soyasaponins and that of group B soyasaponins is better than that of group A soyasaponins."( Comparison of bioavailability (I) between soyasaponins and soyasapogenols, and (II) between group A and B soyasaponins.
Kamo, S; Sato, T; Suzuki, S, 2014
)
0.4
" The NS showed much higher dissolution rate, cytotoxicity and bioavailability when compared with the free drug."( Development and evaluation of optimized sucrose ester stabilized oleanolic acid nanosuspensions prepared by wet ball milling with design of experiments.
Heng, PW; Li, W; Ng, KY, 2014
)
0.64
" The method was successfully applied to assess the pharmacokinetics and oral bioavailability of Pulsatilla saponin D in rats."( A rapid and sensitive LC-MS/MS method for the determination of Pulsatilla saponin D in rat plasma and its application in a rat pharmacokinetic and bioavailability study.
Feng, Y; Guo, Y; He, M; Huang, X; Jiang, H; Ouyang, H; Yang, S; Zhang, J; Zhou, X, 2015
)
0.42
" These results revealed that the C-3 position substitution pattern significantly affects the structure-affinity relationships of oleanane-type triterpenoid binding to BSA and further affects the bioavailability of triterpenoids in the blood circulatory system."( Spectroscopic analysis on structure-affinity relationship in the interactions of different oleanane-type triterpenoids with bovine serum albumin.
Hou, J; Li, Q; Shao, S; Wang, Z; Yue, Y, 2015
)
0.42
" Important aspects of olive oil triterpenoids such as bioavailability and clinical perspectives on cardiovascular disorder are also extensively analyzed."( Oleanolic acid and related triterpenoids from olives on vascular function: molecular mechanisms and therapeutic perspectives.
Rodriguez-Rodriguez, R, 2015
)
1.86
" The experimental results showed that the absorption rate constant, Ka value (B3, BD) and Permeability coefficient, Peff value (B3, B7) displayed significant difference (P <0."( [Intestinal absorption of pulchinenosides from Pulsatilla chinensis in rats].
Chen, ZH; Guan, ZY; Liu, YL; Song, YG; Su, D; Wang, M; Yang, SL; Zhang, L, 2015
)
0.42
" Because of their better bioavailability and their excellent anti-inflammatory profile in vitro, CDDO-2P-Im and CDDO-3P-Im were tested for prevention in a highly relevant mouse lung cancer model, in which A/J mice develop lung carcinomas after injection of vinyl carbamate, a potent carcinogen."( Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention.
Cao, M; Gribble, GW; Liby, KT; Onyango, EO; Royce, DB; Sporn, MB; Williams, CR, 2015
)
0.42
" Therefore, the effects of the orally bioavailable synthetic triterpenoid 2-cyano-3,12-dioxooleana- 1,9(11)-dien-28-oate-ethyl amide (CDDO-EA, RTA 405), which has potent antioxidative and antiinflammatory properties, was evaluated in a chronic carbon tetrachloride (CCl(4))-induced model of liver cirrhosis and hepatocellular carcinoma (HCC)."( The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury.
Cusimano, FA; Getachew, Y; Gopal, P; Reisman, SA; Shay, JW, 2016
)
0.43
" These are the reasons for the low oral bioavailability of OA which have restricted its wide application."( Dual strategies to improve oral bioavailability of oleanolic acid: Enhancing water-solubility, permeability and inhibiting cytochrome P450 isozymes.
Du, P; Jiang, Q; Yang, X; Zhang, H; Zhang, T, 2016
)
0.69
" These are reasons for the low bioavailability of OA which have restricted its wider application."( Pharmacokinetics in Vitro and in Vivo of Two Novel Prodrugs of Oleanolic Acid in Rats and Its Hepatoprotective Effects against Liver Injury Induced by CCl4.
Jiang, T; Li, G; Peng, W; Sun, W; Yu, R; Yu, Z, 2016
)
0.67
" Hederacoside C was quickly but inadequately absorbed from the gastrointestinal tract of rats resulting in extremely low bioavailability and relatively slow clearance."( An ultra-high-performance liquid chromatography-tandem mass spectrometric method for the determination of hederacoside C, a drug candidate for respiratory disorder, in rat plasma.
Choi, MS; Kim, IS; Kim, SH; Rehman, SU; Yoo, HH, 2016
)
0.43
" Still there have been only a few compounds which meet the need of sufficient hydro solubility and bioavailability along with higher anti-inflammatory activities."( Ursolic Acid and Oleanolic Acid: Pentacyclic Terpenoids with Promising Anti-Inflammatory Activities.
Kashyap, D; Punia, S; Sharma, A; Sharma, AK; Tuli, HS, 2016
)
0.77
" However, its medicinal applications were severely impeded by the poor water solubility and resultant low bioavailability and potency."( Solid inclusion complexes of oleanolic acid with amino-appended β-cyclodextrins (ACDs): Preparation, characterization, water solubility and anticancer activity.
Gao, K; Liao, X; Liu, Y; Niu, R; Ren, Y; Yang, B; Yang, Z; Zhang, J, 2016
)
0.73
" UA-medoxomil (NX-201), one of our UA prodrugs, showed an improved bioavailability about 200times better than UA in rodent model."( Discovery of ursolic acid prodrug (NX-201): Pharmacokinetics and in vivo antitumor effects in PANC-1 pancreatic cancer.
Chun, KH; Kim, J; Kim, Y; Lim, JW; Yoon, Y, 2016
)
0.43
" Nanotechnology can enhance solubility, stability, bioavailability and phytochemical delivery, improving the therapeutic efficiency of triterpenes."( Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments.
Günther, G; Morales, J; Rodríguez, L; Valdés, K, 2016
)
0.43
" However, OA, a Biopharmaceutics Classification System IV category drug, has low bioavailability owing to low solubility (<1 μg/mL) and biomembrane permeability."( Preparation, characterization, and in vitro/vivo studies of oleanolic acid-loaded lactoferrin nanoparticles.
Liu, H; Lv, H; Xia, X; Zhang, J; Zhao, Z; Zhou, J, 2017
)
0.7
" There are recent advances in the design and synthesis of chemical derivatives of OA to enhance its solubility, bioavailability and potency."( Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.
Ayeleso, TB; Matumba, MG; Mukwevho, E, 2017
)
1.9
" Together, this study provides the evidence that nano-OA can effectively improve HFF diet-induced metabolic dysfunctions in rats by improving its bioavailability and pharmacodynamic properties and thus nano-OA may be a potentially efficient agent to treat obesity-related diabetes and metabolic disorders."( Nano-oleanolic acid alleviates metabolic dysfunctions in rats with high fat and fructose diet.
Du, LB; Hai, CX; Jin, L; Li, WL; Liao, N; Pauluhn, J; Peng, J; Wang, S; Wang, X; Wang, Z; Zhang, JL; Zhao, YY, 2018
)
0.99
" The oral bioavailability of CA was ~1."( A rapid and sensitive UHPLC-MS/MS method for the determination of celosin A in rat plasma with application to pharmacokinetic study.
Cao, X; Shen, J; Song, J; Zhou, W, 2019
)
0.51
" However, the oral bioavailability of SGG was not obtained due to the extremely poor absorption in rats."( Pharmacokinetics and oral bioavailability studies of three saikogenins in rats using a validated UFLC-MS/MS method.
Fu, R; Liu, J; Ren, S; Song, R; Sun, J; Xue, Y; Zhang, Z, 2019
)
0.51
" Its low bioavailability justifies the search for more hydrophilic OA derivatives."( Morpholide derivative of the novel oleanolic oxime and succinic acid conjugate diminish the expression and activity of NF-κB and STATs in human hepatocellular carcinoma cells.
Baer-Dubowska, W; Bednarczyk-Cwynar, B; Krajka-Kuźniak, V; Narożna, M; Szaefer, H, 2019
)
0.51
" The results were verified by measuring the absolute bioavailability of the active ingredients."( Analysis of five active ingredients of Er-Zhi-Wan, a traditional Chinese medicine water-honeyed pill, using the biopharmaceutics classification system.
Cao, X; Deng, Y; Li, H; Ren, X; Wang, M, 2020
)
0.56
" OA-Leu SD showed higher relative oral bioavailability (189."( Preparation and evaluation of a novel solid dispersion using leucine as carrier.
Deng, J; Fan, Y; Hu, Y; Tan, Z; Xia, X, 2020
)
0.56
" MA bioavailability was greater than that of OA, and consumption of pentacyclic triterpenes was associated with improved endothelial function."( Pharmacokinetics of maslinic and oleanolic acids from olive oil - Effects on endothelial function in healthy adults. A randomized, controlled, dose-response study.
Biel, S; Carbó, M; Covas, MI; de la Torre, R; Díaz-Pellicer, P; Espejo, JA; Expósito, M; Fitó, M; Jimenez-Valladares, F; Mesa, MD; Pozo, O; Pujadas, M; Rosa, C; Sanchez-Rodriguez, E, 2020
)
0.84
"The side effects and low bioavailability of paclitaxel (PTX) limit its clinical application."( Paclitaxel and betulonic acid synergistically enhance antitumor efficacy by forming co-assembled nanoparticles.
Qiao, W; Wang, J; Yang, X; Zhao, H, 2020
)
0.56
" The bioavailability of 29 was significantly improved in comparison with its aglycon."( Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
Chen, C; Cheng, K; Dai, L; Hu, K; Li, H; Liu, L; Sun, H; Wen, X; Xu, Q; Yuan, H, 2021
)
0.86
" These techniques can improve the water solubility and bioavailability of oleanolic acid and lay a foundation for the new drug development."( Development and Evaluation of Oleanolic Acid Dosage Forms and Its Derivatives.
Bo, F; Feng, A; Li, L; Sun, Y; Yang, S; Zhang, L, 2020
)
1.08
" Therefore, our aim was to review current studies on the distribution of ursolic and oleanolic acids in plants, bioavailability and pharmacokinetic properties of these triterpenoids and their derivatives, and to discuss their neuroprotective effects in vitro and in vivo."( Ursolic and Oleanolic Acids: Plant Metabolites with Neuroprotective Potential.
Arandarcikaite, O; Bendokas, V; Gudoityte, E; Liobikas, J; Mazeikiene, I, 2021
)
1.22
" The other therapies like hormonal therapy, surgery, radiotherapy, and immune therapy are in use but showed many side effects like bioavailability issues, non-selectivity, pharmacokinetic-pharmacodynamic problems."( Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
Arya, GC; Jaitak, V; Kaur, K, 2021
)
0.62
" Considering the poor bioavailability and low toxicity of EsA, it is suitable as novel lead for the inhibitor against binding interactions of SARS-CoV-2 of S-protein and ACE2."( A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2).
Liu, JY; Wang, HX; Xu, PP; Yu, WD; Zeng, MS, 2021
)
0.62
" Nanomedicine has played a crucial role in improving the efficacy of treatment by controlling the release of pharmacologically active ingredients to increase bioavailability and achieve uniform and targeted delivery of drug."( Characterization and in vivo evaluation of nanoformulations in FCA induced rheumatoid arthritis in rats.
Aslam, B; Faisal, MN; Muhammad, F; Siddique, R, 2021
)
0.62
" Their oral absorption and bioavailability can be improved through structural modification and formulation design."( Corosolic acid and its structural analogs: A systematic review of their biological activities and underlying mechanism of action.
Chen, BN; Cheng, ZP; Ma, MY; Qian, XP; Sun, LN; Sun, SY; Wang, Y; Wang, YQ; Wu, ZD; Xing, C; Xing, WF; Zhang, XH, 2021
)
0.62
" Notably, QTS had much better oral bioavailability (F = 41."( Qi-Tai-Suan, an oleanolic acid derivative, ameliorates ischemic heart failure via suppression of cardiac apoptosis, inflammation and fibrosis.
Dai, L; Feng, ZQ; Hu, KW; Qian, M; Sun, HB; Sun, JZ; Zheng, RN, 2022
)
1.07
"Research suggests that soyasaponins are poorly absorbed in the GI tract and that soyasaponin aglycones or soyasapogenols are absorbed faster and in greater amounts than the corresponding soyasaponins."( The Fate and Intermediary Metabolism of Soyasapogenol in the Rat.
Pan, C; Yan, Y; Zhao, D, 2022
)
0.72
" However, its use in functional foods, dietary supplements, or nutraceuticals is hindered by limited human bioavailability studies."( Bioavailability and systemic transport of oleanolic acid in humans, formulated as a functional olive oil.
Castellano, JM; Cerrillo, I; Del Carmen Roque-Cuellar, M; Espinosa-Cabello, JM; García-González, A; García-Luna, PP; García-Rey, S; Jiménez-Andreu, MD; Jiménez-Sánchez, A; Mangas-Cruz, MÁ; Martínez-Ortega, AJ; Montero-Romero, E; Pereira-Cunill, JL; Perona, JS; Rivas-Melo, JJ; Rodríguez-Rodríguez, A; Romero-Báez, A; Ruíz-Trillo, CA, 2023
)
1.17

Dosage Studied

Oleanolic acid (OA) inhibits the growth of ras oncogene-transformed R6 cells at a dosage that is not toxic to the co-cultivated normal fibroblasts. Those predicted parameters may be useful in designing dosing schedules of oleanolic Acid in future clinical studies.

ExcerptRelevanceReference
" These rats were fed the diet containing 200 ppm of each test chemical for 5 weeks, starting 1 week before the first dosing of AOM."( Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Hara, A; Kawamori, T; Mori, H; Tanaka, T; Yamahara, J, 1995
)
0.29
" Plasma Zn concentration decreased after alpha-hederin treatment to a level approximately 75% of control at a dosage of 30 mumol/kg and 50% of control at 300 mumol/kg."( Altered Zn status by alpha-hederin in the pregnant rat and its relationship to adverse developmental outcome.
Baines, D; Daston, GP; Keen, CL; Lehman-McKeeman, LD; Overmann, GJ; Rogers, JM; Taubeneck, MW,
)
0.13
" The commercial health-supplemental foods of five companies were investigated for the contents of gymnemic acids as DAGA and there were large differences from 38 to 251 mg in the dosage per day recommended by each company."( [Quantitative analysis of deacylgymnemic acid by high-performance liquid chromatography].
Ishihara, S; Komoda, Y; Suzuki, K; Uchida, M, 1993
)
0.29
" The objective of this study was to determine whether dosing of alpha-hederin throughout organogenesis would result in a sustained elevation of maternal hepatic metallothionein and subsequent developmental abnormalities."( Repeated administration of alpha-hederin results in alterations in maternal zinc status and adverse developmental outcome in the rat.
Baines, D; Daston, GP; Duffy, JY; Keen, CL; Overmann, GJ, 1997
)
0.3
" The need for sustaining dosing may imply daily successive attacks of ETs in the cerebral vessel compartment after the introduction of autologous blood into the subarachnoid space."( Profiles of an intravenously available endothelin A-receptor antagonist, S-0139, for preventing cerebral vasospasm in a canine two-hemorrhage model.
Fujimoto, M; Hiramatsu, K; Kita, T; Kubo, K; Nakashima, T; Sakaki, T; Sato, S; Yonetani, Y, 1998
)
0.3
" berghei) the top dosage employed of 250 mg/kg/day was ineffective at reducing parasitaemia and exhibited some toxicity."( In vitro and in vivo evaluation of betulinic acid as an antimalarial.
Kirby, GC; Simmonds, MS; Steele, JC; Warhurst, DC, 1999
)
0.3
" In a dose-response study, compound 4 stimulated insulin production of INS-1 cells by 20."( Insulin secretion and cyclooxygenase enzyme inhibition by cabernet sauvignon grape skin compounds.
DeWitt, D; Jayaprakasam, B; Nair, MG; Olson, LK; Seeram, NP; Zhang, Y, 2004
)
0.32
" They displayed significant, dose-response vasodepressor effect and sinus bradicardia, most prominent for OA and MM."( Cardiotonic and antidysrhythmic effects of oleanolic and ursolic acids, methyl maslinate and uvaol.
Mipando, M; Shode, FO; Somova, LI, 2004
)
0.32
" These observations suggest that Meta050 at a dosage of 440 mg three times a day has a beneficial effect on pain in arthritis subjects."( A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia.
Bland, JS; Darland, G; Lerman, RH; Liska, D; Lukaczer, D; Schiltz, B; Tripp, M, 2005
)
0.54
" Dose-response studies showed that the growth inhibition seen at lower concentrations of CDDO correlated with induction of the tumor suppressor gene caveolin-1, which is known to inhibit breast cancer cell growth."( Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells.
Abdelrahim, M; Andreeff, M; Hung, MC; Johansen, M; Konopleva, M; Madden, T; McQueen, T; Munsell, MF; Safe, SH; Shi, YX; Tsao, T; Yu, D; Zhang, W, 2006
)
0.33
"Hepatic fibrosis models were induced by subcutaneous injection of CCl(4) at a dosage of 3 mL/kg in rats."( Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats.
Cheng, YA; Dang, SS; Li, ZF; Liu, ZG; Song, P; Wang, BF, 2007
)
0.34
" If mice were fed either the methyl ester or the ethyl amide derivative of the synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO-ME and CDDO-EA, respectively), beginning 1 week after dosing with carcinogen, the number, size, and severity of lung carcinomas were markedly reduced."( The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.
Dmitrovsky, E; Gribble, GW; Honda, T; Liby, K; Risingsong, R; Royce, DB; Sporn, MB; Sporn, TA; Williams, CR; Yore, MM, 2007
)
0.34
" Those predicted parameters of oleanolic acid may be useful in designing dosing schedules of oleanolic acid in future clinical studies."( Interspecies scaling of oleanolic acid in mice, rats, rabbits and dogs and prediction of human pharmacokinetics.
Jeong, DW; Ji, HY; Lee, HS; Park, EJ; Park, ES; Shin, BS; Yoo, SD, 2009
)
0.95
"Our data showed that among the samples tested, oleanolic acid (OA), but not the structural isomer ursolic acid (UA), inhibits the growth of ras oncogene-transformed R6 cells at a dosage that is not toxic to the co-cultivated normal fibroblasts."( Oleanolic acid isolated from Oldenlandia diffusa exhibits a unique growth inhibitory effect against ras-transformed fibroblasts.
Chi Shing Tai, W; Hsiao, WL; Liang, ZT; Wu, PK; Zhao, ZZ, 2009
)
2.05
" Wild-type and Nrf2-disrupted C57BL/6J female mice were dosed 3 times per week with 30 micromol/kg CDDO-Im or vehicle by oral gavage, during 95 days of access to a control diet or a high-fat diet."( Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.
Aja, S; Dolan, PM; Kensler, TW; Liby, KT; Shin, S; Sporn, MB; Wakabayashi, J; Wakabayashi, N; Yamamoto, M; Yates, MS, 2009
)
0.35
" The four diterpene acids dosed at 25 approximately 100 mg/kg had dose-dependently anti-asthmatic effects: 7-oxo-sandaracopimaric acid > 17-hydroxy-ent-kaur-15-en-19-oic acid > kaurenoic acid > hederagenin."( Inhibitory effects of diterpene acids from root of Aralia cordata on IgE-mediated asthma in guinea pigs.
Cho, JH; Kim, CJ; Lee, JY; Sim, SS; Whang, WK, 2010
)
0.36
" BLM group was similarly dosed with normal saline."( [Therapeutic effects and mechanism of saikosaponin-d in mice with bleomycin-induced pulmonary fibrosis].
Huang, ZJ; Lu, KQ; Tian, GR; Xia, DG; Zheng, JX, 2010
)
0.36
" The non-cytotoxic dosage of OA for primary adipocytes was established by MTT test."( [Oleanolic acid-stimulated lipolysis in primary adipocytes and its mechanisms].
Kong, T; Li, S; Li, Y; Sun, C, 2011
)
1.28
"6 mg/kg) was found to inhibit mammary carcinogenesis in a dose-response manner."( Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.
Bhatia, D; Bishayee, A; Mandal, A, 2014
)
0.4
" A lifetime cancer bioassay was undertaken in F344 rats dosed with AFB1 (200 μg/kg rat/day) for four weeks and receiving either vehicle or CDDO-Im (three times weekly), one week before and throughout the exposure period."( Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.
Baxter, VK; Egner, PA; Groopman, JD; Johnson, NM; Kensler, TW; Roebuck, BD; Sporn, MB; Sutter, TR; Wible, RS, 2014
)
0.4
" Using a DSS colitis model, mice were dosed orally with vehicle or CDDO-Im (20 mg/kg) over a 5-day period."( The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice.
Fitzpatrick, LR; Liby, KT; Small, JS; Stonesifer, E, 2014
)
0.4
" These findings suggest that this class of compound is worthy of further study to lessen diabetes complications but that dosage needs consideration."( Derivative of bardoxolone methyl, dh404, in an inverse dose-dependent manner lessens diabetes-associated atherosclerosis and improves diabetic kidney disease.
Cooper, ME; de Haan, JB; Karagiannis, TC; Meyer, C; Sharma, A; Stefanovic, N; Tan, SM; Ward, KW; Yuen, DY, 2014
)
0.4
" OPTN could be acted as a novel and new dosage form to be used in cancer treatment study."( A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
Bao, X; Chu, QC; Gao, M; Guan, X; Jiang, N; Liu, KX; Tian, Y; Xu, H; Zhang, CH, 2015
)
0.85
"The liquid self-emulsifying drug delivery system (L-SEDDS), commonly used to deliver effective but poorly water-soluble oleanolic acid (OA), has many limitations such as high manufacturing costs, few choices of dosage forms, risk of leakage from hard gelatin capsules, low stability, limited portability, incompatibility with capsule materials, and relatively restricted storage conditions."( Formulation and in vitro characterization of a novel solid lipid-based drug delivery system.
Chu, M; Fu, J; Itagaki, K; Ma, H; Sun, S; Wang, Y; Xin, P; Zhang, D; Zhou, X, 2014
)
0.61
" BARD at a dosage of 10mg/kg body weight was administered orally in drinking water."( Bardoxolone methyl prevents fat deposition and inflammation in the visceral fat of mice fed a high-fat diet.
Camer, D; Dinh, CH; Huang, XF; Szabo, A; Wang, H; Yu, Y, 2015
)
0.42
" The pharmacokinetic behaviors of oral dosage of QingGanSanJie decoctions were then studied in rats following the developed approach."( Simultaneous Determination of Oleanolic and Ursolic Acids in Rat Plasma by HPLC-MS: Application to a Pharmacokinetic Study After Oral Administration of Different Combinations of QingGanSanJie Decoction Extracts.
Chai, Y; Li, W; Li, Y; Lv, L; Wang, X; Xu, H; Zhang, G; Zhao, L, 2015
)
0.42
" In contrast, treatment with a high dh404 dosage intensified proteinuria, renal dysfunction, and histological abnormalities; amplified upregulation of NF-κB and fibrotic pathways; and suppressed the Nrf2 system."( Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease.
Farzaneh, SH; Khazaeli, M; Liu, S; Nazertehrani, S; Vaziri, ND; Zhao, YY, 2015
)
0.42
" When OA-4 was administered at a dosage of 500 mg/kg, the results revealed a significant inhibitory effects of DHBV at 19."( A Series of Oleanolic Acid Derivatives as Anti-Hepatitis B Virus Agents: Design, Synthesis, and in Vitro and in Vivo Biological Evaluation.
Chu, F; Gu, S; Lei, H; Li, B; Liang, M; Ren, J; Wang, P; Xu, B; Xu, X; Yan, W; Zhang, C, 2016
)
0.81
"The aim of the present study was to develop a novel dosage form of multivesicular liposomes for oleanolic acid (OA) to overcome its poor solubility, prolong therapeutic drug levels in the blood, and enhance the antitumor effect on hepatocellular carcinoma."( Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo.
Huang, J; Li, J; Liu, Z; Luo, Y; Sun, X; Xiong, D; Yu, X; Zhang, X; Zhong, Z, 2016
)
0.89
" The chemosensitization of HeLa cells to CP suggests a potential beneficial effect of OA in cervical cancer patients due to reduced CP dosage requirements, which requires further investigation."( Oleanolic acid attenuates cisplatin-induced nephrotoxicity in mice and chemosensitizes human cervical cancer cells to cisplatin cytotoxicity.
Domitrović, R; Potočnjak, I; Šimić, L; Vukelić, I, 2019
)
1.96
" Compared to the NTS control group, the middle dosage (10 mg/kg/day) of SSC significantly alleviated the development of nephritis based on urine protein measurements (34."( Utilizing methylglyoxal and D-lactate in urine to evaluate saikosaponin C treatment in mice with accelerated nephrotoxic serum nephritis.
Chen, BL; Chen, SM; Hua, SC; Lee, JA; Lee, TH; Lin, CE; Lin, CY; Lin, PY; Tsai, PY, 2020
)
0.56
" OA, LY294002 (a PI3K inhibitor), and OA combined with LY294002 were dosed to rats in 3 therapeutic groups, respectively."( Oleanolic Acid Improves the Symptom of Renal Ischemia Reperfusion Injury via the PI3K/AKT Pathway.
Li, X; Long, C; Yang, H; Yang, J, 2021
)
2.06
" Through the application of modern preparation techniques and methods, different oleanolic acid dosage forms and derivatives have been designed and synthesized."( Development and Evaluation of Oleanolic Acid Dosage Forms and Its Derivatives.
Bo, F; Feng, A; Li, L; Sun, Y; Yang, S; Zhang, L, 2020
)
1.07
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
pentacyclic triterpenoid
hydroxy monocarboxylic acidAny monocarboxylic acid which also contains a separate (alcoholic or phenolic) hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (48)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATAD5 protein, partialHomo sapiens (human)Potency23.09990.004110.890331.5287AID504467
TDP1 proteinHomo sapiens (human)Potency26.10110.000811.382244.6684AID686978; AID686979
chromobox protein homolog 1Homo sapiens (human)Potency50.11870.006026.168889.1251AID540317
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency26.67950.168316.404067.0158AID720504
gemininHomo sapiens (human)Potency0.51740.004611.374133.4983AID624297
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency28.18380.251215.843239.8107AID504327
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency22.38723.981146.7448112.2020AID720708
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Phosphotyrosine protein phosphatase Mycobacterium tuberculosisIC50 (µMol)19.36671.20005.04898.5114AID1354804; AID1541621; AID1591953
Aldo-keto reductase family 1 member B10Homo sapiens (human)IC50 (µMol)2.04500.00101.94459.6000AID697008; AID697009
Aldo-keto reductase family 1 member B10Homo sapiens (human)Ki1.07840.04602.16066.0000AID697012; AID697013; AID697014; AID697015; AID697016
Glycogen phosphorylase, muscle formOryctolagus cuniculus (rabbit)IC50 (µMol)16.44650.01405.93249.0000AID1800199; AID266475; AID404873; AID469220; AID603224; AID640379
Epidermal growth factor receptorHomo sapiens (human)IC50 (µMol)20.00000.00000.536910.0000AID1617466; AID1617467; AID1617468
Pancreatic alpha-amylaseSus scrofa (pig)IC50 (µMol)94.10001.35304.31088.9300AID1465050
Phospholipase A2Homo sapiens (human)IC50 (µMol)3.00000.00300.91223.9000AID697028
Prostaglandin G/H synthase 1Ovis aries (sheep)IC50 (µMol)42.00000.00032.177410.0000AID1617778
DNA polymerase betaHomo sapiens (human)IC50 (µMol)14.36601.40006.56679.0000AID328030; AID328031; AID356610; AID402569; AID697027
DNA polymerase betaRattus norvegicus (Norway rat)IC50 (µMol)5.60003.70006.20008.5000AID376695; AID376696
Receptor-type tyrosine-protein phosphatase CHomo sapiens (human)IC50 (µMol)1.00000.30002.757110.0000AID1430419
Receptor-type tyrosine-protein phosphatase FHomo sapiens (human)IC50 (µMol)33.37331.30002.66604.2300AID1275393; AID1310317; AID1800516; AID409689; AID687543
Tissue factorHomo sapiens (human)IC50 (µMol)0.00500.00010.734410.0000AID1436859
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)124.00000.00101.191310.0000AID697010
Tyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)IC50 (µMol)10.79000.70004.58049.4500AID1126806; AID1176098; AID1234943; AID1256604; AID1275390; AID1310311; AID1351465; AID1367384; AID1430418; AID1434741; AID1524963; AID1551280; AID1634005; AID1659876; AID1800516; AID1830871; AID1846779; AID409687
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)54.44030.00053.49849.7600AID1126804; AID1166644; AID1176097; AID1190699; AID1191561; AID1195229; AID1230554; AID1234944; AID1238547; AID1243368; AID1256603; AID1269249; AID1275389; AID1310309; AID1315356; AID1328330; AID1351464; AID1367376; AID1385463; AID1430417; AID1434743; AID1501174; AID1504114; AID1524958; AID1551277; AID1617004; AID1617643; AID1634004; AID1651328; AID1659870; AID1773062; AID1800516; AID1801408; AID1830870; AID1846778; AID265377; AID391031; AID409686; AID471324; AID633480; AID674353; AID687539; AID727120; AID740218; AID767560; AID776086
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)Ki6.00000.19004.83279.6000AID1166648; AID687544
Receptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)IC50 (µMol)40.00004.60004.60004.6000AID409690
Liver carboxylesterase 1Homo sapiens (human)IC50 (µMol)0.10000.00400.25510.6000AID1697439
Prostaglandin G/H synthase 1Homo sapiens (human)IC50 (µMol)380.00000.00021.557410.0000AID402403; AID403341
Low molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)IC50 (µMol)22.05002.86009.633617.2000AID1166646; AID1166647; AID687540; AID687541
Tyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)IC50 (µMol)34.33000.29002.20754.2300AID1275391; AID1310313; AID1800516; AID409688
M-phase inducer phosphatase 2Homo sapiens (human)IC50 (µMol)0.98000.10002.31039.5100AID1176099
Nitric oxide synthase, inducibleHomo sapiens (human)IC50 (µMol)40.00000.00022.319010.0000AID241425
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)179.25000.00010.995010.0000AID1617780; AID336477; AID402402; AID403340
Signal transducer and activator of transcription 3Homo sapiens (human)IC50 (µMol)50.00000.02304.13789.9800AID1378642
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)IC50 (µMol)120.00000.00030.71237.0700AID1275392
Dual specificity protein phosphatase 3Homo sapiens (human)IC50 (µMol)5.40004.00005.97508.5000AID1430420
Transcription factor p65Homo sapiens (human)IC50 (µMol)2.40000.00011.89818.8000AID1398545
Tyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)IC50 (µMol)34.43750.31804.00429.6000AID1275392; AID1310315; AID1800516
NAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)IC50 (µMol)70.00000.10003.38006.6000AID1873015
Protease Human immunodeficiency virus 1IC50 (µMol)41.13330.00000.81769.8500AID1075595; AID1540971; AID600424
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nuclear factor erythroid 2-related factor 2Homo sapiens (human)EC50 (µMol)18.90000.06002.61679.9000AID1378643
Env polyprotein Human immunodeficiency virus 1EC50 (µMol)100.00000.01010.18870.5420AID1161581
G-protein coupled bile acid receptor 1Homo sapiens (human)EC50 (µMol)2.25000.02372.52598.9000AID444761
Egl nine homolog 1Homo sapiens (human)EC50 (µMol)50.00006.11006.11006.1100AID1612308
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Pancreatic alpha-amylaseSus scrofa (pig)Kii95.80005.87005.87005.8700AID1465093
DNA topoisomerase 1Homo sapiens (human)Activity265.00000.10000.10000.1000AID1061261
DNA topoisomerase 2-alphaHomo sapiens (human)Activity275.80008.50008.50008.5000AID1061260
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (637)

Processvia Protein(s)Taxonomy
retinoid metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
farnesol catabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
cellular detoxification of aldehydeAldo-keto reductase family 1 member B10Homo sapiens (human)
cell surface receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell population proliferationEpidermal growth factor receptorHomo sapiens (human)
MAPK cascadeEpidermal growth factor receptorHomo sapiens (human)
ossificationEpidermal growth factor receptorHomo sapiens (human)
embryonic placenta developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein phosphorylationEpidermal growth factor receptorHomo sapiens (human)
hair follicle developmentEpidermal growth factor receptorHomo sapiens (human)
translationEpidermal growth factor receptorHomo sapiens (human)
signal transductionEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
activation of phospholipase C activityEpidermal growth factor receptorHomo sapiens (human)
salivary gland morphogenesisEpidermal growth factor receptorHomo sapiens (human)
midgut developmentEpidermal growth factor receptorHomo sapiens (human)
learning or memoryEpidermal growth factor receptorHomo sapiens (human)
circadian rhythmEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell population proliferationEpidermal growth factor receptorHomo sapiens (human)
diterpenoid metabolic processEpidermal growth factor receptorHomo sapiens (human)
peptidyl-tyrosine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
cerebral cortex cell migrationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell growthEpidermal growth factor receptorHomo sapiens (human)
lung developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell migrationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of superoxide anion generationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
response to cobalaminEpidermal growth factor receptorHomo sapiens (human)
response to hydroxyisoflavoneEpidermal growth factor receptorHomo sapiens (human)
cellular response to reactive oxygen speciesEpidermal growth factor receptorHomo sapiens (human)
peptidyl-tyrosine autophosphorylationEpidermal growth factor receptorHomo sapiens (human)
ERBB2-EGFR signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of protein catabolic processEpidermal growth factor receptorHomo sapiens (human)
vasodilationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of phosphorylationEpidermal growth factor receptorHomo sapiens (human)
ovulation cycleEpidermal growth factor receptorHomo sapiens (human)
hydrogen peroxide metabolic processEpidermal growth factor receptorHomo sapiens (human)
negative regulation of apoptotic processEpidermal growth factor receptorHomo sapiens (human)
positive regulation of MAP kinase activityEpidermal growth factor receptorHomo sapiens (human)
tongue developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA repairEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA replicationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of bone resorptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of vasoconstrictionEpidermal growth factor receptorHomo sapiens (human)
negative regulation of mitotic cell cycleEpidermal growth factor receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEpidermal growth factor receptorHomo sapiens (human)
regulation of JNK cascadeEpidermal growth factor receptorHomo sapiens (human)
symbiont entry into host cellEpidermal growth factor receptorHomo sapiens (human)
protein autophosphorylationEpidermal growth factor receptorHomo sapiens (human)
astrocyte activationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of fibroblast proliferationEpidermal growth factor receptorHomo sapiens (human)
digestive tract morphogenesisEpidermal growth factor receptorHomo sapiens (human)
positive regulation of smooth muscle cell proliferationEpidermal growth factor receptorHomo sapiens (human)
neuron projection morphogenesisEpidermal growth factor receptorHomo sapiens (human)
epithelial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of epithelial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
protein insertion into membraneEpidermal growth factor receptorHomo sapiens (human)
response to calcium ionEpidermal growth factor receptorHomo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicEpidermal growth factor receptorHomo sapiens (human)
positive regulation of glial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
morphogenesis of an epithelial foldEpidermal growth factor receptorHomo sapiens (human)
eyelid development in camera-type eyeEpidermal growth factor receptorHomo sapiens (human)
response to UV-AEpidermal growth factor receptorHomo sapiens (human)
positive regulation of mucus secretionEpidermal growth factor receptorHomo sapiens (human)
regulation of ERK1 and ERK2 cascadeEpidermal growth factor receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeEpidermal growth factor receptorHomo sapiens (human)
cellular response to amino acid stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to mechanical stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to cadmium ionEpidermal growth factor receptorHomo sapiens (human)
cellular response to epidermal growth factor stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to estradiol stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to xenobiotic stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to dexamethasone stimulusEpidermal growth factor receptorHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
liver regenerationEpidermal growth factor receptorHomo sapiens (human)
cell-cell adhesionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein kinase C activityEpidermal growth factor receptorHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleEpidermal growth factor receptorHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of prolactin secretionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of miRNA transcriptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein localization to plasma membraneEpidermal growth factor receptorHomo sapiens (human)
negative regulation of cardiocyte differentiationEpidermal growth factor receptorHomo sapiens (human)
neurogenesisEpidermal growth factor receptorHomo sapiens (human)
multicellular organism developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of kinase activityEpidermal growth factor receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
positive regulation of interleukin-8 productionPhospholipase A2Homo sapiens (human)
positive regulation of MAP kinase activityPhospholipase A2Homo sapiens (human)
innate immune response in mucosaPhospholipase A2Homo sapiens (human)
neutrophil mediated immunityPhospholipase A2Homo sapiens (human)
fatty acid biosynthetic processPhospholipase A2Homo sapiens (human)
actin filament organizationPhospholipase A2Homo sapiens (human)
signal transductionPhospholipase A2Homo sapiens (human)
positive regulation of cell population proliferationPhospholipase A2Homo sapiens (human)
positive regulation of calcium ion transport into cytosolPhospholipase A2Homo sapiens (human)
lipid catabolic processPhospholipase A2Homo sapiens (human)
leukotriene biosynthetic processPhospholipase A2Homo sapiens (human)
antibacterial humoral responsePhospholipase A2Homo sapiens (human)
neutrophil chemotaxisPhospholipase A2Homo sapiens (human)
activation of phospholipase A2 activityPhospholipase A2Homo sapiens (human)
cellular response to insulin stimulusPhospholipase A2Homo sapiens (human)
intracellular signal transductionPhospholipase A2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIPhospholipase A2Homo sapiens (human)
regulation of glucose importPhospholipase A2Homo sapiens (human)
phosphatidylcholine metabolic processPhospholipase A2Homo sapiens (human)
phosphatidylglycerol metabolic processPhospholipase A2Homo sapiens (human)
positive regulation of fibroblast proliferationPhospholipase A2Homo sapiens (human)
arachidonic acid secretionPhospholipase A2Homo sapiens (human)
positive regulation of protein secretionPhospholipase A2Homo sapiens (human)
positive regulation of immune responsePhospholipase A2Homo sapiens (human)
defense response to Gram-positive bacteriumPhospholipase A2Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityPhospholipase A2Homo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptidePhospholipase A2Homo sapiens (human)
positive regulation of podocyte apoptotic processPhospholipase A2Homo sapiens (human)
phospholipid metabolic processPhospholipase A2Homo sapiens (human)
nucleotide-excision repair, DNA gap fillingDNA polymerase betaHomo sapiens (human)
in utero embryonic developmentDNA polymerase betaHomo sapiens (human)
DNA-templated DNA replicationDNA polymerase betaHomo sapiens (human)
DNA repairDNA polymerase betaHomo sapiens (human)
base-excision repairDNA polymerase betaHomo sapiens (human)
base-excision repair, gap-fillingDNA polymerase betaHomo sapiens (human)
pyrimidine dimer repairDNA polymerase betaHomo sapiens (human)
inflammatory responseDNA polymerase betaHomo sapiens (human)
DNA damage responseDNA polymerase betaHomo sapiens (human)
salivary gland morphogenesisDNA polymerase betaHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageDNA polymerase betaHomo sapiens (human)
response to gamma radiationDNA polymerase betaHomo sapiens (human)
somatic hypermutation of immunoglobulin genesDNA polymerase betaHomo sapiens (human)
response to ethanolDNA polymerase betaHomo sapiens (human)
lymph node developmentDNA polymerase betaHomo sapiens (human)
spleen developmentDNA polymerase betaHomo sapiens (human)
homeostasis of number of cellsDNA polymerase betaHomo sapiens (human)
neuron apoptotic processDNA polymerase betaHomo sapiens (human)
response to hyperoxiaDNA polymerase betaHomo sapiens (human)
immunoglobulin heavy chain V-D-J recombinationDNA polymerase betaHomo sapiens (human)
DNA biosynthetic processDNA polymerase betaHomo sapiens (human)
double-strand break repair via nonhomologous end joiningDNA polymerase betaHomo sapiens (human)
MAPK cascadeReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
natural killer cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of T cell mediated cytotoxicityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of cytokine-mediated signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
hematopoietic progenitor cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of immunoglobulin productionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of humoral immune response mediated by circulating immunoglobulinReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of protein kinase activityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
protein dephosphorylationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of cell adhesion involved in substrate-bound cell migrationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
leukocyte cell-cell adhesionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
cell surface receptor signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
response to gamma radiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of gene expressionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
dephosphorylationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
B cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
T cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of B cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of protein autophosphorylationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of interleukin-8 productionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of interleukin-2 productionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of interleukin-2 productionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of tumor necrosis factor productionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
heterotypic cell-cell adhesionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
B cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of T cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
T cell activationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
gamma-delta T cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of MAPK cascadeReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
cell cycle phase transitionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive thymic T cell selectionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative thymic T cell selectionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of gamma-delta T cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of protein kinase activityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of receptor signaling pathway via JAK-STATReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
alpha-beta T cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of alpha-beta T cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of isotype switching to IgG isotypesReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
bone marrow developmentReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
stem cell developmentReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of peptidyl-tyrosine phosphorylationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of phagocytosisReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of phagocytosisReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of calcium-mediated signalingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
T cell receptor signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
B cell receptor signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of T cell receptor signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of antigen receptor-mediated signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
release of sequestered calcium ion into cytosolReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
defense response to virusReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of cell cycleReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of Fc receptor mediated stimulatory signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of protein tyrosine kinase activityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
extrinsic apoptotic signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of microglial cell activationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
response to aldosteroneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
DN2 thymocyte differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of hematopoietic stem cell migrationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of stem cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
cell adhesionReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
cell surface receptor protein tyrosine phosphatase signaling pathwayReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
cell migrationReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
neuron projection regenerationReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
peptidyl-tyrosine dephosphorylationReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
regulation of axon regenerationReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
synaptic membrane adhesionReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
negative regulation of receptor bindingReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
DNA topological changeDNA topoisomerase 1Homo sapiens (human)
chromatin remodelingDNA topoisomerase 1Homo sapiens (human)
circadian rhythmDNA topoisomerase 1Homo sapiens (human)
response to xenobiotic stimulusDNA topoisomerase 1Homo sapiens (human)
programmed cell deathDNA topoisomerase 1Homo sapiens (human)
phosphorylationDNA topoisomerase 1Homo sapiens (human)
peptidyl-serine phosphorylationDNA topoisomerase 1Homo sapiens (human)
circadian regulation of gene expressionDNA topoisomerase 1Homo sapiens (human)
embryonic cleavageDNA topoisomerase 1Homo sapiens (human)
chromosome segregationDNA topoisomerase 1Homo sapiens (human)
DNA replicationDNA topoisomerase 1Homo sapiens (human)
hematopoietic progenitor cell differentiationDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topological changeDNA topoisomerase 2-alphaHomo sapiens (human)
DNA ligationDNA topoisomerase 2-alphaHomo sapiens (human)
DNA damage responseDNA topoisomerase 2-alphaHomo sapiens (human)
chromosome segregationDNA topoisomerase 2-alphaHomo sapiens (human)
female meiotic nuclear divisionDNA topoisomerase 2-alphaHomo sapiens (human)
apoptotic chromosome condensationDNA topoisomerase 2-alphaHomo sapiens (human)
embryonic cleavageDNA topoisomerase 2-alphaHomo sapiens (human)
regulation of circadian rhythmDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of apoptotic processDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of single stranded viral RNA replication via double stranded DNA intermediateDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIDNA topoisomerase 2-alphaHomo sapiens (human)
rhythmic processDNA topoisomerase 2-alphaHomo sapiens (human)
negative regulation of DNA duplex unwindingDNA topoisomerase 2-alphaHomo sapiens (human)
resolution of meiotic recombination intermediatesDNA topoisomerase 2-alphaHomo sapiens (human)
sister chromatid segregationDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of gene expressionTissue factorHomo sapiens (human)
positive regulation of interleukin-8 productionTissue factorHomo sapiens (human)
positive regulation of endothelial cell proliferationTissue factorHomo sapiens (human)
activation of plasma proteins involved in acute inflammatory responseTissue factorHomo sapiens (human)
activation of blood coagulation via clotting cascadeTissue factorHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processTissue factorHomo sapiens (human)
blood coagulationTissue factorHomo sapiens (human)
positive regulation of platelet-derived growth factor receptor signaling pathwayTissue factorHomo sapiens (human)
protein processingTissue factorHomo sapiens (human)
positive regulation of cell migrationTissue factorHomo sapiens (human)
positive regulation of TOR signalingTissue factorHomo sapiens (human)
positive regulation of angiogenesisTissue factorHomo sapiens (human)
positive regulation of positive chemotaxisTissue factorHomo sapiens (human)
cytokine-mediated signaling pathwayTissue factorHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of tumor necrosis factor-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of lipid storageTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
B cell differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
T cell differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
erythrocyte differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of tyrosine phosphorylation of STAT proteinTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
glucose homeostasisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of macrophage differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of gluconeogenesisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of inflammatory responseTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of chemotaxisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
regulation of type II interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-6-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-2-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-4-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of macrophage colony-stimulating factor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of positive thymic T cell selectionTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
integrin-mediated signaling pathwayReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
insulin receptor signaling pathwayReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
modulation of chemical synaptic transmissionReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
regulation of focal adhesion assemblyReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
protein dephosphorylationReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
cholesterol biosynthetic processLiver carboxylesterase 1Homo sapiens (human)
cholesterol metabolic processLiver carboxylesterase 1Homo sapiens (human)
response to toxic substanceLiver carboxylesterase 1Homo sapiens (human)
positive regulation of cholesterol effluxLiver carboxylesterase 1Homo sapiens (human)
negative regulation of cholesterol storageLiver carboxylesterase 1Homo sapiens (human)
epithelial cell differentiationLiver carboxylesterase 1Homo sapiens (human)
cholesterol homeostasisLiver carboxylesterase 1Homo sapiens (human)
reverse cholesterol transportLiver carboxylesterase 1Homo sapiens (human)
medium-chain fatty acid metabolic processLiver carboxylesterase 1Homo sapiens (human)
regulation of bile acid biosynthetic processLiver carboxylesterase 1Homo sapiens (human)
cellular response to cholesterolLiver carboxylesterase 1Homo sapiens (human)
cellular response to low-density lipoprotein particle stimulusLiver carboxylesterase 1Homo sapiens (human)
cholesterol ester hydrolysis involved in cholesterol transportLiver carboxylesterase 1Homo sapiens (human)
positive regulation of cholesterol metabolic processLiver carboxylesterase 1Homo sapiens (human)
regulation of bile acid secretionLiver carboxylesterase 1Homo sapiens (human)
lipid catabolic processLiver carboxylesterase 1Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 1Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 1Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 1Homo sapiens (human)
regulation of cell population proliferationProstaglandin G/H synthase 1Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 1Homo sapiens (human)
protein dephosphorylationReceptor-type tyrosine-protein phosphatase epsilonHomo sapiens (human)
negative regulation of insulin receptor signaling pathwayReceptor-type tyrosine-protein phosphatase epsilonHomo sapiens (human)
MAPK cascadeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
hematopoietic progenitor cell differentiationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of humoral immune response mediated by circulating immunoglobulinTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
G protein-coupled receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
positive regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of angiogenesisTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytokine-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cell differentiationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
platelet formationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
T cell costimulationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of interleukin-6 productionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of tumor necrosis factor productionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of mast cell activation involved in immune responseTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
megakaryocyte developmentTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
T cell proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of T cell proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
natural killer cell mediated cytotoxicityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of apoptotic processTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of MAPK cascadeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of B cell differentiationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
platelet aggregationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of inflammatory response to woundingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
epididymis developmentTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of G1/S transition of mitotic cell cycleTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
intracellular signal transductionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
mitotic cell cycleTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
G2/M transition of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
oocyte maturationM-phase inducer phosphatase 2Homo sapiens (human)
protein phosphorylationM-phase inducer phosphatase 2Homo sapiens (human)
female meiosis IM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of cell population proliferationM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of cytokinesisM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
cell divisionM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of G2/MI transition of meiotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
response to hypoxiaNitric oxide synthase, inducibleHomo sapiens (human)
positive regulation of leukocyte mediated cytotoxicityNitric oxide synthase, inducibleHomo sapiens (human)
innate immune response in mucosaNitric oxide synthase, inducibleHomo sapiens (human)
arginine catabolic processNitric oxide synthase, inducibleHomo sapiens (human)
superoxide metabolic processNitric oxide synthase, inducibleHomo sapiens (human)
nitric oxide biosynthetic processNitric oxide synthase, inducibleHomo sapiens (human)
circadian rhythmNitric oxide synthase, inducibleHomo sapiens (human)
response to bacteriumNitric oxide synthase, inducibleHomo sapiens (human)
negative regulation of gene expressionNitric oxide synthase, inducibleHomo sapiens (human)
peptidyl-cysteine S-nitrosylationNitric oxide synthase, inducibleHomo sapiens (human)
prostaglandin secretionNitric oxide synthase, inducibleHomo sapiens (human)
positive regulation of interleukin-6 productionNitric oxide synthase, inducibleHomo sapiens (human)
positive regulation of interleukin-8 productionNitric oxide synthase, inducibleHomo sapiens (human)
regulation of cell population proliferationNitric oxide synthase, inducibleHomo sapiens (human)
negative regulation of protein catabolic processNitric oxide synthase, inducibleHomo sapiens (human)
defense response to bacteriumNitric oxide synthase, inducibleHomo sapiens (human)
regulation of cellular respirationNitric oxide synthase, inducibleHomo sapiens (human)
cell redox homeostasisNitric oxide synthase, inducibleHomo sapiens (human)
regulation of insulin secretionNitric oxide synthase, inducibleHomo sapiens (human)
defense response to Gram-negative bacteriumNitric oxide synthase, inducibleHomo sapiens (human)
positive regulation of killing of cells of another organismNitric oxide synthase, inducibleHomo sapiens (human)
cellular response to lipopolysaccharideNitric oxide synthase, inducibleHomo sapiens (human)
cellular response to type II interferonNitric oxide synthase, inducibleHomo sapiens (human)
cellular response to xenobiotic stimulusNitric oxide synthase, inducibleHomo sapiens (human)
regulation of cytokine production involved in inflammatory responseNitric oxide synthase, inducibleHomo sapiens (human)
negative regulation of blood pressureNitric oxide synthase, inducibleHomo sapiens (human)
response to hormoneNitric oxide synthase, inducibleHomo sapiens (human)
nitric oxide mediated signal transductionNitric oxide synthase, inducibleHomo sapiens (human)
response to lipopolysaccharideNitric oxide synthase, inducibleHomo sapiens (human)
inflammatory responseNitric oxide synthase, inducibleHomo sapiens (human)
positive regulation of guanylate cyclase activityNitric oxide synthase, inducibleHomo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionSignal transducer and activator of transcription 3Homo sapiens (human)
negative regulation of transcription by RNA polymerase IISignal transducer and activator of transcription 3Homo sapiens (human)
temperature homeostasisSignal transducer and activator of transcription 3Homo sapiens (human)
eye photoreceptor cell differentiationSignal transducer and activator of transcription 3Homo sapiens (human)
regulation of DNA-templated transcriptionSignal transducer and activator of transcription 3Homo sapiens (human)
regulation of transcription by RNA polymerase IISignal transducer and activator of transcription 3Homo sapiens (human)
protein import into nucleusSignal transducer and activator of transcription 3Homo sapiens (human)
inflammatory responseSignal transducer and activator of transcription 3Homo sapiens (human)
signal transductionSignal transducer and activator of transcription 3Homo sapiens (human)
transforming growth factor beta receptor signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATSignal transducer and activator of transcription 3Homo sapiens (human)
nervous system developmentSignal transducer and activator of transcription 3Homo sapiens (human)
cell population proliferationSignal transducer and activator of transcription 3Homo sapiens (human)
negative regulation of cell population proliferationSignal transducer and activator of transcription 3Homo sapiens (human)
negative regulation of autophagySignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of gene expressionSignal transducer and activator of transcription 3Homo sapiens (human)
negative regulation of gene expressionSignal transducer and activator of transcription 3Homo sapiens (human)
phosphorylationSignal transducer and activator of transcription 3Homo sapiens (human)
cytokine-mediated signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
sexual reproductionSignal transducer and activator of transcription 3Homo sapiens (human)
cell differentiationSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of cell migrationSignal transducer and activator of transcription 3Homo sapiens (human)
intracellular receptor signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
response to estradiolSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of interleukin-1 beta productionSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of interleukin-10 productionSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of interleukin-6 productionSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of interleukin-8 productionSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of tumor necrosis factor productionSignal transducer and activator of transcription 3Homo sapiens (human)
cellular response to hormone stimulusSignal transducer and activator of transcription 3Homo sapiens (human)
leptin-mediated signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
somatic stem cell population maintenanceSignal transducer and activator of transcription 3Homo sapiens (human)
interleukin-15-mediated signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
interleukin-2-mediated signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
interleukin-9-mediated signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
interleukin-11-mediated signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
regulation of multicellular organism growthSignal transducer and activator of transcription 3Homo sapiens (human)
glucose homeostasisSignal transducer and activator of transcription 3Homo sapiens (human)
eating behaviorSignal transducer and activator of transcription 3Homo sapiens (human)
mRNA transcription by RNA polymerase IISignal transducer and activator of transcription 3Homo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionSignal transducer and activator of transcription 3Homo sapiens (human)
cellular response to leptin stimulusSignal transducer and activator of transcription 3Homo sapiens (human)
response to leptinSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of erythrocyte differentiationSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of Notch signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of angiogenesisSignal transducer and activator of transcription 3Homo sapiens (human)
negative regulation of glycolytic processSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of DNA-templated transcriptionSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of transcription by RNA polymerase IISignal transducer and activator of transcription 3Homo sapiens (human)
astrocyte differentiationSignal transducer and activator of transcription 3Homo sapiens (human)
negative regulation of inflammatory responseSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activitySignal transducer and activator of transcription 3Homo sapiens (human)
regulation of cell cycleSignal transducer and activator of transcription 3Homo sapiens (human)
radial glial cell differentiationSignal transducer and activator of transcription 3Homo sapiens (human)
retinal rod cell differentiationSignal transducer and activator of transcription 3Homo sapiens (human)
regulation of feeding behaviorSignal transducer and activator of transcription 3Homo sapiens (human)
growth hormone receptor signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATSignal transducer and activator of transcription 3Homo sapiens (human)
interleukin-6-mediated signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
T-helper 17 type immune responseSignal transducer and activator of transcription 3Homo sapiens (human)
T-helper 17 cell lineage commitmentSignal transducer and activator of transcription 3Homo sapiens (human)
energy homeostasisSignal transducer and activator of transcription 3Homo sapiens (human)
cellular response to interleukin-17Signal transducer and activator of transcription 3Homo sapiens (human)
cell surface receptor signaling pathway via STATSignal transducer and activator of transcription 3Homo sapiens (human)
negative regulation of inflammatory response to woundingSignal transducer and activator of transcription 3Homo sapiens (human)
interleukin-10-mediated signaling pathwaySignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of cytokine production involved in inflammatory responseSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of miRNA transcriptionSignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of metalloendopeptidase activitySignal transducer and activator of transcription 3Homo sapiens (human)
positive regulation of vascular endothelial cell proliferationSignal transducer and activator of transcription 3Homo sapiens (human)
negative regulation of primary miRNA processingSignal transducer and activator of transcription 3Homo sapiens (human)
negative regulation of stem cell differentiationSignal transducer and activator of transcription 3Homo sapiens (human)
negative regulation of neuron migrationSignal transducer and activator of transcription 3Homo sapiens (human)
regulation of cell population proliferationSignal transducer and activator of transcription 3Homo sapiens (human)
response to peptide hormoneSignal transducer and activator of transcription 3Homo sapiens (human)
defense responseSignal transducer and activator of transcription 3Homo sapiens (human)
dephosphorylationDual specificity protein phosphatase 3Homo sapiens (human)
negative regulation of cell migrationDual specificity protein phosphatase 3Homo sapiens (human)
peptidyl-tyrosine dephosphorylationDual specificity protein phosphatase 3Homo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayDual specificity protein phosphatase 3Homo sapiens (human)
negative regulation of MAPK cascadeDual specificity protein phosphatase 3Homo sapiens (human)
positive regulation of mitotic cell cycleDual specificity protein phosphatase 3Homo sapiens (human)
negative regulation of JNK cascadeDual specificity protein phosphatase 3Homo sapiens (human)
negative regulation of T cell receptor signaling pathwayDual specificity protein phosphatase 3Homo sapiens (human)
negative regulation of T cell activationDual specificity protein phosphatase 3Homo sapiens (human)
negative regulation of chemotaxisDual specificity protein phosphatase 3Homo sapiens (human)
regulation of focal adhesion assemblyDual specificity protein phosphatase 3Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeDual specificity protein phosphatase 3Homo sapiens (human)
cellular response to epidermal growth factor stimulusDual specificity protein phosphatase 3Homo sapiens (human)
positive regulation of focal adhesion disassemblyDual specificity protein phosphatase 3Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityDual specificity protein phosphatase 3Homo sapiens (human)
positive regulation of interleukin-1 beta productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-6 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-8 productionTranscription factor p65Homo sapiens (human)
positive regulation of amyloid-beta formationTranscription factor p65Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityTranscription factor p65Homo sapiens (human)
nucleotide-binding oligomerization domain containing 2 signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
liver developmentTranscription factor p65Homo sapiens (human)
hair follicle developmentTranscription factor p65Homo sapiens (human)
defense response to tumor cellTranscription factor p65Homo sapiens (human)
response to ischemiaTranscription factor p65Homo sapiens (human)
acetaldehyde metabolic processTranscription factor p65Homo sapiens (human)
chromatin organizationTranscription factor p65Homo sapiens (human)
DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
inflammatory responseTranscription factor p65Homo sapiens (human)
cellular defense responseTranscription factor p65Homo sapiens (human)
neuropeptide signaling pathwayTranscription factor p65Homo sapiens (human)
canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
positive regulation of cell population proliferationTranscription factor p65Homo sapiens (human)
response to xenobiotic stimulusTranscription factor p65Homo sapiens (human)
animal organ morphogenesisTranscription factor p65Homo sapiens (human)
response to UV-BTranscription factor p65Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionTranscription factor p65Homo sapiens (human)
positive regulation of gene expressionTranscription factor p65Homo sapiens (human)
positive regulation of Schwann cell differentiationTranscription factor p65Homo sapiens (human)
negative regulation of angiogenesisTranscription factor p65Homo sapiens (human)
cytokine-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
protein catabolic processTranscription factor p65Homo sapiens (human)
response to muramyl dipeptideTranscription factor p65Homo sapiens (human)
response to progesteroneTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-12 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-6 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-8 productionTranscription factor p65Homo sapiens (human)
response to insulinTranscription factor p65Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of protein sumoylationTranscription factor p65Homo sapiens (human)
response to cobalaminTranscription factor p65Homo sapiens (human)
toll-like receptor 4 signaling pathwayTranscription factor p65Homo sapiens (human)
intracellular signal transductionTranscription factor p65Homo sapiens (human)
cellular response to hepatocyte growth factor stimulusTranscription factor p65Homo sapiens (human)
response to muscle stretchTranscription factor p65Homo sapiens (human)
non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
vascular endothelial growth factor signaling pathwayTranscription factor p65Homo sapiens (human)
prolactin signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of protein catabolic processTranscription factor p65Homo sapiens (human)
negative regulation of apoptotic processTranscription factor p65Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
response to amino acidTranscription factor p65Homo sapiens (human)
negative regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTranscription factor p65Homo sapiens (human)
regulation of inflammatory responseTranscription factor p65Homo sapiens (human)
positive regulation of T cell receptor signaling pathwayTranscription factor p65Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityTranscription factor p65Homo sapiens (human)
response to cAMPTranscription factor p65Homo sapiens (human)
defense response to virusTranscription factor p65Homo sapiens (human)
cellular response to hydrogen peroxideTranscription factor p65Homo sapiens (human)
interleukin-1-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
response to interleukin-1Transcription factor p65Homo sapiens (human)
cellular response to lipopolysaccharideTranscription factor p65Homo sapiens (human)
cellular response to lipoteichoic acidTranscription factor p65Homo sapiens (human)
cellular response to peptidoglycanTranscription factor p65Homo sapiens (human)
cellular response to nicotineTranscription factor p65Homo sapiens (human)
cellular response to interleukin-1Transcription factor p65Homo sapiens (human)
cellular response to interleukin-6Transcription factor p65Homo sapiens (human)
cellular response to tumor necrosis factorTranscription factor p65Homo sapiens (human)
postsynapse to nucleus signaling pathwayTranscription factor p65Homo sapiens (human)
antiviral innate immune responseTranscription factor p65Homo sapiens (human)
negative regulation of non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
negative regulation of miRNA transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of miRNA transcriptionTranscription factor p65Homo sapiens (human)
cellular response to angiotensinTranscription factor p65Homo sapiens (human)
positive regulation of leukocyte adhesion to vascular endothelial cellTranscription factor p65Homo sapiens (human)
positive regulation of miRNA metabolic processTranscription factor p65Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayTranscription factor p65Homo sapiens (human)
cellular response to stressTranscription factor p65Homo sapiens (human)
response to cytokineTranscription factor p65Homo sapiens (human)
innate immune responseTranscription factor p65Homo sapiens (human)
DNA damage checkpoint signalingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
triglyceride metabolic processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
epidermal growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
integrin-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
axonogenesisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
brain developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
heart developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
fibroblast growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
hormone-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytokine-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cerebellar cortex formationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
platelet formationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
T cell costimulationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of chondrocyte differentiationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of type I interferon productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
microvillus organizationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of interferon-beta productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of interleukin-6 productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of tumor necrosis factor productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
multicellular organism growthTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
organ growthTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
megakaryocyte developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
atrioventricular canal developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
ERBB signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
hormone metabolic processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
glucose homeostasisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of protein-containing complex assemblyTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of ossificationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of mitotic cell cycleTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of glucose importTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of insulin secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of protein export from nucleusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of hormone secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
neurotrophin TRK receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
ephrin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
multicellular organismal reproductive processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
genitalia developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
inner ear developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
homeostasis of number of cells within a tissueTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of cortisol secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
Bergmann glial cell differentiationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of growth hormone secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
face morphogenesisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
intestinal epithelial cell migrationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cellular response to epidermal growth factor stimulusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
response to ischemiaNuclear factor erythroid 2-related factor 2Homo sapiens (human)
regulation of transcription by RNA polymerase IINuclear factor erythroid 2-related factor 2Homo sapiens (human)
inflammatory responseNuclear factor erythroid 2-related factor 2Homo sapiens (human)
response to oxidative stressNuclear factor erythroid 2-related factor 2Homo sapiens (human)
proteasomal ubiquitin-independent protein catabolic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of gene expressionNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of cardiac muscle cell apoptotic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of neuron projection developmentNuclear factor erythroid 2-related factor 2Homo sapiens (human)
protein ubiquitinationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of blood coagulationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
endoplasmic reticulum unfolded protein responseNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to oxidative stressNuclear factor erythroid 2-related factor 2Homo sapiens (human)
PERK-mediated unfolded protein responseNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to glucose starvationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
regulation of innate immune responseNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cell redox homeostasisNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of angiogenesisNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IINuclear factor erythroid 2-related factor 2Homo sapiens (human)
regulation of embryonic developmentNuclear factor erythroid 2-related factor 2Homo sapiens (human)
aflatoxin catabolic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of glucose importNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to hydrogen peroxideNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to copper ionNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to tumor necrosis factorNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to hypoxiaNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to xenobiotic stimulusNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to fluid shear stressNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to laminar fluid shear stressNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of ferroptosisNuclear factor erythroid 2-related factor 2Homo sapiens (human)
integrated stress response signalingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of cellular response to hypoxiaNuclear factor erythroid 2-related factor 2Homo sapiens (human)
regulation of cellular response to oxidative stressNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of hematopoietic stem cell differentiationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathwayNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of glutathione biosynthetic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of ERAD pathwayNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to angiotensinNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of vascular associated smooth muscle cell migrationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of ubiquitin-dependent protein catabolic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
regulation of removal of superoxide radicalsNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of endothelial cell apoptotic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cell surface bile acid receptor signaling pathwayG-protein coupled bile acid receptor 1Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeG-protein coupled bile acid receptor 1Homo sapiens (human)
cellular response to bile acidG-protein coupled bile acid receptor 1Homo sapiens (human)
positive regulation of cholangiocyte proliferationG-protein coupled bile acid receptor 1Homo sapiens (human)
regulation of bicellular tight junction assemblyG-protein coupled bile acid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayG-protein coupled bile acid receptor 1Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of cell growthProlyl hydroxylase EGLN2Homo sapiens (human)
response to hypoxiaProlyl hydroxylase EGLN2Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl hydroxylase EGLN2Homo sapiens (human)
intracellular estrogen receptor signaling pathwayProlyl hydroxylase EGLN2Homo sapiens (human)
regulation of neuron apoptotic processProlyl hydroxylase EGLN2Homo sapiens (human)
cell redox homeostasisProlyl hydroxylase EGLN2Homo sapiens (human)
positive regulation of protein catabolic processProlyl hydroxylase EGLN2Homo sapiens (human)
cellular response to hypoxiaProlyl hydroxylase EGLN2Homo sapiens (human)
response to hypoxiaEgl nine homolog 1Homo sapiens (human)
intracellular iron ion homeostasisEgl nine homolog 1Homo sapiens (human)
intracellular oxygen homeostasisEgl nine homolog 1Homo sapiens (human)
negative regulation of DNA-binding transcription factor activityEgl nine homolog 1Homo sapiens (human)
regulation of angiogenesisEgl nine homolog 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIEgl nine homolog 1Homo sapiens (human)
negative regulation of cyclic-nucleotide phosphodiesterase activityEgl nine homolog 1Homo sapiens (human)
cardiac muscle tissue morphogenesisEgl nine homolog 1Homo sapiens (human)
heart trabecula formationEgl nine homolog 1Homo sapiens (human)
ventricular septum morphogenesisEgl nine homolog 1Homo sapiens (human)
labyrinthine layer developmentEgl nine homolog 1Homo sapiens (human)
response to nitric oxideEgl nine homolog 1Homo sapiens (human)
regulation of modification of postsynaptic structureEgl nine homolog 1Homo sapiens (human)
regulation protein catabolic process at postsynapseEgl nine homolog 1Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineEgl nine homolog 1Homo sapiens (human)
cellular response to hypoxiaEgl nine homolog 1Homo sapiens (human)
response to hypoxiaProlyl hydroxylase EGLN3Homo sapiens (human)
apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
DNA damage responseProlyl hydroxylase EGLN3Homo sapiens (human)
protein hydroxylationProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of cell population proliferationProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of neuron apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
cellular response to hypoxiaProlyl hydroxylase EGLN3Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl hydroxylase EGLN3Homo sapiens (human)
protein deacetylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein deacetylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
mitochondrion organizationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
regulation of ketone biosynthetic processNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
negative regulation of cardiac muscle cell apoptotic processNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
response to nutrient levelsNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein demalonylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
peptidyl-lysine demalonylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein desuccinylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
peptidyl-lysine desuccinylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein deglutarylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
negative regulation of reactive oxygen species metabolic processNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
epigenetic regulation of gene expressionNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
regulation of erythrocyte differentiationTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (165)

Processvia Protein(s)Taxonomy
retinal dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldo-keto reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B10Homo sapiens (human)
alcohol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
geranylgeranyl reductase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
indanol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
epidermal growth factor receptor activityEpidermal growth factor receptorHomo sapiens (human)
virus receptor activityEpidermal growth factor receptorHomo sapiens (human)
chromatin bindingEpidermal growth factor receptorHomo sapiens (human)
double-stranded DNA bindingEpidermal growth factor receptorHomo sapiens (human)
MAP kinase kinase kinase activityEpidermal growth factor receptorHomo sapiens (human)
protein tyrosine kinase activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane signaling receptor activityEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor activityEpidermal growth factor receptorHomo sapiens (human)
integrin bindingEpidermal growth factor receptorHomo sapiens (human)
protein bindingEpidermal growth factor receptorHomo sapiens (human)
calmodulin bindingEpidermal growth factor receptorHomo sapiens (human)
ATP bindingEpidermal growth factor receptorHomo sapiens (human)
enzyme bindingEpidermal growth factor receptorHomo sapiens (human)
kinase bindingEpidermal growth factor receptorHomo sapiens (human)
protein kinase bindingEpidermal growth factor receptorHomo sapiens (human)
protein phosphatase bindingEpidermal growth factor receptorHomo sapiens (human)
protein tyrosine kinase activator activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activator activityEpidermal growth factor receptorHomo sapiens (human)
ubiquitin protein ligase bindingEpidermal growth factor receptorHomo sapiens (human)
identical protein bindingEpidermal growth factor receptorHomo sapiens (human)
cadherin bindingEpidermal growth factor receptorHomo sapiens (human)
actin filament bindingEpidermal growth factor receptorHomo sapiens (human)
ATPase bindingEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor bindingEpidermal growth factor receptorHomo sapiens (human)
phospholipase A2 activityPhospholipase A2Homo sapiens (human)
signaling receptor bindingPhospholipase A2Homo sapiens (human)
calcium ion bindingPhospholipase A2Homo sapiens (human)
bile acid bindingPhospholipase A2Homo sapiens (human)
calcium-dependent phospholipase A2 activityPhospholipase A2Homo sapiens (human)
phospholipid bindingPhospholipase A2Homo sapiens (human)
damaged DNA bindingDNA polymerase betaHomo sapiens (human)
DNA-directed DNA polymerase activityDNA polymerase betaHomo sapiens (human)
DNA-(apurinic or apyrimidinic site) endonuclease activityDNA polymerase betaHomo sapiens (human)
protein bindingDNA polymerase betaHomo sapiens (human)
microtubule bindingDNA polymerase betaHomo sapiens (human)
lyase activityDNA polymerase betaHomo sapiens (human)
enzyme bindingDNA polymerase betaHomo sapiens (human)
metal ion bindingDNA polymerase betaHomo sapiens (human)
5'-deoxyribose-5-phosphate lyase activityDNA polymerase betaHomo sapiens (human)
class I DNA-(apurinic or apyrimidinic site) endonuclease activityDNA polymerase betaHomo sapiens (human)
protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
signaling receptor bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
protein bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
heparin bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
protein kinase bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
ankyrin bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
spectrin bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
heparan sulfate proteoglycan bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
heparin bindingReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
chondroitin sulfate proteoglycan bindingReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
protein-containing complex bindingReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
cell adhesion molecule bindingReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA bindingDNA topoisomerase 1Homo sapiens (human)
chromatin bindingDNA topoisomerase 1Homo sapiens (human)
double-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
single-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
RNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA topoisomerase type I (single strand cut, ATP-independent) activityDNA topoisomerase 1Homo sapiens (human)
protein serine/threonine kinase activityDNA topoisomerase 1Homo sapiens (human)
protein bindingDNA topoisomerase 1Homo sapiens (human)
ATP bindingDNA topoisomerase 1Homo sapiens (human)
DNA binding, bendingDNA topoisomerase 1Homo sapiens (human)
protein domain specific bindingDNA topoisomerase 1Homo sapiens (human)
supercoiled DNA bindingDNA topoisomerase 1Homo sapiens (human)
magnesium ion bindingDNA topoisomerase 2-alphaHomo sapiens (human)
DNA bindingDNA topoisomerase 2-alphaHomo sapiens (human)
chromatin bindingDNA topoisomerase 2-alphaHomo sapiens (human)
RNA bindingDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activityDNA topoisomerase 2-alphaHomo sapiens (human)
protein kinase C bindingDNA topoisomerase 2-alphaHomo sapiens (human)
protein bindingDNA topoisomerase 2-alphaHomo sapiens (human)
ATP bindingDNA topoisomerase 2-alphaHomo sapiens (human)
ATP-dependent activity, acting on DNADNA topoisomerase 2-alphaHomo sapiens (human)
DNA binding, bendingDNA topoisomerase 2-alphaHomo sapiens (human)
protein homodimerization activityDNA topoisomerase 2-alphaHomo sapiens (human)
ubiquitin bindingDNA topoisomerase 2-alphaHomo sapiens (human)
protein heterodimerization activityDNA topoisomerase 2-alphaHomo sapiens (human)
serine-type endopeptidase activityTissue factorHomo sapiens (human)
protease bindingTissue factorHomo sapiens (human)
protein bindingTissue factorHomo sapiens (human)
phospholipid bindingTissue factorHomo sapiens (human)
cytokine receptor activityTissue factorHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
integrin bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
syntaxin bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
STAT family protein bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
protein bindingReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
sterol esterase activityLiver carboxylesterase 1Homo sapiens (human)
methylumbelliferyl-acetate deacetylase activityLiver carboxylesterase 1Homo sapiens (human)
carboxylesterase activityLiver carboxylesterase 1Homo sapiens (human)
carboxylic ester hydrolase activityLiver carboxylesterase 1Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 1Homo sapiens (human)
protein bindingProstaglandin G/H synthase 1Homo sapiens (human)
heme bindingProstaglandin G/H synthase 1Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 1Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 1Homo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase epsilonHomo sapiens (human)
protein bindingReceptor-type tyrosine-protein phosphatase epsilonHomo sapiens (human)
protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase epsilonHomo sapiens (human)
acid phosphatase activityLow molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)
protein tyrosine phosphatase activityLow molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityLow molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)
protein bindingLow molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
SH3 domain bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
SH2 domain bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cell adhesion molecule bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
phosphorylation-dependent protein bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
phosphoprotein phosphatase activityM-phase inducer phosphatase 2Homo sapiens (human)
protein tyrosine phosphatase activityM-phase inducer phosphatase 2Homo sapiens (human)
protein bindingM-phase inducer phosphatase 2Homo sapiens (human)
protein kinase bindingM-phase inducer phosphatase 2Homo sapiens (human)
nitric-oxide synthase activityNitric oxide synthase, inducibleHomo sapiens (human)
protein bindingNitric oxide synthase, inducibleHomo sapiens (human)
calmodulin bindingNitric oxide synthase, inducibleHomo sapiens (human)
FMN bindingNitric oxide synthase, inducibleHomo sapiens (human)
heme bindingNitric oxide synthase, inducibleHomo sapiens (human)
tetrahydrobiopterin bindingNitric oxide synthase, inducibleHomo sapiens (human)
arginine bindingNitric oxide synthase, inducibleHomo sapiens (human)
protein homodimerization activityNitric oxide synthase, inducibleHomo sapiens (human)
metal ion bindingNitric oxide synthase, inducibleHomo sapiens (human)
flavin adenine dinucleotide bindingNitric oxide synthase, inducibleHomo sapiens (human)
NADP bindingNitric oxide synthase, inducibleHomo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
transcription cis-regulatory region bindingSignal transducer and activator of transcription 3Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingSignal transducer and activator of transcription 3Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificSignal transducer and activator of transcription 3Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificSignal transducer and activator of transcription 3Homo sapiens (human)
DNA bindingSignal transducer and activator of transcription 3Homo sapiens (human)
DNA-binding transcription factor activitySignal transducer and activator of transcription 3Homo sapiens (human)
nuclear receptor activitySignal transducer and activator of transcription 3Homo sapiens (human)
signaling receptor bindingSignal transducer and activator of transcription 3Homo sapiens (human)
protein bindingSignal transducer and activator of transcription 3Homo sapiens (human)
protein kinase bindingSignal transducer and activator of transcription 3Homo sapiens (human)
protein phosphatase bindingSignal transducer and activator of transcription 3Homo sapiens (human)
chromatin DNA bindingSignal transducer and activator of transcription 3Homo sapiens (human)
signaling adaptor activitySignal transducer and activator of transcription 3Homo sapiens (human)
identical protein bindingSignal transducer and activator of transcription 3Homo sapiens (human)
protein homodimerization activitySignal transducer and activator of transcription 3Homo sapiens (human)
protein dimerization activitySignal transducer and activator of transcription 3Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingSignal transducer and activator of transcription 3Homo sapiens (human)
primary miRNA bindingSignal transducer and activator of transcription 3Homo sapiens (human)
lncRNA bindingSignal transducer and activator of transcription 3Homo sapiens (human)
DNA-binding transcription factor bindingSignal transducer and activator of transcription 3Homo sapiens (human)
RNA sequestering activitySignal transducer and activator of transcription 3Homo sapiens (human)
protein tyrosine phosphatase activityDual specificity protein phosphatase 3Homo sapiens (human)
protein bindingDual specificity protein phosphatase 3Homo sapiens (human)
cytoskeletal protein bindingDual specificity protein phosphatase 3Homo sapiens (human)
protein tyrosine/serine/threonine phosphatase activityDual specificity protein phosphatase 3Homo sapiens (human)
phosphatase activityDual specificity protein phosphatase 3Homo sapiens (human)
myosin phosphatase activityDual specificity protein phosphatase 3Homo sapiens (human)
protein kinase bindingDual specificity protein phosphatase 3Homo sapiens (human)
receptor tyrosine kinase bindingDual specificity protein phosphatase 3Homo sapiens (human)
MAP kinase phosphatase activityDual specificity protein phosphatase 3Homo sapiens (human)
protein tyrosine kinase bindingDual specificity protein phosphatase 3Homo sapiens (human)
transcription cis-regulatory region bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II core promoter sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
transcription coactivator bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
DNA bindingTranscription factor p65Homo sapiens (human)
chromatin bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor activityTranscription factor p65Homo sapiens (human)
protein bindingTranscription factor p65Homo sapiens (human)
enzyme bindingTranscription factor p65Homo sapiens (human)
protein kinase bindingTranscription factor p65Homo sapiens (human)
chromatin DNA bindingTranscription factor p65Homo sapiens (human)
ubiquitin protein ligase bindingTranscription factor p65Homo sapiens (human)
peptide bindingTranscription factor p65Homo sapiens (human)
phosphate ion bindingTranscription factor p65Homo sapiens (human)
identical protein bindingTranscription factor p65Homo sapiens (human)
protein homodimerization activityTranscription factor p65Homo sapiens (human)
actinin bindingTranscription factor p65Homo sapiens (human)
histone deacetylase bindingTranscription factor p65Homo sapiens (human)
NF-kappaB bindingTranscription factor p65Homo sapiens (human)
ankyrin repeat bindingTranscription factor p65Homo sapiens (human)
general transcription initiation factor bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor bindingTranscription factor p65Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
phosphoprotein phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
signaling receptor complex adaptor activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cell adhesion molecule bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptide hormone receptor bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
molecular adaptor activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
transcription cis-regulatory region bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear factor erythroid 2-related factor 2Homo sapiens (human)
transcription coregulator bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificNuclear factor erythroid 2-related factor 2Homo sapiens (human)
DNA bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
DNA-binding transcription factor activityNuclear factor erythroid 2-related factor 2Homo sapiens (human)
protein bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
protein domain specific bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
ubiquitin protein ligase bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
sequence-specific DNA bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
molecular condensate scaffold activityNuclear factor erythroid 2-related factor 2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
protein bindingG-protein coupled bile acid receptor 1Homo sapiens (human)
bile acid receptor activityG-protein coupled bile acid receptor 1Homo sapiens (human)
G protein-coupled bile acid receptor activityG-protein coupled bile acid receptor 1Homo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingProlyl hydroxylase EGLN2Homo sapiens (human)
ferrous iron bindingProlyl hydroxylase EGLN2Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
oxygen sensor activityProlyl hydroxylase EGLN2Homo sapiens (human)
L-ascorbic acid bindingProlyl hydroxylase EGLN2Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
protein bindingEgl nine homolog 1Homo sapiens (human)
ferrous iron bindingEgl nine homolog 1Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityEgl nine homolog 1Homo sapiens (human)
enzyme bindingEgl nine homolog 1Homo sapiens (human)
L-ascorbic acid bindingEgl nine homolog 1Homo sapiens (human)
peptidyl-proline dioxygenase activityEgl nine homolog 1Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityEgl nine homolog 1Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityEgl nine homolog 1Homo sapiens (human)
protein bindingProlyl hydroxylase EGLN3Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
L-ascorbic acid bindingProlyl hydroxylase EGLN3Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
ferrous iron bindingProlyl hydroxylase EGLN3Homo sapiens (human)
NAD+ ADP-ribosyltransferase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
NAD+-protein ADP-ribosyltransferase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
zinc ion bindingNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
NAD-dependent protein lysine deacetylase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein-malonyllysine demalonylase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein-succinyllysine desuccinylase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein-glutaryllysine deglutarylase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
NAD+ bindingNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
iron ion bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
calcium ion bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
L-ascorbic acid bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
procollagen-proline 4-dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (96)

Processvia Protein(s)Taxonomy
extracellular regionAldo-keto reductase family 1 member B10Homo sapiens (human)
lysosomeAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
mitochondrionAldo-keto reductase family 1 member B10Homo sapiens (human)
endosomeEpidermal growth factor receptorHomo sapiens (human)
plasma membraneEpidermal growth factor receptorHomo sapiens (human)
ruffle membraneEpidermal growth factor receptorHomo sapiens (human)
Golgi membraneEpidermal growth factor receptorHomo sapiens (human)
extracellular spaceEpidermal growth factor receptorHomo sapiens (human)
nucleusEpidermal growth factor receptorHomo sapiens (human)
cytoplasmEpidermal growth factor receptorHomo sapiens (human)
endosomeEpidermal growth factor receptorHomo sapiens (human)
endoplasmic reticulum membraneEpidermal growth factor receptorHomo sapiens (human)
plasma membraneEpidermal growth factor receptorHomo sapiens (human)
focal adhesionEpidermal growth factor receptorHomo sapiens (human)
cell surfaceEpidermal growth factor receptorHomo sapiens (human)
endosome membraneEpidermal growth factor receptorHomo sapiens (human)
membraneEpidermal growth factor receptorHomo sapiens (human)
basolateral plasma membraneEpidermal growth factor receptorHomo sapiens (human)
apical plasma membraneEpidermal growth factor receptorHomo sapiens (human)
cell junctionEpidermal growth factor receptorHomo sapiens (human)
clathrin-coated endocytic vesicle membraneEpidermal growth factor receptorHomo sapiens (human)
early endosome membraneEpidermal growth factor receptorHomo sapiens (human)
nuclear membraneEpidermal growth factor receptorHomo sapiens (human)
membrane raftEpidermal growth factor receptorHomo sapiens (human)
perinuclear region of cytoplasmEpidermal growth factor receptorHomo sapiens (human)
multivesicular body, internal vesicle lumenEpidermal growth factor receptorHomo sapiens (human)
intracellular vesicleEpidermal growth factor receptorHomo sapiens (human)
protein-containing complexEpidermal growth factor receptorHomo sapiens (human)
receptor complexEpidermal growth factor receptorHomo sapiens (human)
Shc-EGFR complexEpidermal growth factor receptorHomo sapiens (human)
basal plasma membraneEpidermal growth factor receptorHomo sapiens (human)
extracellular regionPhospholipase A2Homo sapiens (human)
extracellular spacePhospholipase A2Homo sapiens (human)
cell surfacePhospholipase A2Homo sapiens (human)
nucleusDNA polymerase betaHomo sapiens (human)
nucleoplasmDNA polymerase betaHomo sapiens (human)
cytoplasmDNA polymerase betaHomo sapiens (human)
microtubuleDNA polymerase betaHomo sapiens (human)
spindle microtubuleDNA polymerase betaHomo sapiens (human)
protein-containing complexDNA polymerase betaHomo sapiens (human)
nucleusDNA polymerase betaHomo sapiens (human)
plasma membraneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
focal adhesionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
external side of plasma membraneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
cytoplasmic side of plasma membraneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
cell surfaceReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
membraneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
secretory granule membraneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
blebReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
membrane raftReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
synapseReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
extracellular exosomeReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
membrane microdomainReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
plasma membraneReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
neuron projectionReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
neuronal cell bodyReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
extracellular exosomeReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
nuclear chromosomeDNA topoisomerase 1Homo sapiens (human)
P-bodyDNA topoisomerase 1Homo sapiens (human)
fibrillar centerDNA topoisomerase 1Homo sapiens (human)
male germ cell nucleusDNA topoisomerase 1Homo sapiens (human)
nucleusDNA topoisomerase 1Homo sapiens (human)
nucleoplasmDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
perikaryonDNA topoisomerase 1Homo sapiens (human)
protein-DNA complexDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 2-alphaHomo sapiens (human)
nuclear chromosomeDNA topoisomerase 2-alphaHomo sapiens (human)
centrioleDNA topoisomerase 2-alphaHomo sapiens (human)
chromosome, centromeric regionDNA topoisomerase 2-alphaHomo sapiens (human)
condensed chromosomeDNA topoisomerase 2-alphaHomo sapiens (human)
male germ cell nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleoplasmDNA topoisomerase 2-alphaHomo sapiens (human)
nucleolusDNA topoisomerase 2-alphaHomo sapiens (human)
cytoplasmDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complexDNA topoisomerase 2-alphaHomo sapiens (human)
protein-containing complexDNA topoisomerase 2-alphaHomo sapiens (human)
ribonucleoprotein complexDNA topoisomerase 2-alphaHomo sapiens (human)
nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
extracellular spaceTissue factorHomo sapiens (human)
plasma membraneTissue factorHomo sapiens (human)
external side of plasma membraneTissue factorHomo sapiens (human)
cell surfaceTissue factorHomo sapiens (human)
membraneTissue factorHomo sapiens (human)
collagen-containing extracellular matrixTissue factorHomo sapiens (human)
serine-type peptidase complexTissue factorHomo sapiens (human)
plasma membraneTissue factorHomo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
plasma membraneReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
focal adhesionReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
membraneReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
extracellular exosomeReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
synaptic membraneReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
Schaffer collateral - CA1 synapseReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
receptor complexReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
cytoplasmLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulumLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulum lumenLiver carboxylesterase 1Homo sapiens (human)
lipid dropletLiver carboxylesterase 1Homo sapiens (human)
cytosolLiver carboxylesterase 1Homo sapiens (human)
lipid dropletLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulumLiver carboxylesterase 1Homo sapiens (human)
photoreceptor outer segmentProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1Homo sapiens (human)
Golgi apparatusProstaglandin G/H synthase 1Homo sapiens (human)
intracellular membrane-bounded organelleProstaglandin G/H synthase 1Homo sapiens (human)
extracellular exosomeProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 1Homo sapiens (human)
nucleusReceptor-type tyrosine-protein phosphatase epsilonHomo sapiens (human)
cytoplasmReceptor-type tyrosine-protein phosphatase epsilonHomo sapiens (human)
plasma membraneReceptor-type tyrosine-protein phosphatase epsilonHomo sapiens (human)
cytoplasmLow molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)
cytosolLow molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)
cytoplasmic side of plasma membraneLow molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)
sarcolemmaLow molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)
extracellular exosomeLow molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
extracellular regionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nucleolusTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cell-cell junctionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
membraneTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
specific granule lumenTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
extracellular exosomeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
tertiary granule lumenTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
alpha-beta T cell receptor complexTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
spindle poleM-phase inducer phosphatase 2Homo sapiens (human)
nucleoplasmM-phase inducer phosphatase 2Homo sapiens (human)
centrosomeM-phase inducer phosphatase 2Homo sapiens (human)
cytosolM-phase inducer phosphatase 2Homo sapiens (human)
nucleusM-phase inducer phosphatase 2Homo sapiens (human)
cytoplasmM-phase inducer phosphatase 2Homo sapiens (human)
nucleusNitric oxide synthase, inducibleHomo sapiens (human)
nucleoplasmNitric oxide synthase, inducibleHomo sapiens (human)
cytoplasmNitric oxide synthase, inducibleHomo sapiens (human)
peroxisomeNitric oxide synthase, inducibleHomo sapiens (human)
peroxisomal matrixNitric oxide synthase, inducibleHomo sapiens (human)
cytosolNitric oxide synthase, inducibleHomo sapiens (human)
cortical cytoskeletonNitric oxide synthase, inducibleHomo sapiens (human)
perinuclear region of cytoplasmNitric oxide synthase, inducibleHomo sapiens (human)
plasma membraneNitric oxide synthase, inducibleHomo sapiens (human)
nucleusNitric oxide synthase, inducibleHomo sapiens (human)
cytosolNitric oxide synthase, inducibleHomo sapiens (human)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
nucleusSignal transducer and activator of transcription 3Homo sapiens (human)
nucleusSignal transducer and activator of transcription 3Homo sapiens (human)
nucleoplasmSignal transducer and activator of transcription 3Homo sapiens (human)
cytoplasmSignal transducer and activator of transcription 3Homo sapiens (human)
cytosolSignal transducer and activator of transcription 3Homo sapiens (human)
plasma membraneSignal transducer and activator of transcription 3Homo sapiens (human)
RNA polymerase II transcription regulator complexSignal transducer and activator of transcription 3Homo sapiens (human)
chromatinSignal transducer and activator of transcription 3Homo sapiens (human)
transcription regulator complexSignal transducer and activator of transcription 3Homo sapiens (human)
cytoplasmSignal transducer and activator of transcription 3Homo sapiens (human)
immunological synapseDual specificity protein phosphatase 3Homo sapiens (human)
nucleusDual specificity protein phosphatase 3Homo sapiens (human)
nucleoplasmDual specificity protein phosphatase 3Homo sapiens (human)
cytosolDual specificity protein phosphatase 3Homo sapiens (human)
cytosolDual specificity protein phosphatase 3Homo sapiens (human)
cytoplasmDual specificity protein phosphatase 3Homo sapiens (human)
nucleolusTranscription factor p65Homo sapiens (human)
nucleusTranscription factor p65Homo sapiens (human)
glutamatergic synapseTranscription factor p65Homo sapiens (human)
nucleusTranscription factor p65Homo sapiens (human)
nucleoplasmTranscription factor p65Homo sapiens (human)
cytoplasmTranscription factor p65Homo sapiens (human)
cytosolTranscription factor p65Homo sapiens (human)
NF-kappaB p50/p65 complexTranscription factor p65Homo sapiens (human)
NF-kappaB complexTranscription factor p65Homo sapiens (human)
chromatinTranscription factor p65Homo sapiens (human)
transcription regulator complexTranscription factor p65Homo sapiens (human)
cytoplasmTranscription factor p65Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
mediator complexNuclear factor erythroid 2-related factor 2Homo sapiens (human)
non-membrane-bounded organelleNuclear factor erythroid 2-related factor 2Homo sapiens (human)
nucleusNuclear factor erythroid 2-related factor 2Homo sapiens (human)
nucleoplasmNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cytoplasmNuclear factor erythroid 2-related factor 2Homo sapiens (human)
Golgi apparatusNuclear factor erythroid 2-related factor 2Homo sapiens (human)
centrosomeNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cytosolNuclear factor erythroid 2-related factor 2Homo sapiens (human)
plasma membraneNuclear factor erythroid 2-related factor 2Homo sapiens (human)
RNA polymerase II transcription regulator complexNuclear factor erythroid 2-related factor 2Homo sapiens (human)
chromatinNuclear factor erythroid 2-related factor 2Homo sapiens (human)
protein-DNA complexNuclear factor erythroid 2-related factor 2Homo sapiens (human)
nucleusNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cytoplasmG-protein coupled bile acid receptor 1Homo sapiens (human)
plasma membraneG-protein coupled bile acid receptor 1Homo sapiens (human)
receptor complexG-protein coupled bile acid receptor 1Homo sapiens (human)
plasma membraneG-protein coupled bile acid receptor 1Homo sapiens (human)
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
nucleusProlyl hydroxylase EGLN2Homo sapiens (human)
nucleoplasmProlyl hydroxylase EGLN2Homo sapiens (human)
nucleusProlyl hydroxylase EGLN2Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN2Homo sapiens (human)
cytoplasmEgl nine homolog 1Homo sapiens (human)
cytosolEgl nine homolog 1Homo sapiens (human)
postsynaptic densityEgl nine homolog 1Homo sapiens (human)
intracellular membrane-bounded organelleEgl nine homolog 1Homo sapiens (human)
glutamatergic synapseEgl nine homolog 1Homo sapiens (human)
nucleusEgl nine homolog 1Homo sapiens (human)
cytoplasmEgl nine homolog 1Homo sapiens (human)
nucleusProlyl hydroxylase EGLN3Homo sapiens (human)
nucleoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
cytosolProlyl hydroxylase EGLN3Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
nucleusProlyl hydroxylase EGLN3Homo sapiens (human)
nucleusNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
mitochondrionNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
mitochondrial intermembrane spaceNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
mitochondrial matrixNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
cytosolNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
mitochondrial matrixNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
endoplasmic reticulum membraneTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
endoplasmic reticulumTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (803)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID697029Non-competitive inhibition of reductase activity of N-terminal 6His-tagged human AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID376969Growth inhibition of human HL60 cells after 3 days by trypan blue method2006Journal of natural products, May, Volume: 69, Issue:5
Triterpenoids from the resin of Styrax tonkinensis and their antiproliferative and differentiation effects in human leukemia HL-60 cells.
AID290248Enhancement of LPS-stimulated blastogenic responsiveness in BALB/c mouse splenocytes at 10 mg/kg2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID600424Inhibition of HIV1 protease activity2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Novel 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2)-curcumin, kojic acid, quercetin, and baicalein conjugates as HIV agents.
AID735308Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated TNF-alpha production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID379280Inhibition of HIV1 protease at 100 ug/ml2000Journal of natural products, Feb, Volume: 63, Issue:2
Inhibitory effects on HIV-1 protease of constituents from the wood of Xanthoceras sorbifolia.
AID1243949Cytotoxicity against human MCF7 cells assessed as cell survival after 96 hrs by SRB assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
AID409691Inhibition of human recombinant PTPepsilon2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID275125Inhibition of activation of human complement2007Journal of natural products, Jan, Volume: 70, Issue:1
9,19-cyclolanostane derivatives from the roots of Actaea pachypoda.
AID697012Competitive inhibition of dehydrogenase activity of N-terminal 6His-tagged human AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as NADP+-linked geraniol oxidation2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1195231Inhibition of SHP1 (unknown origin)2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Design and synthesis of novel 1,2-dithiolan-4-yl benzoate derivatives as PTP1B inhibitors.
AID1504266Cytotoxic activity in human MDA-MB-231 cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID1617467Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M double mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo k2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1075590Induction of apoptosis in mouse B16F10 cells assessed as early apoptotic cells at 2 X IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 3.9 +/- 0.4%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1504114Inhibition of recombinant human GST-tagged PTP1B catalytic domain expressed in Escherichia coli BL21 using para-nitrophenyl phosphate as substrate2017Journal of natural products, 11-22, Volume: 80, Issue:11
Camellianols A-G, Barrigenol-like Triterpenoids with PTP1B Inhibitory Effects from the Endangered Ornamental Plant Camellia crapnelliana.
AID697023Cytotoxicity against human mitomycin C-resistant HT-29 cells assessed as growth inhibition after 96 hrs by trypan blue exclusion assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1651804Suppression of prostate epithelial thickness in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 10 mg/kg, ip by hematoxylin and eosin staining-based microscopic analysis relative to control2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1565063Antiviral activity against Influenza A virus A/WSN/33 assessed as inhibition of virus-induced cytopathic effect after 40 hrs by Celltiter-Glo assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
AID1416506Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay2017MedChemComm, Aug-01, Volume: 8, Issue:8
Extraction of antioxidant and antiproliferative ingredients from fruits of
AID1386851Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID1187410Cytotoxicity against mouse J774A1 cells assessed as cell viability by MTT assay relative to control2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: synthesis, biological evaluation and docking studies.
AID471324Inhibition of GST-tagged human PTP1B2009Journal of natural products, Sep, Volume: 72, Issue:9
Chemical Constituents of the Roots of Euphorbia micractina.
AID1378643Activation of Nrf2 (unknown origin) expressed in human HaCaT-ARE-luc cells after 6 hrs by luciferase reporter gene assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Electrophilic Triterpenoid Enones: A Comparative Thiol-Trapping and Bioactivity Study.
AID377096Cytotoxicity against human WI 38 cells after 48 hrs by WST-8 assay2005Journal of natural products, Feb, Volume: 68, Issue:2
Three new triterpenes from Nerium oleander and biological activity of the isolated compounds.
AID378966Antitrypanosomal activity against Trypanosoma brucei brucei MITat 1.2 variant 221 after 72 hrs2006Journal of natural products, Jan, Volume: 69, Issue:1
Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities.
AID1515727Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID735307Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated IL12 production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID1385463Inhibition of recombinant human PTP1B catalytic domain (91 to 1053 residues) expressed in Escherichia coli BL21-codon plus (DE3) using pNPP as substrate measured continuously for 3 mins by colorimetric method2018Journal of natural products, 08-24, Volume: 81, Issue:8
Enantiomeric Pairs of Meroterpenoids with Diverse Heterocyclic Systems from Rhododendron nyingchiense.
AID340840Cytotoxicity against human Hep3B cells assessed as cell death at 1 uM after 24 hrs by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID355137Antimicrobial activity against Streptococcus mutans Ingbritt by disk diffusion method1996Journal of natural products, Oct, Volume: 59, Issue:10
Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens.
AID767560Inhibition of PTP1B (unknown origin)2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
The first synthesis of natural disulfide bruguiesulfurol and biological evaluation of its derivatives as a novel scaffold for PTP1B inhibitors.
AID1500871MRT (0 to 48 hrs) in normal fed guinea pig at 30 mg/kg administered via oral gavage by LC-MS/MS analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID1310315Inhibition of human SHP2 using pNPP as substrate incubated for 30 mins2016European journal of medicinal chemistry, Aug-08, Volume: 118Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
AID1504267Cytotoxic activity in human DU145 cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID1431437Cytotoxicity against human 8505C cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID340969Cytotoxicity against human Hep3B cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1328330Inhibition of human recombinant GST-tagged PTP1B catalytic domain expressed in Escherichia coli BL21-Conden plus (DE3) using pNPP as substrate2016European journal of medicinal chemistry, Oct-21, Volume: 122Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.
AID1617462Antiproliferative activity against human KB cells incubated for 72 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1504291Antiproliferative activity in human KB cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID381214Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay1999Journal of natural products, Sep, Volume: 62, Issue:9
Triterpene saponins and lignans from the roots of Pulsatilla chinensis and their cytotoxic activity against HL-60 cells.
AID1770391Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID1256604Inhibition of TCPTP (unknown origin) assessed as hydrolysis of pNPP to pNP after 30 mins2015Bioorganic & medicinal chemistry, Nov-01, Volume: 23, Issue:21
Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (methanesulfonyl-phenyl-amino)-acetic acid methyl ester phosphotyrosine mimetic.
AID340835Cytotoxicity against human HepG2 cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID664365Antioxidant activity in LPS-stimulated mouse RAW264.7 cells assessed as induction of HO-1 mRNA expression at 100 uM after 4 hrs by RT-PCR analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.
AID1414762Cytotoxicity activity against mouse B16F10 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID1383851Cytotoxicity against human FADU cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID1697439Inhibition of CES1A1 in human liver microsomes using D-luciferin methyl ester as substrate preincubated for 10 mins followed by substrate addition and measured after 10 mins by fluorescence assay2020Journal of natural products, 10-23, Volume: 83, Issue:10
Bioactivity-Guided Discovery of Human Carboxylesterase Inhibitors from the Roots of
AID1524957Inhibition of PTP1B (unknown origin) at 20 ug/ml using pNPP as substrate2019Bioorganic & medicinal chemistry letters, 05-15, Volume: 29, Issue:10
Discovery of 1,3-diphenyl-1H-pyrazole derivatives containing rhodanine-3-alkanoic acid groups as potential PTP1B inhibitors.
AID1465089Inhibition of porcine pancreatic alpha-amylase assessed as Vmax for substrate using starch as substrate at 94.1 uM by Michaelis-Menten plot analysis (Rvb = 28.6 +/- 1.8 microg/ml/min)2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID1201616Upregulation of seaR gene expression in Staphylococcus aureus ATCC 25923 at 0.5 x MIC by Q-RT-PCR analysis relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID1256913Inhibition of human IDH1 expressed in IPTG-induced Escherichia coli BL21 cells assessed as reduction of NADP+ to NADPH after 5 mins by spectrophotometry2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
AID377094Antiinflammatory activity against human A549 cells assessed as inhibition of IL-1-alpha-induced ICAM1 expression treated after 1 hr before IL1alpha challenge2005Journal of natural products, Feb, Volume: 68, Issue:2
Three new triterpenes from Nerium oleander and biological activity of the isolated compounds.
AID687539Inhibition of human recombinant PTP-1B expressed in Escherichia coli TB1 using p-nitrophenyl phosphate as substrate after 1 hr2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID224272Inhibitory activity against nitric oxide production induced by interferon-gamma (IFN-gamma) in mouse macrophages2002Journal of medicinal chemistry, Oct-24, Volume: 45, Issue:22
Design and synthesis of tricyclic compounds with enone functionalities in rings A and C: a novel class of highly active inhibitors of nitric oxide production in mouse macrophages.
AID340973Cytotoxicity against human HEK293 cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID378288Therapeutic index, IC50 for human T-lymphoid H9 cells to EC50 for HIV1 3B isolate2000Journal of natural products, Dec, Volume: 63, Issue:12
Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives.
AID393223Cell membrane permeabilization in human DLD1 cells assessed as drug level causing decrease in calcein fluorescence2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID1873015Inhibition of SIRT5 (unknown origin)2022European journal of medicinal chemistry, Jun-05, Volume: 236Overview of SIRT5 as a potential therapeutic target: Structure, function and inhibitors.
AID1275389Inhibition of recombinant human PTP1B catalytic domain assessed as hydrolysis of pNPP after 2 mins2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity.
AID1075594Induction of apoptosis in mouse B16F10 cells assessed as normal cells at 2 X IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 77.9 +/- 1.5%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID290237Immunostimulatory effect against SRBC-inducing hormoral response in BALB/c mouse assessed as antibody production at 100 mg/kg2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID338351Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 1000 mol ratio after 48 hrs relative to TPA
AID1195523Inhibition of PTP1B (unknown origin) using pNPP substrate measured after 3 mins by colorimetric assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
PTP1B inhibitors from stems of Angelica keiskei (Ashitaba).
AID1435531Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1201622Downregulation of necl gene expression in Streptomyces scabiei CGMCC4.7610246 at 0.5 x MIC by Q-RT-PCR analysis relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID1515731Cytotoxicity against human A549/T cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID640379Inhibition of rabbit muscle glycogen phosphorylase a assessed as release of phosphate from glucose-1-phosphate after 25 mins using malachite green staining2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Design and synthesis of novel photoaffinity probes for study of the target proteins of oleanolic acid.
AID328031Inhibition of polymerase activity of DNA polymerase beta2008Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8
Inhibitors of DNA polymerase beta: activity and mechanism.
AID1604321Antiparasitic activity against Toxoplasma gondii2019European journal of medicinal chemistry, Dec-01, Volume: 183Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
AID1382747Growth inhibition of mouse B16F10 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Mar-25, Volume: 148Diamine and PEGylated-diamine conjugates of triterpenic acids as potential anticancer agents.
AID1347572Cytotoxicity against human HT-29 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and cytotoxic activity of N-Modified oleanolic saponins bearing A glucosamine.
AID398030Spasmolytic activity in rabbit jejunum assessed as inhibition of K+-induced muscle contraction at 1 mg/mL after 30 mins2002Journal of natural products, Dec, Volume: 65, Issue:12
Structure and spasmolytic activity of eucalyptanoic acid from Eucalyptus camaldulensis var. obtusa and synthesis of its active derivative from oleanolic acid.
AID1610456Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect at 100 uM measured after 45 hrs by CellTiter-Glo luminescence assay2019Bioorganic & medicinal chemistry, 12-01, Volume: 27, Issue:23
Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
AID338354Inhibition of EBV-early antigen activation in human Raji cells assessed as early antigen activation at 1 uM ratio after 48 hrs
AID1074436Aqueous equilibrium solubility of the compound after 24 hrs by HPLC analysis2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
AID437575Cytotoxicity against human HepG2 cells assessed as cell survival at 5 uM after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Palbinone and triterpenes from Moutan Cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells.
AID697026Inhibition of AKR1B10 mRNA expression in human HT-29 cells at 3 to 30 uM after 24 hrs by RT-PCR analysis2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1386852Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID1270869Inhibition of human DNA polymerase-beta using gapped DNA as substrate assessed as reduction of gap-filling activity at 50 uM incubated for 30 mins by fluorimetric analysis2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity.
AID378965Antileishmanial activity against Leishmania donovani MHOM/SD/62/IS-CL2D axenic amastigotes after 3 days2006Journal of natural products, Jan, Volume: 69, Issue:1
Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities.
AID355882Enhancement of nerve growth factor-stimulated neurite outgrowth in rat PC12D cells at 3 to 10 uM2003Journal of natural products, May, Volume: 66, Issue:5
Sterol and triterpenoid constituents of Verbena littoralis with NGF-potentiating activity.
AID671762Inhibition of HCV NS3 helicase overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of DNA unwinding activity at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID393224Cell membrane permeabilization in human WS1 cells assessed as drug level causing decrease in calcein fluorescence2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID1431438Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1386855Modulation of human ABCB1 expressed in mouse L5178Y cells assessed as fluorescence activity ratio at 2 uM pretreated for 10 mins followed by rhodamine 123 addition and measured after 20 mins by flow cytometry (Rvb = 1.01 No_unit)2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID1617780Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as decrease in PGE2 formation using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID338357Cytotoxicity against human Raji cells assessed as cell viability at 100 mol ratio after 48 hrs relative to TPA
AID1551283Inhibition of human recombinant GST-tagged SHP2 (catalytic domain 1116 to 2162 residues) expressed in Escherichia coli BL21 (DE3) using pNPP as substrate measured for 2 mins by colorimetric analysis2019European journal of medicinal chemistry, Jun-15, Volume: 172Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
AID1166642Inhibition of purified human GST-tagged PTP-1B using p-nitrophenylphosphate as substrate at 50 uM by spectrophotometry2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
AID1501174Inhibition of PTP1B (unknown origin) using p-nitrophenyl phosphate as substrate measured after 30 mins2017Journal of natural products, 09-22, Volume: 80, Issue:9
Meroterpenoids with Protein Tyrosine Phosphatase 1B Inhibitory Activity from a Hyrtios sp. Marine Sponge.
AID1383847Cytotoxicity against human MCF7 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID1126804Inhibition of PTP1B (unknown origin) using pNPP as substrate2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Synthesis and biological evaluation of novel bis-aromatic amides as novel PTP1B inhibitors.
AID1195229Inhibition of PTP1B (unknown origin)2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Design and synthesis of novel 1,2-dithiolan-4-yl benzoate derivatives as PTP1B inhibitors.
AID1591953Inhibition of Mycobacterium tuberculosis H37Ra PTPB expressed in Escherichia coli BL21 (DE3) using p-nitrophenyl phosphate as substrate preincubated for 10 mins followed by substrate addition and measured for 5 mins by spectrophotometric analysis2019Journal of natural products, 08-23, Volume: 82, Issue:8
Ophiobolin-Type Sesterterpenoids from the Mangrove Endophytic Fungus
AID545992Inhibition of recombinant PTP1B expressed in Escherichia coli BL21 up to 5 ug/ml after 30 mins by spectrophotometry2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Synthesis and biological evaluation of oleanolic acid derivatives as inhibitors of protein tyrosine phosphatase 1B.
AID1416505Cytotoxicity against human A549 cells after 24 hrs by MTT assay2017MedChemComm, Aug-01, Volume: 8, Issue:8
Extraction of antioxidant and antiproliferative ingredients from fruits of
AID290238Immunostimulatory effect against SRBC-inducing plaque forming cells in BALB/c mouse assessed as antibody secreting B cells at 10 mg/kg, po relative to control2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1243947Cytotoxicity against human A549 cells assessed as cell survival after 96 hrs by SRB assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
AID1061261Inhibition of topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled plasmid DNA assessed as concentration of the compound exhibiting activity of 100 uM camptothecin after 30 mins by agarose gel electrophoresis2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.
AID1770387Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID376697Inhibition of rat DNA polymerase beta at 50 ug/mL1999Journal of natural products, Dec, Volume: 62, Issue:12
DNA polymerase beta inhibitors from Baeckea gunniana.
AID399882Antiviral activity against HIV2004Journal of natural products, Feb, Volume: 67, Issue:2
Current developments in the discovery and design of new drug candidates from plant natural product leads.
AID378923Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio2000Journal of natural products, Jan, Volume: 63, Issue:1
Bioactive steroids from the whole herb of Euphorbia chamaesyce.
AID1201624Downregulation of txtC gene expression in Streptomyces scabiei CGMCC4.7610246 at 0.5 x MIC by Q-RT-PCR analysis relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID1617777Inhibition of human recombinant N-terminal His-tagged 15-LOX2 expressed in Escherichia coli assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1422361Cytotoxicity against human MCF7 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1504264Cytotoxic activity in human SiHa cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID340972Cytotoxicity against human MCF7 cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1246449Antiinflammatory activity in IRC mouse assessed as inhibition of TPA-induced IL-1alpha mRNA expression in epidermis at 2 umol administered topically 30 mins prior to TPA challenge for twice weekly over 2 weeks measured 6 hrs post last TPA challenge by qRT2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties.
AID1166648Mixed-type inhibition of purified human GST-tagged PTP-1B using p-nitrophenylphosphate as substrate by double-reciprocal plot method2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
AID1634006Selectivity ratio of IC50 for TCPTP (unknown origin) using pNPP as substrate to IC50 for PTP1B (unknown origin) using pNPP as substrate2019Bioorganic & medicinal chemistry letters, 08-15, Volume: 29, Issue:16
Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B).
AID1617460Antiproliferative activity against human A549 cells harbouring wild type EGFR incubated for 72 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID718394Cytotoxicity against human Raji cells assessed as cell viability at 100 mol ratio/TPA by trypan blue staining method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Synthesis and docking studies of novel antitumor benzimidazoles.
AID355136Antimicrobial activity against Prevotella intermedia by disk diffusion method1996Journal of natural products, Oct, Volume: 59, Issue:10
Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens.
AID595746Inhibition of fMLP/CB-stimulated superoxide anion generation in human neutrophils2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID1436859Inhibition of LPS-induced tissue factor procoagulant activity in human THP1 cells preincubated for 1 hr followed by LPS addition measured after 5 hrs using factor 10a chromogenic substrate in presence of prothrombin complex2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Microbial hydroxylation and glycosylation of pentacyclic triterpenes as inhibitors on tissue factor procoagulant activity.
AID1504268Cytotoxic activity in human KB cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID735305Cytotoxicity against C57BL/6 mouse BMDCs at 2 to 50 microM by MTT assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID1371026Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside substrate incubated for 30 mins2017Journal of natural products, 04-28, Volume: 80, Issue:4
α-Glucosidase Inhibitory and Cytotoxic Taxane Diterpenoids from the Stem Bark of Taxus wallichiana.
AID1700046Antagonist activity at human TRPV1 stably transfected in HEK293 cells assessed as inhibition of capsaicin response at 25 uM preincubated for 5 mins followed by capsaicin addition by Fluo-4-AM dye based spectrofluorimetric method relative to control2020Journal of natural products, 11-25, Volume: 83, Issue:11
Discovery of a Remarkable Methyl Shift Effect in the Vanilloid Activity of Triterpene Amides.
AID377617Cicatrizant activity against mouse measured by wound breaking strength at 40 ug/g administered every 12 hrs measured after 48 hrs relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
In vivo wound-healing activity of oleanolic acid derived from the acid hydrolysis of Anredera diffusa.
AID437580Induction of GSK3-beta phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Palbinone and triterpenes from Moutan Cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells.
AID1666865Antibiofilm activity against Escherichia coli UTI89 incubated for 2 days at 23 degC followed by 1 day incubation at RT2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
Optimized plant compound with potent anti-biofilm activity across gram-negative species.
AID396347Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 1000 molar ratio after 48 hrs relative to TPA2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Lanostane-type triterpenoids from the sclerotia of Inonotus obliquus possessing anti-tumor promoting activity.
AID1617775Inhibition of human recombinant 5-LOX expressed in insect cells assessed residual activity using arachidonic acid at 42 uM as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric ion oxidation-xylenol o2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1398546Inhibition of mitochondrial membrane potential in human HT-29 cells after 3 hrs by JC-1 staining based fluorescence assay2018Bioorganic & medicinal chemistry, 08-15, Volume: 26, Issue:15
Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives.
AID340836Cytotoxicity against human HepG2 cells assessed as cell death at 1 uM after 24 hrs by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1617776Inhibition of human recombinant N-terminal His-tagged 15-LOX2 expressed in Escherichia coli using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric ion oxidation-xylenol orange as2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID402596Cytotoxicity against human A2780 cells2004Journal of natural products, Jun, Volume: 67, Issue:6
Cytotoxic triterpenoids from Acridocarpus vivy from the Madagascar rain forest.
AID393219Cytotoxicity against human A549 cells after 48 hrs by resazurin reduction test2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID736005Antimycobacterial activity against Mycobacterium tuberculosis2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Quantitative purity-activity relationships of natural products: the case of anti-tuberculosis active triterpenes from Oplopanax horridus.
AID1424331Cytotoxicity in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1500868Inhibition of recombinant human CETP after 3 hrs using fluorescent cholesteryl containing HDL after 3 hrs by fluorescence assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID1066415Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID290244Enhancement of ConA-Stimulated lymphocyte proliferation in BALB/c mouse at 100 mg/kg by MTT assay2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID718396Inhibition of tumor promotion in human Raji cells assessed as TPA-induced Epstein-Barr virus early antigen activation at 100 mol ratio/TPA after 48 hrs by indirect immunofluorescence analysis relative to TPA alone2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Synthesis and docking studies of novel antitumor benzimidazoles.
AID1910672Binding affinity to human recombinant VHL assessed as dissociation constant by SPR assay2022Journal of medicinal chemistry, 05-26, Volume: 65, Issue:10
Discovery of Pentacyclic Triterpenoid PROTACs as a Class of Effective Hemagglutinin Protein Degraders.
AID1651815Downregulation of PCNA expression in prostate tissue of Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 to 10 mg/kg, ip by Western blot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID697008Inhibition of N-terminal 6His-tagged human AKR1B10 overexpressed in human HeLa cells assessed as inhibition of [1-14C]farnesol reduction pretreated for 2 hrs before [1-14C]farnesol challenge measured after 6 hrs2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID671761Inhibition of SARS coronavirus nsP13 helicase activity expressed in Escherichia coli Rosetta assessed inhibition of DNA unwinding activity at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID1770427Antibacterial activity against Staphylococcus aureus ATCC65385 assessed as growth inhibition after 20 hrs by broth microdilution method2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID1578452Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID334272Growth inhibition of mouse B16 2F2 cells after 3 days2002Journal of natural products, May, Volume: 65, Issue:5
Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line.
AID1191561Inhibition of PTP1B (unknown origin) using pNPP as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by microplate reader analysis2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Absolute structures and bioactivities of euryspongins and eurydiene obtained from the marine sponge Euryspongia sp. collected at Iriomote Island.
AID1435529Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1272457Cytotoxicity against human A549 cells after 96 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
AID1504115Cytotoxicity against human L02 cells assessed as cell viability at 10 uM after 24 hrs by MTS assay relative to control2017Journal of natural products, 11-22, Volume: 80, Issue:11
Camellianols A-G, Barrigenol-like Triterpenoids with PTP1B Inhibitory Effects from the Endangered Ornamental Plant Camellia crapnelliana.
AID1770430Antibacterial activity against Listeria innocua LMG11387 assessed as growth inhibition after 20 hrs by broth microdilution method2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID379279Inhibition of HIV1 protease2000Journal of natural products, Feb, Volume: 63, Issue:2
Inhibitory effects on HIV-1 protease of constituents from the wood of Xanthoceras sorbifolia.
AID1246450Antiinflammatory activity in IRC mouse assessed as inhibition of TPA-induced IL-1beta mRNA expression in epidermis at 2 umol administered topically 30 mins prior to TPA challenge for twice weekly over 2 weeks measured 6 hrs post last TPA challenge by qRT-2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties.
AID1351464Inhibition of recombinant human PTP1B using pNNP as substrate after 30 mins2018European journal of medicinal chemistry, Jan-20, Volume: 144Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site.
AID1634011Cytotoxicity against human L02 cells assessed as cell viability at 1 to 250 uM after 72 hrs by WST1 assay2019Bioorganic & medicinal chemistry letters, 08-15, Volume: 29, Issue:16
Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B).
AID1315356Inhibition of PTP1B (unknown origin) using pNPP as substrate after 3 mins by colorimetric analysis2016Journal of natural products, 05-27, Volume: 79, Issue:5
Eucarobustols A-I, Conjugates of Sesquiterpenoids and Acylphloroglucinols from Eucalyptus robusta.
AID1176105Inhibition of SHP1 (unknown origin) using pNPP as substrate at 20 ug/ml by spectrophotometry2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Bioactive constituents from the green alga Caulerpa racemosa.
AID767557Inhibition of SHP1 (unknown origin)2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
The first synthesis of natural disulfide bruguiesulfurol and biological evaluation of its derivatives as a novel scaffold for PTP1B inhibitors.
AID396349Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 100 molar ratio after 24 hrs relative to TPA2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Lanostane-type triterpenoids from the sclerotia of Inonotus obliquus possessing anti-tumor promoting activity.
AID402403Inhibition of COX1-catalyzed prostaglandin biosynthesis 10 mins of preincubation1998Journal of natural products, Oct, Volume: 61, Issue:10
Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis.
AID1651814Downregulation of Cyclin E expression in prostate tissue of Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 to 10 mg/kg, ip by Western blot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1651817Downregulation of PCNA mRNA expression in prostate tissue of Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 10 mg/kg, ip by qRT-PCR method2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1161581Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells after 6 to 8 hrs by luciferase assay2014Journal of medicinal chemistry, Sep-11, Volume: 57, Issue:17
Conjugation of a nonspecific antiviral sapogenin with a specific HIV fusion inhibitor: a promising strategy for discovering new antiviral therapeutics.
AID396351Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Lanostane-type triterpenoids from the sclerotia of Inonotus obliquus possessing anti-tumor promoting activity.
AID1424279Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID337155Inhibition of carrageenan-induced edema in Wistar rat paw at 20 mg/kg, po after 3 hrs
AID1061258Inhibition of topoisomerase 2 (unknown origin)-mediated kinetoplast DNA decatenation assessed as intensity of supercoiled DNA after 30 mins by agarose gel electrophoresis relative to etoposide2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.
AID776086Inhibition of GST-tagged PTP1B (unknown origin) using pNPP as substrate measured for 2 mins by colorimetric analysis2013European journal of medicinal chemistry, Nov, Volume: 69Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy.
AID1187623Inhibition of PTP1B (unknown origin)2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
AID1172640Inhibition of cell proliferation of rat C6 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID290245Enhancement of ConA-stimulated blastogenic responsiveness in BALB/c mouse splenocytes at 100 mg/kg2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID393221Cytotoxicity against human WS1 cells after 48 hrs by resazurin reduction test2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID1551284Inhibition of human recombinant GST-tagged LAR (catalytic domain 1275 to 1613 residues) expressed in Escherichia coli BL21 (DE3) using pNPP as substrate measured for 2 mins by colorimetric analysis2019European journal of medicinal chemistry, Jun-15, Volume: 172Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
AID1500883Inhibition of rat liver microsomal ACAT2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID437582Induction of glucose uptake in human HepG2 cells at 10 uM in presence of 33 mM 2-[14C]-DOG by scintillation counting2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Palbinone and triterpenes from Moutan Cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells.
AID1770472Antimigratory activity against human MDA-MB-231 cells assessed as inhibition of cell migration measured by wound healing assay relative to control
AID1315161Induction of shape change of actin cytoskeleton in human non-diabetic primary fibroblasts at 10 nM after 2 hrs by rhodamine phalloidin-staining based fluorescence microscopic analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Influence of Birch Bark Triterpenes on Keratinocytes and Fibroblasts from Diabetic and Nondiabetic Donors.
AID1434745Inhibition of GST-tagged human SHP1 expressed in Escherichia coli at 20 ug/ml using pNPP as substrate relative to control2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Discovery of core-structurally novel PTP1B inhibitors with specific selectivity containing oxindole-fused spirotetrahydrofurochroman by one-pot reaction.
AID426249Antiosteoclast activity in ICR mouse osteoblast like cells co-cultured with bone marrow cells assessed as effect on 1-alpha,25(OH)2D3-induced TRAP-positive osteoclast like multinucleated cell formation at 200 uM after 6 days medium replaced every 2 days r2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.
AID336477Inhibition of COX2 by scintillation proximity assay2002Journal of natural products, Nov, Volume: 65, Issue:11
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
AID1465051Inhibition of yeast alpha-glucosidase using 4-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID426247Antiosteoclast activity in ICR mouse osteoblast like cells co-cultured with bone marrow cells assessed as effect on 1-alpha,25(OH)2D3-induced TRAP-positive osteoclast like multinucleated cell formation at 20 uM after 6 days medium replaced every 2 days re2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.
AID1434743Inhibition of recombinant human PTP1B catalytic domain expressed in Escherichia coli BL21-CodonPlus (DE3) using pNPP as substrate measured for 2 mins2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Discovery of core-structurally novel PTP1B inhibitors with specific selectivity containing oxindole-fused spirotetrahydrofurochroman by one-pot reaction.
AID1634719Antibacterial activity against Escherichia coli measured after 5 to 6 hrs by microdilution titre technique2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1617463Antiproliferative activity against human KB-VIN10 cells incubated for 72 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1176107Inhibition of LAR (unknown origin) using pNPP as substrate at 20 ug/ml by spectrophotometry2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Bioactive constituents from the green alga Caulerpa racemosa.
AID687544Mixed type inhibition of human recombinant PTP-1B expressed in Escherichia coli TB1 using p-nitrophenyl phosphate as substrate2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID718395Inhibition of tumor promotion in human Raji cells assessed as TPA-induced Epstein-Barr virus early antigen activation at 10 mol ratio/TPA after 48 hrs by indirect immunofluorescence analysis relative to TPA alone2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Synthesis and docking studies of novel antitumor benzimidazoles.
AID1551277Inhibition of human recombinant GST-tagged PTP1B expressed in Escherichia coli BL21 (DE3) using pNPP as substrate measured for 2 mins by colorimetric analysis2019European journal of medicinal chemistry, Jun-15, Volume: 172Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
AID1243948Cytotoxicity against human HT-29 cells assessed as cell survival after 96 hrs by SRB assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
AID1422360Cytotoxicity against human HT-29 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1067061Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Synthesis of novel ring-A fused hybrids of oleanolic acid with capabilities to arrest cell cycle and induce apoptosis in breast cancer cells.
AID1666863Inhibition of swarming motility of Pseudomonas aeruginosa HONKR at 16 ug/mL incubated for 16 to 20 hrs relative to control2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
Optimized plant compound with potent anti-biofilm activity across gram-negative species.
AID378920Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA induction at 100 molar ratio by immunofluorescence assay relative to TPA2000Journal of natural products, Jan, Volume: 63, Issue:1
Bioactive steroids from the whole herb of Euphorbia chamaesyce.
AID1504269Cytotoxic activity in human Hep2 cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID486200Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio by trypan blue staining method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Hybrids of 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2) and various anti-oxidants as cancer chemopreventive agents.
AID595748Inhibition of fMLP/CB-activated human neutrophil degranulation assessed as inhibition of elastase release using MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide as a substrate after 5 mins2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID1075595Inhibition of HIV1 recombinant protease expressed in Escherichia coli using Abz-Ala-Arg-Val-Nle-Tyr(NO2)-Glu-Ala-Nle-NH2 as substrate by FRET assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID623340Induction of apoptosis in human M14 cells assessed as activation of caspase-3 at 50 uM after 24 hrs by Western blot analysis presence of polycaspase inhibitor z-VAD-fmk2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii.
AID1434746Inhibition of GST-tagged human SHP1 expressed in Escherichia coli using pNPP as substrate2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Discovery of core-structurally novel PTP1B inhibitors with specific selectivity containing oxindole-fused spirotetrahydrofurochroman by one-pot reaction.
AID1398545Inhibition of biotinylated consensus sequence binding to NF-kB p65 in human HeLa nuclear extracts after 3 hrs by ELISA2018Bioorganic & medicinal chemistry, 08-15, Volume: 26, Issue:15
Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives.
AID1201620Downregulation of murX gene expression in Streptomyces scabiei CGMCC4.7610246 at 0.5 x MIC by Q-RT-PCR analysis relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID265377Inhibition of human recombinant PTP1B2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Protein tyrosine phosphatase 1B inhibitory activity of triterpenes isolated from Astilbe koreana.
AID687537Antidiabetic activity in normal Swiss mouse assessed as reduction of blood glucose level by glucose tolerance test relative to control2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID1201621Downregulation of tomA gene expression in Streptomyces scabiei CGMCC4.7610246 at 0.5 x MIC by Q-RT-PCR analysis relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID772916Cytotoxicity against human A549 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Bioactive oleanane-type saponins from the rhizomes of Anemone taipaiensis.
AID697021Inhibition of N-terminal 6His-tagged human AKR1B10 overexpressed in human HeLa cells assessed as inhibition of [1-14C]farnesol reduction at 1 uM pretreated for 2 hrs before [1-14C]farnesol challenge measured after 6 hrs2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1651328Inhibition of human PTP1B2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Spirobiflavonoid stereoisomers from the endangered conifer Glyptostrobus pensilis and their protein tyrosine phosphatase 1B inhibitory activity.
AID1163422Inhibition of c-Jun protein expression in human HT-29 cells at 10 uM incubated for 1 hr by Western blotting method2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Identification of 4'-O-β-D-glucosyl-5-O-methylvisamminol as a novel epigenetic suppressor of histone H3 phosphorylation at Ser10 and its interaction with 14-3-3ε.
AID1434741Inhibition of GST-tagged human TCPCP expressed in Escherichia coli using pNPP as substrate2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Discovery of core-structurally novel PTP1B inhibitors with specific selectivity containing oxindole-fused spirotetrahydrofurochroman by one-pot reaction.
AID378921Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA induction at 500 molar ratio by immunofluorescence assay relative to TPA2000Journal of natural products, Jan, Volume: 63, Issue:1
Bioactive steroids from the whole herb of Euphorbia chamaesyce.
AID1617004Inhibition of N-terminal GST tagged recombinant human PTP1B catalytic domain (1 to 321 residues) expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by substrate addition and measured every 5 mins for 30 mins2019Journal of natural products, 10-25, Volume: 82, Issue:10
Protein Tyrosine Phosphatase 1B Inhibitory Iridoids from
AID538480Cytotoxicity against human HCT116 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Dec-01, Volume: 20, Issue:23
Oleanane-type triterpenoids from Panax stipuleanatus and their anticancer activities.
AID697009Inhibition of reductase activity of N-terminal 6His-tagged human AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1075586Induction of apoptosis in mouse B16F10 cells assessed as total apoptotic cells at 2 X IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 13.7 +/- 2.7%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1500889Cmax in normal fed guinea pig at 30 mg/kg administered via oral gavage by LC-MS/MS analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID311139Cytotoxicity against mouse J774 cells by alamar blue assay2007Journal of natural products, Aug, Volume: 70, Issue:8
Antitrypanosomal activity of triterpenoids and sterols from the leaves of Strychnos spinosa and related compounds.
AID1443719Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by neutral red assay2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Cytotoxic dammarane-type triterpenoids from the leaves of Viburnum sambucinum.
AID1067065Cytotoxicity against human MDA-MB-453 cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Synthesis of novel ring-A fused hybrids of oleanolic acid with capabilities to arrest cell cycle and induce apoptosis in breast cancer cells.
AID1201591Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition at 100 uM after 24 hrs by turbidimetric analysis2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID1310317Inhibition of human LAR using pNPP as substrate incubated for 30 mins2016European journal of medicinal chemistry, Aug-08, Volume: 118Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
AID1785787Selectivity ratio of CC50 for MDCK cells to IC50 for Influenza A virus A/WSN/33(H1N1) infected in MDCK cells2021ACS medicinal chemistry letters, Nov-11, Volume: 12, Issue:11
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.
AID340971Cytotoxicity against human PC3 cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1256912Inhibition of human IDH1 R132H mutant expressed in IPTG-induced Escherichia coli BL21 cells assessed as oxidation of NADPH to NADP+ after 5 mins by spectrophotometry2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
AID1351465Inhibition of human TCPTP using pNNP as substrate after 30 mins2018European journal of medicinal chemistry, Jan-20, Volume: 144Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site.
AID402092Cytotoxicity against mock-infected human H9 cells after 4 days1998Journal of natural products, Sep, Volume: 61, Issue:9
Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids.
AID1659870Inhibition of GST-tagged PTP1B (unknown origin) using pNPP as substrate measured for 3 mins by colorimetric assay2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Synthesis and biological evaluation of heterocyclic bis-aryl amides as novel Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.
AID1383846Cytotoxicity against human HT-29 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID1662669Inhibition of calf thymus Top1 assessed as reduction in supercoiled pBR322 DNA relaxation at 100 uM measured after 30 mins by agarose gel electrophoresis relative to camptothecin2020Bioorganic & medicinal chemistry, 06-01, Volume: 28, Issue:11
Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors.
AID1066421Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID437577Cytotoxicity against human HepG2 cells assessed as cell survival at 20 uM after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Palbinone and triterpenes from Moutan Cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells.
AID409689Inhibition of human recombinant LAR2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID1785786Cytotoxicity against MDCK cells assessed as reduction in cell viability by CellTiter-Glo assay2021ACS medicinal chemistry letters, Nov-11, Volume: 12, Issue:11
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.
AID1915606Inhibition of human carboxylesterase using 4-benzoyl-N-butyl-1,8-naphthalimide as substrate by fluorescence based assay2021European journal of medicinal chemistry, Jan-15, Volume: 210Recent research progress of Uncaria spp. based on alkaloids: phytochemistry, pharmacology and structural chemistry.
AID566011Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 100 molar ratio after 48 hrs relative to positive control2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives.
AID1234944Inhibition of recombinant PTP1B (unknown origin) assessed as pNPP hydrolysis after 30 mins2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Discovery of novel, potent, selective and cellular active ADC type PTP1B inhibitors via fragment-docking-oriented de novel design.
AID377098Cytotoxicity against human Hep G2 cells after 48 hrs by WST-8 assay2005Journal of natural products, Feb, Volume: 68, Issue:2
Three new triterpenes from Nerium oleander and biological activity of the isolated compounds.
AID1628356Cytotoxicity against human A2780 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID1706906Inhibition of Ebola virus pseudoparticle GP HR2 domain-mediated viral entry into human 293T cells at 1 uM incubated for 72 hrs by Bright-Glo reagent based assay relative to control2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature?
AID1578455Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID437576Cytotoxicity against human HepG2 cells assessed as cell survival at 10 uM after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Palbinone and triterpenes from Moutan Cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells.
AID1422358Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID340968Cytotoxicity against HEK293 cells assessed as cell death by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID603224Inhibition of rabbit muscle glycogen phosphorylase A assessed as release of phosphate from glucose-1-phosphate after 25 mins by microplate reader based method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.
AID241425Inhibition of inducible nitric oxide synthase in activated macrophages2005Bioorganic & medicinal chemistry letters, May-02, Volume: 15, Issue:9
Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action.
AID1418488Inhibition of LPS binding to TLR4 in IFNgamma-stimulated mouse RAW264.7 cells assessed as reduction in nitric oxide production at 25 to 100 uM pretreated for 2 hrs followed by LPS/IFNgamma stimulation and measured after 24 hrs2018Bioorganic & medicinal chemistry letters, 12-01, Volume: 28, Issue:22
Sentulic acid isolated from Sandoricum koetjape Merr attenuates lipopolysaccharide and interferon gamma co-stimulated nitric oxide production in murine macrophage RAW264 cells.
AID378287Cytotoxicity against mock-infected human H9 cells2000Journal of natural products, Dec, Volume: 63, Issue:12
Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives.
AID398029Spasmolytic activity in rabbit jejunum assessed as inhibition of calcium influx-mediated spontaneous muscle contraction at 1 mg/mL after 30 mins2002Journal of natural products, Dec, Volume: 65, Issue:12
Structure and spasmolytic activity of eucalyptanoic acid from Eucalyptus camaldulensis var. obtusa and synthesis of its active derivative from oleanolic acid.
AID1770389Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID328033Cytotoxicity against human A549 cells after 1 hr by MTT assay2008Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8
Inhibitors of DNA polymerase beta: activity and mechanism.
AID746436Antiplasmodial activity against Plasmodium falciparum W22013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Voulkensin C-E, new 11-oxocassane-type diterpenoids and a steroid glycoside from Caesalpinia volkensii stem bark and their antiplasmodial activities.
AID616210Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 100 molar ratio after 48 hrs relative to control2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Conjugates of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) as cancer chemopreventive agents.
AID311142Antitrypanosomal activity against South American Trypanosoma cruzi bloodstream trypomastigotes at 80.4 uM2007Journal of natural products, Aug, Volume: 70, Issue:8
Antitrypanosomal activity of triterpenoids and sterols from the leaves of Strychnos spinosa and related compounds.
AID1430420Inhibition of human VHR expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by substrate addition measured after 30 mins2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Furanoterpenes, new types of protein tyrosine phosphatase 1B inhibitors, from two Indonesian marine sponges, Ircinia and Spongia spp.
AID1424283Cytotoxicity in human HL60 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID333229Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate Alamar blue assay2004Journal of natural products, Sep, Volume: 67, Issue:9
Constituents of Senecio chionophilus with potential antitubercular activity.
AID1272455Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
AID674353Inhibition of GST-tagged human recombinant PTP1B using para-nitrophenyl phosphate as substrate by spectrophotometric analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Structure and bioassay of triterpenoids and steroids isolated from Sinocalamus affinis.
AID1617643Inhibition of PTP1B (unknown origin) using pNPP as substrate incubated for 30 mins by ELISA
AID437579Induction of AMPK phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Palbinone and triterpenes from Moutan Cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells.
AID774923Cytotoxicity against human Raji cells assessed as cell viability at 1000 mol ratio/TPA after 48 hrs by trypan blue staining method2013European journal of medicinal chemistry, Nov, Volume: 69Design, synthesis and structure-activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor.
AID664377Induction of Nrf2 in mouse RAW264.7 cells assessed as decrease in CAT mRNA expression at 100 uM after 24 hrs by quantitative RT-PCR analysis relative to control2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.
AID746437Antiplasmodial activity against Plasmodium falciparum D62013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Voulkensin C-E, new 11-oxocassane-type diterpenoids and a steroid glycoside from Caesalpinia volkensii stem bark and their antiplasmodial activities.
AID1075585Induction of apoptosis in mouse B16F10 cells assessed as necrotic cells at IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 4.0 +/- 0.6%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1266498Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as growth inhibition after 24 to 168 hrs by microplate resazurin assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Dibenz[b,f]oxepin and Antimycobacterial Chalcone Constituents of Empetrum nigrum.
AID1075589Induction of apoptosis in mouse B16F10 cells assessed as late apoptotic cells at IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 9.8 +/- 2.2%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID664373Induction of Nrf2-mediated NQO1 mRNA expression in mouse RAW264.7 cells at 100 uM after 2 to 4 hrs by quantitative RT-PCR analysis relative to control2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.
AID1256621Cytotoxicity against rat PC12 cells assessed as cell viability at 10 and 20 uM after 72 hrs by SRB assay2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells.
AID566010Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 500 molar ratio after 48 hrs relative to positive control2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives.
AID1504271Cytotoxic activity in HEK293 cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID1651798Toxicity in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia assessed as effect on animal health at 1 to 10 mg/kg, ip2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1275390Inhibition of human TCPTP as hydrolysis of pNPP after 2 mins2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity.
AID393220Cytotoxicity against human DLD1 cells after 48 hrs by resazurin reduction test2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID1067066Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Synthesis of novel ring-A fused hybrids of oleanolic acid with capabilities to arrest cell cycle and induce apoptosis in breast cancer cells.
AID1317200Selectivity index, ratio of CC50 for MDCK cells to IC50 for Influenza A virus H5 subtype (A/Thailand/Kan353/2004(H5N1)) pseudovirus infected in MDCK cells co-infected with HA/HIV2016European journal of medicinal chemistry, Aug-25, Volume: 119Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors.
AID1443717Cytotoxicity against human Lu1 cells assessed as growth inhibition after 72 hrs by neutral red assay2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Cytotoxic dammarane-type triterpenoids from the leaves of Viburnum sambucinum.
AID1500873Inhibition of recombinant human CETP at 10 uM using fluorescent cholesteryl containing HDL after 3 hrs by fluorescence assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID1290523Induction of NRF2 activation in rat H42E cells expressing ARE8L assessed as reporter transgene activity after 24 hrs by luminescence assay2016Journal of medicinal chemistry, Mar-24, Volume: 59, Issue:6
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites.
AID1386850Cytotoxicity against human COLO320 cells after 24 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID633480Inhibition of GST-tagged human recombinant PTP1B assessed as dephosphorylation of para-nitrophenyl phosphate after 10 mins by spectrophotometric analysis2011Journal of natural products, Nov-28, Volume: 74, Issue:11
Cucurbitane glucosides from the root of Machilus yaoshansis.
AID718397Inhibition of tumor promotion in human Raji cells assessed as TPA-induced Epstein-Barr virus early antigen activation at 500 mol ratio/TPA after 48 hrs by indirect immunofluorescence analysis relative to TPA alone2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Synthesis and docking studies of novel antitumor benzimidazoles.
AID1551282Inhibition of human recombinant GST-tagged SHP1 (catalytic domain 244 to 570 residues) expressed in Escherichia coli BL21 (DE3) using pNPP as substrate measured for 2 mins by colorimetric analysis2019European journal of medicinal chemistry, Jun-15, Volume: 172Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
AID1067067Cytotoxicity against human ME180 cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Synthesis of novel ring-A fused hybrids of oleanolic acid with capabilities to arrest cell cycle and induce apoptosis in breast cancer cells.
AID595751Cytotoxicity against human KB cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID1187409Cytotoxicity mouse RAW264.7 cells assessed as cell viability by MTT assay relative to control2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: synthesis, biological evaluation and docking studies.
AID340977Antitumor activity against human Hep3B cells xenografted in non-obese diabetic SCID mouse assessed as reduction in tumor size at 15 mg/kg, ip after 35 days2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1612308Inhibition of PHD (unknown origin) expressed in mouse NIH/3T3 cells harboring HRE-driven luciferase gene assessed as transactivation of HIF1alpha after 6 hrs by luciferase reporter gene assay2018Journal of natural products, 10-26, Volume: 81, Issue:10
Triterpenoid Hydroxamates as HIF Prolyl Hydrolase Inhibitors.
AID1391720Selectivity index, ratio of CC50 for human HepG2.215 cells to IC50 for Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID1166643Inhibition of purified human GST-tagged PTP-1B assessed as reversibility of enzyme activity using p-nitrophenylphosphate as substrate at 10 times IC50 after 1 hr incubation followed by 250 fold dilution by spectrophotometry2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
AID1504289Antiproliferative activity in human MDA-MB-231 cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID1628355Cytotoxicity against human A549 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID1195232Inhibition of SHP2 (unknown origin)2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Design and synthesis of novel 1,2-dithiolan-4-yl benzoate derivatives as PTP1B inhibitors.
AID1628352Cytotoxicity against human FADU cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID1201625Downregulation of p450 gene expression in Streptomyces scabiei CGMCC4.7610246 at 0.5 x MIC by Q-RT-PCR analysis relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID1651794Suppression of prostate tissue weight in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 10 mg/kg, ip relative to control2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1504270Cytotoxic activity in African green monkey Vero cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID1651793Suppression of prostate tissue weight in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 mg/kg, ip relative to control2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1785785Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in MDCK cells assessed as s reduction in virus-induced cytopathic effect after 40 hrs incubation by CellTiter-Glo assay2021ACS medicinal chemistry letters, Nov-11, Volume: 12, Issue:11
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.
AID774922Inhibition of TPA-induced EBV early antigen activation infected in human Raji cells assessed as antigen activity at 500 mol ratio/TPA after 48 hrs by immunofluorescence method relative to control2013European journal of medicinal chemistry, Nov, Volume: 69Design, synthesis and structure-activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor.
AID1465095Non-competitive inhibition of porcine pancreatic alpha-amylase assessed as inhibitor-enzyme-substrate complex using starch as substrate by Lineweaver-Burk plot analysis2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID774924Inhibition of TPA-induced EBV early antigen activation infected in human Raji cells assessed as antigen activity at 1000 mol ratio/TPA after 48 hrs by immunofluorescence method relative to control2013European journal of medicinal chemistry, Nov, Volume: 69Design, synthesis and structure-activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor.
AID409687Inhibition of TCPTP by pNPP assay2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID1386859Modulation of ABCB1 (unknown origin) expressed in human COLO320 cells co-expressing LRP assessed as fluorescence activity ratio at 20 uM pretreated for 10 mins followed by rhodamine 123 addition and measured after 20 mins by flow cytometry (Rvb = 0.79 No_2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID1424281Cytotoxicity in human T47D cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1195230Inhibition of TCPTP (unknown origin)2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Design and synthesis of novel 1,2-dithiolan-4-yl benzoate derivatives as PTP1B inhibitors.
AID1414759Cytotoxicity activity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID1275393Inhibition of human LAR as hydrolysis of pNPP after 2 mins2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity.
AID1446872Inhibition of recombinant HIV-1 group M subtype B RT-RNase H activity expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA annealed to a complementary 18-nucleotide 5'-dabsyl-labeled DNA as substrate measured after 1 hr2017European journal of medicinal chemistry, Apr-21, Volume: 130Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase.
AID1578454Cytotoxicity against human FADU cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID750453Hemolytic activity against rabbit RBC after 60 mins by spectrophotometry2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
AID1075593Cytotoxicity against mouse B16F10 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1391716Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBsAg secretion after 3 days by ELISA2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID79123Concentration which was toxic to 50% of the mock-infected H9 lymphocyte.2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Synthesis and anti-HIV activity of oleanolic acid derivatives.
AID697025Cytotoxicity against human HT-29 cells after 96 hrs by trypan blue exclusion assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID623338Cytotoxicity against human M14 cells after 48 hrs by MTT assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii.
AID664364Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 50 to 100 uM after 24 hrs by Griess method2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.
AID1325413Oral bioavailability in Sprague-Dawley rat at 25 mg/kg2016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
Discovery of ursolic acid prodrug (NX-201): Pharmacokinetics and in vivo antitumor effects in PANC-1 pancreatic cancer.
AID1728066Activation of AMPK in human Huh-7 cells assessed as increase in AMPK phosphorylation at Thr172 residue at 10 uM measured after 12 hrs by Western blot analysis2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
AID1066416Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID338358Cytotoxicity against human Raji cells assessed as cell viability at 10 mol ratio after 48 hrs relative to TPA
AID664370Induction of Nrf2-mediated HO1 mRNA expression in mouse RAW264.7 cells at 100 uM after 2 to 4 hrs by quantitative RT-PCR analysis relative to control2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.
AID1500896Drug level in normal fed guinea pig treated with 3-beta-[(2-Carboxyphenyl)carbonyloxy]-olean-12-en-28-oic acid at 30 mg/kg administered via oral gavage by LC-MS/MS analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID1234943Inhibition of TCPTP (unknown origin) assessed as pNPP hydrolysis after 30 mins2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Discovery of novel, potent, selective and cellular active ADC type PTP1B inhibitors via fragment-docking-oriented de novel design.
AID1386849Antiproliferative activity against mouse L5178Y cells harboring human ABCB1 after 72 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID545993Inhibition of recombinant PTP1B expressed in Escherichia coli BL21 after 30 mins by spectrophotometry2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Synthesis and biological evaluation of oleanolic acid derivatives as inhibitors of protein tyrosine phosphatase 1B.
AID629583Induction of apoptosis in mouse B16F10 cells assessed as necrotic cells at 30 uM after 24 hrs using annexin V-FITC/propidium iodide staining by flow cytometry2011European journal of medicinal chemistry, Dec, Volume: 46, Issue:12
Maslinic acid derivatives induce significant apoptosis in b16f10 murine melanoma cells.
AID340967Cytotoxicity against human MCF7 cells assessed as cell death by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID340974Toxicity in BALB/c mouse at 15 to 100 mg/kg, ip daily for 3 days assessed after 15 days2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1867266Inhibition of porcine pancreas elastase activity preincubated for 10 mins along with substrate followed by enzyme addition using N-succinyl-Ala-Ala-Ala-p-nitroanilide as substrate and measured after 30 mins by microplate reader assay2022Bioorganic & medicinal chemistry, 06-01, Volume: 63Elastase inhibitory activity of quinoline Analogues: Synthesis, kinetic mechanism, cytotoxicity, chemoinformatics and molecular docking studies.
AID587675Antibacterial activity against Escherichia coli assessed as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID718398Inhibition of tumor promotion in human Raji cells assessed as TPA-induced Epstein-Barr virus early antigen activation at 1000 mol ratio/TPA after 48 hrs by indirect immunofluorescence analysis relative to TPA alone2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Synthesis and docking studies of novel antitumor benzimidazoles.
AID1195233Inhibition of LAR (unknown origin)2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Design and synthesis of novel 1,2-dithiolan-4-yl benzoate derivatives as PTP1B inhibitors.
AID739907Cytotoxicity against human MCF7 cells by MTT assay2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
AID402569Inhibition of DNA polymerase beta lyase activity2004Journal of natural products, Jun, Volume: 67, Issue:6
New neolignans that inhibit DNA polymerase beta lyase.
AID1354804Inhibition of Mycobacterium tuberculosis H37Ra PTPB expressed in Escherichia coli BL21 (DE3) using p-nitrophenyl phosphate as substrate preincubated for 10 mins followed by substrate addition measured for 5 mins by spectrophotometric analysis2018Journal of natural products, 06-22, Volume: 81, Issue:6
Peniisocoumarins A-J: Isocoumarins from Penicillium commune QQF-3, an Endophytic Fungus of the Mangrove Plant Kandelia candel.
AID1243368Inhibition of PTP1B (unknown origin) pre-incubated for 10 mins before addition of p-nitrophenyl phosphate substrate and measured 30 mins post substrate addition2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Strongylophorines, new protein tyrosine phosphatase 1B inhibitors, from the marine sponge Strongylophora strongilata collected at Iriomote Island.
AID623342Induction of apoptosis in human M14 cells assessed as increase in hypodiploid cells up to 25 uM after 24 hrs using propidium iodide staining by flow cytometry2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii.
AID1551278Inhibition of human recombinant GST-tagged PTP1B expressed in Escherichia coli BL21 (DE3) using pNPP as substrate at 20 ug/ml measured for 2 mins by colorimetric analysis2019European journal of medicinal chemistry, Jun-15, Volume: 172Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
AID1430419Inhibition of human CD45 cytoplasmic domain (584 to 1281 residues) expressed in yeast using pNPP as substrate preincubated for 10 mins followed by substrate addition measured after 30 mins2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Furanoterpenes, new types of protein tyrosine phosphatase 1B inhibitors, from two Indonesian marine sponges, Ircinia and Spongia spp.
AID1578450Cytotoxicity against human A375 cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID337068Cytotoxicity against human A2780 cells2003Journal of natural products, Mar, Volume: 66, Issue:3
New cytotoxic lupane triterpenoids from the twigs of Coussarea paniculata.
AID1431432Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1364653Inhibition of human 17beta-HSD2 expressed in HEK293 cell lysates at 20 uM incubated for 10 mins using [2,4,6,7-3H]-estradiol and NAD+ by scintillation counting method2017Journal of natural products, 04-28, Volume: 80, Issue:4
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.
AID409686Inhibition of PTP1B by pNPP assay2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID1500891Terminal half life in normal fed guinea pig at 30 mg/kg administered via oral gavage by LC-MS/MS analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID1347570Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and cytotoxic activity of N-Modified oleanolic saponins bearing A glucosamine.
AID1398544Cytotoxicity against human OVCAR3 cells assessed as reduction in cell viability after 72 hrs by CellTiter 96 aqueous one solution assay2018Bioorganic & medicinal chemistry, 08-15, Volume: 26, Issue:15
Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives.
AID1187408Inhibition of LPS-induced NO production in mouse J774A1 cells compound preincubated for 1 hr before LPS treatment by Griess reaction2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: synthesis, biological evaluation and docking studies.
AID1515733Cytotoxicity against human Bel7402/5-FU cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID1272461Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
AID1651820Downregulation of PCNA expression in human BPH1 cells at 125 to 500 uM after 24 hrs by immunoblot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID204562The concentration required to inhibit complement mediated hemolysis of sensitized sheep RBC2003Bioorganic & medicinal chemistry letters, Apr-07, Volume: 13, Issue:7
Synthesis of low molecular weight compounds with complement inhibition activity.
AID380765Inhibition of rat DNA polymerase in absence of bovine serum albumin2006Journal of natural products, Mar, Volume: 69, Issue:3
Bioactive triterpenoids from Salvia species.
AID311143Selectivity index, ratio of IC50 for mouse J774 cells to IC50 for Trypanosoma brucei brucei bloodstream trypomastigotes2007Journal of natural products, Aug, Volume: 70, Issue:8
Antitrypanosomal activity of triterpenoids and sterols from the leaves of Strychnos spinosa and related compounds.
AID290246Enhancement of LPS-Stimulated lymphocyte proliferation in BALB/c mouse at 10 mg/kg by MTT assay2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1166647Inhibition of human LMW-PTP IF2 using p-nitrophenylphosphate as substrate by spectrophotometry2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
AID1910671Antiviral activity against Influenza A A/WSN/33 (H1N1) infected in dog MDCK cells assessed as inhibition of viral induced cytopathic effect incubated for 40 hrs by CellTiter-Glo assay2022Journal of medicinal chemistry, 05-26, Volume: 65, Issue:10
Discovery of Pentacyclic Triterpenoid PROTACs as a Class of Effective Hemagglutinin Protein Degraders.
AID467997Cytotoxicity activity against mouse LLC cells after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Oleanane-type triterpenoids from Aceriphyllum rossii and their cytotoxic activity.
AID338355Cytotoxicity against human Raji cells assessed as cell viability at 5000 mol ratio after 48 hrs relative to TPA
AID201653Compound was tested for its cytotoxicity against human malignant melanoma cell line SK-MEL1999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and evaluation of potential complement inhibitory semisynthetic analogs of oleanolic acid.
AID1243946Cytotoxicity against human 8505C cells assessed as cell survival after 96 hrs by SRB assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
AID697028Inhibition of phospholipase A22011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID22426350 percent inhibitory concentration of compound to inhibit nitric oxide production induced by IFN-gamma in mouse macrophages2000Journal of medicinal chemistry, May-04, Volume: 43, Issue:9
Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages.
AID1176099Inhibition of CDC25B (unknown origin) using pNPP as substrate by spectrophotometry2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Bioactive constituents from the green alga Caulerpa racemosa.
AID1770429Antibacterial activity against Salmonella enterica subsp.enterica ATCC13076 assessed as growth inhibition after 20 hrs by broth microdilution method2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID300494Cytotoxicity against human KB-VIN cells by sulforhodamine B assay2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID538479Cytotoxicity against human HL60 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Dec-01, Volume: 20, Issue:23
Oleanane-type triterpenoids from Panax stipuleanatus and their anticancer activities.
AID1617470Antiproliferative activity against human NCI-H1975 cells harbouring EGFR L858R/T790M/C797S mutant incubated for 72 hrs by MTS assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID687538Inhibition of human recombinant PTP-1B expressed in Escherichia coli TB1 using p-nitrophenyl phosphate as substrate at 10 to 50 uM after 1 hr2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID1075592Induction of apoptosis in mouse B16F10 cells assessed as normal cells at IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 77.9 +/- 1.5%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1617774Inhibition of human recombinant 5-LOX expressed in insect cells assessed as decrease in production of 5-HPETE and 5-HETE using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric io2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1416504Cytotoxicity against human Bel7402 cells after 24 hrs by MTT assay2017MedChemComm, Aug-01, Volume: 8, Issue:8
Extraction of antioxidant and antiproliferative ingredients from fruits of
AID1201590Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition at 100 uM after 24 hrs by turbidimetric analysis2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID396350Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 10 molar ratio after 24 hrs relative to TPA2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Lanostane-type triterpenoids from the sclerotia of Inonotus obliquus possessing anti-tumor promoting activity.
AID403340Inhibition of COX22005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID1504263Cytotoxic activity in human HeLa cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID1061259Inhibition of topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled plasmid DNA assessed as intensity of supercoiled DNA after 30 mins by agarose gel electrophoresis relative to camptothecin2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.
AID1075591Induction of apoptosis in mouse B16F10 cells assessed as early apoptotic cells at IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 3.9 +/- 0.4%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID378922Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA induction at 1000 molar ratio by immunofluorescence assay relative to TPA2000Journal of natural products, Jan, Volume: 63, Issue:1
Bioactive steroids from the whole herb of Euphorbia chamaesyce.
AID1651812Downregulation of Cyclin D1 expression in prostate tissue of Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 to 10 mg/kg, ip by Western blot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1617464Antiproliferative activity against human MCF7 cells incubated for 72 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID595753Cytotoxicity against human A549 cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID767559Inhibition of TCPTP (unknown origin)2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
The first synthesis of natural disulfide bruguiesulfurol and biological evaluation of its derivatives as a novel scaffold for PTP1B inhibitors.
AID1910684Induction of degradation of influenza A Hemagglutinin transfected in HEK293T cells assessed as reduction in level of hemagglutinin at upto 25 uM by immunoblot analysis2022Journal of medicinal chemistry, 05-26, Volume: 65, Issue:10
Discovery of Pentacyclic Triterpenoid PROTACs as a Class of Effective Hemagglutinin Protein Degraders.
AID687543Inhibition of human recombinant LAR expressed in Escherichia coli TB1 using p-nitrophenyl phosphate as substrate after 1 hr2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID1297379Antitrichomonal activity against metronidazole-sensitive Trichomonas vaginalis ATCC 30236 clinical isolate trophozoites assessed as parasite viability at 100 uM after 24 hrs by trypan blue dye based hemocytometry2016Bioorganic & medicinal chemistry letters, May-01, Volume: 26, Issue:9
Caatinga plants: Natural and semi-synthetic compounds potentially active against Trichomonas vaginalis.
AID1367384Inhibition of GST-tagged TCPTP (unknown origin) using pNPP as substrate measured for 3 mins by colorimetric assay2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Benzo[c][1,2,5]thiadiazole derivatives: A new class of potent Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.
AID1434747Inhibition of GST-tagged human LAR expressed in Escherichia coli at 20 ug/ml using pNPP as substrate relative to control2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Discovery of core-structurally novel PTP1B inhibitors with specific selectivity containing oxindole-fused spirotetrahydrofurochroman by one-pot reaction.
AID1624293Inhibition of baker's yeast alpha-glucosidase using phenol-alphaD-glycopyranoside as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins2019European journal of medicinal chemistry, Feb-15, Volume: 164Synthesis and biological evaluation of novel oleanolic acid analogues as potential α-glucosidase inhibitors.
AID334271Induction of melanogenesis in mouse B16 2F2 cells assessed as intracellular melanin content up to 10 uM after 3 days2002Journal of natural products, May, Volume: 65, Issue:5
Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line.
AID735306Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated IL-12p40 production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID1310453Cytotoxicity against mouse B16F10 cells assessed as growth inhibition after 72 hrs by MTT assay2016European journal of medicinal chemistry, Aug-08, Volume: 118Semi-synthesis and antiproliferative evaluation of PEGylated pentacyclic triterpenes.
AID1310311Inhibition of human TCPTP using pNPP as substrate incubated for 30 mins2016European journal of medicinal chemistry, Aug-08, Volume: 118Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
AID1773062Inhibition of recombinant PTP1B catalytic domain (unknown origin) assessed as reduction in pNP formation using pNPP as substrate by absorbance based analysis
AID1074432Effective permeability in Sprague-Dawley rat single-pass intestinal perfusion model assessed as PepT1-mediated drug transport at 0.1 mM administered in MES buffer at pH 6 via PVC tubing after 20 to 120 mins by HPLC analysis2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
AID1617781Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis r2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1266499Cytotoxicity against human HEK293 cells assessed as cell viability after 24 hrs by cell titer-blue assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Dibenz[b,f]oxepin and Antimycobacterial Chalcone Constituents of Empetrum nigrum.
AID328034Effect on DNA polymerase beta expression in human A549 cells at 25 uM after 48 hrs by Western blot analysis2008Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8
Inhibitors of DNA polymerase beta: activity and mechanism.
AID486209Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 1000 molar ratio after 48 hrs2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Hybrids of 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2) and various anti-oxidants as cancer chemopreventive agents.
AID1424280Cytotoxicity in human MDA-MB-468 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1250814Antiproliferative activity against human HeLa cells after 48 hrs by CCK-8 assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
AID338352Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 100 mol ratio after 48 hrs relative to TPA
AID1275392Inhibition of human SHP2 as hydrolysis of pNPP after 2 mins2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity.
AID1504290Antiproliferative activity in human DU145 cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID774920Inhibition of TPA-induced EBV early antigen activation infected in human Raji cells assessed as antigen activity at 10 mol ratio/TPA after 48 hrs by immunofluorescence method relative to control2013European journal of medicinal chemistry, Nov, Volume: 69Design, synthesis and structure-activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor.
AID1102317Antifeedant activity against fourth-instar larval stage of Spodoptera litura reared on castor leaves assessed as decrease in food consumption at 100 ug/cm2 after 48 hr by no-choice leaf disk assay relative to untreated control2003Journal of agricultural and food chemistry, Mar-26, Volume: 51, Issue:7
Antifeedant activity of some pentacyclic triterpene acids and their fatty acid ester analogues.
AID1201623Downregulation of txtA gene expression in Streptomyces scabiei CGMCC4.7610246 at 0.5 x MIC by Q-RT-PCR analysis relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID1634718Antibacterial activity against Bacillus thuringiensis measured after 5 to 6 hrs by microdilution titre technique2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1770395Antiproliferative activity against human Z138 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID1371027Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by WST-8 dye based assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
α-Glucosidase Inhibitory and Cytotoxic Taxane Diterpenoids from the Stem Bark of Taxus wallichiana.
AID1378642Inhibition of IFN-gamma stimulated STAT3 (unknown origin) expressed in human HeLa cells after 6 hrs by luciferase reporter gene assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Electrophilic Triterpenoid Enones: A Comparative Thiol-Trapping and Bioactivity Study.
AID1102316Antifeedant activity against fourth-instar larval stage of Spodoptera litura reared on castor leaves assessed as decrease in food consumption at 150 ug/cm2 after 48 hr by no-choice leaf disk assay relative to untreated control2003Journal of agricultural and food chemistry, Mar-26, Volume: 51, Issue:7
Antifeedant activity of some pentacyclic triterpene acids and their fatty acid ester analogues.
AID409688Inhibition of human recombinant SHP12008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID1431433Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1770390Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID1414760Cytotoxicity activity against mouse 4T1 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID1422362Cytotoxicity against human A549 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID566009Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 1000 molar ratio after 48 hrs relative to positive control2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives.
AID1770393Antiproliferative activity against human HL-60 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID697016Competitive inhibition of dehydrogenase activity of N-terminal 6His-tagged human AKR1B10 W220Y mutant expressed in Escherichia coli BL21(DE3) assessed as NADP+-linked geraniol oxidation2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1272460Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
AID1651809Induction of PARP1 cleavage in prostate tissue of Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 10 mg/kg, ip by Western blot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1246452Antiinflammatory activity in IRC mouse assessed as inhibition of TPA-induced IL-23 mRNA expression in epidermis at 2 umol administered topically 30 mins prior to TPA challenge for twice weekly over 2 weeks measured 6 hrs post last TPA challenge by qRT-PCR2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties.
AID1191562Cytotoxicity against human HuH7 cells after 90 mins by MTT assay2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Absolute structures and bioactivities of euryspongins and eurydiene obtained from the marine sponge Euryspongia sp. collected at Iriomote Island.
AID356610Inhibition of DNA polymerase beta lyase activity by deoxyribose phosphate excision assay2003Journal of natural products, Nov, Volume: 66, Issue:11
A new acylated oleanane triterpenoid from Couepia polyandra that inhibits the lyase activity of DNA polymerase beta.
AID595752Cytotoxicity against human DU145 cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID340844Cytotoxicity against human HeLa cells assessed as cell death by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1378641Inhibition of TNF-alpha stimulated NF-kappaB (unknown origin) expressed in mouse NIH/3T3 cells after 6 hrs by luciferase reporter gene assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Electrophilic Triterpenoid Enones: A Comparative Thiol-Trapping and Bioactivity Study.
AID1651329Neuroprotective activity against CoCl2-induced neuronal injury in rat PC12 cells2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Application of tandem biotransformation for biosynthesis of new pentacyclic triterpenoid derivatives with neuroprotective effect.
AID1617778Inhibition of ovine recombinant COX1 assessed as decrease in formation of PGE2 using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1337346Aqueous solubility of the compound by HPLC method2016European journal of medicinal chemistry, Nov-29, Volume: 124Synthesis and biological evaluation of novel pentacyclic triterpene α-cyclodextrin conjugates as HCV entry inhibitors.
AID378285Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by BACTEC 460 radiorespirometric assay2000Journal of natural products, Dec, Volume: 63, Issue:12
Oleanane triterpenes from Junellia tridens.
AID1075584Induction of apoptosis in mouse B16F10 cells assessed as necrotic cells at 2 X IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 4.0 +/- 0.6%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID290239Enhancement of ConA-Stimulated lymphocyte proliferation in BALB/c mouse at 10 mg/kg by MTT assay2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1466835Inhibition of human amyloid beta (1 to 40) aggregation assessed as aggregation level at 25 uM after 24 hrs by Th-T fluorescence assay relative to control2017Bioorganic & medicinal chemistry, 07-01, Volume: 25, Issue:13
Inhibition of amyloid β aggregation and protective effect on SH-SY5Y cells by triterpenoid saponins from the cactus Polaskia chichipe.
AID1666867Inhibition of swarming motility of Escherichia coli clinical isolates incubated for 16 to 20 hrs2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
Optimized plant compound with potent anti-biofilm activity across gram-negative species.
AID266475Inhibition of rabbit muscle GPa2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase.
AID1176097Inhibition of purified recombinant PTP1B catalytic domain (unknown origin) using pNPP as substrate by spectrophotometry2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Bioactive constituents from the green alga Caulerpa racemosa.
AID469220Inhibition of rabbit muscle glycogen phosphorylase assessed as release of phosphate from glucose-1-phosphate after 25 mins2009Journal of natural products, Aug, Volume: 72, Issue:8
Synthesis of 3-deoxypentacyclic triterpene derivatives as inhibitors of glycogen phosphorylase.
AID664366Cytotoxicity against mouse RAW264.7 cells at 100 uM after 8 hrs by MTT assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.
AID1651805Downregulation of prostate Bcl2 expression in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 to 10 mg/kg, ip by Western blot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1443718Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by neutral red assay2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Cytotoxic dammarane-type triterpenoids from the leaves of Viburnum sambucinum.
AID1424282Cytotoxicity in human MCF12A cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1651801Suppression of 5-alpha reductase2 mRNA expression in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 to 10 mg/kg, ip by qRT-PCR method2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1666869Inhibition of swarming motility of Salmonella enterica clinical isolates incubated for 16 to 20 hrs2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
Optimized plant compound with potent anti-biofilm activity across gram-negative species.
AID290236Immunostimulatory effect against SRBC-induced hormonal response in BALB/c mouse assessed as antibody production at 10 m/kg2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1500872MRT (0 to infinity) in normal fed guinea pig at 30 mg/kg administered via oral gavage by LC-MS/MS analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID1773664Inhibition of Saccharomyces cerevisiae alpha-glucosidase using pNPG as substrate preincubated for 10 mins followed by substrate addition and measured for 35 mins by microplate photometric method2021Journal of natural products, 09-24, Volume: 84, Issue:9
Dual High-Resolution α-Glucosidase and PTP1B Inhibition Profiling Combined with HPLC-PDA-HRMS-SPE-NMR Analysis for the Identification of Potentially Antidiabetic Chromene Meroterpenoids from
AID1172696Cytotoxicity against human HepG2 cells2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and cytotoxic evaluation of novel ester-triazole-linked triterpenoid-AZT conjugates.
AID402404Ratio of IC50 for COX2 to IC50 for COX11998Journal of natural products, Oct, Volume: 61, Issue:10
Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis.
AID380764Inhibition of rat DNA polymerase in presence of bovine serum albumin2006Journal of natural products, Mar, Volume: 69, Issue:3
Bioactive triterpenoids from Salvia species.
AID201655Cytotoxicity against human malignant melanoma cell line SK-MEL2001Bioorganic & medicinal chemistry letters, Jul-09, Volume: 11, Issue:13
Enantioselective synthesis and complement inhibitory assay of A/B-ring partial analogues of oleanolic acid.
AID1617461Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1706900Antiviral activity against HCV pseudoparticle infected in Huh-7 cells assessed as inhibition of viral entry pretreated for 30 mins with cells followed by viral infection for 4 hrs and subsequent compound wash out and measured after 72 hrs by Bright-Glo re2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature?
AID1191563Cytotoxicity against human HCT15 cells after 48 hrs by MTT assay2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Absolute structures and bioactivities of euryspongins and eurydiene obtained from the marine sponge Euryspongia sp. collected at Iriomote Island.
AID1416508Cytotoxicity against human Bel7402 cells assessed as inhibition of cell proliferation at 100 ug/ml after 24 hrs by MTT assay relative to control2017MedChemComm, Aug-01, Volume: 8, Issue:8
Extraction of antioxidant and antiproliferative ingredients from fruits of
AID1785791Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect at 100 uM measured after 40 hrs incubation by inverted microscpic imaging analysis2021ACS medicinal chemistry letters, Nov-11, Volume: 12, Issue:11
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.
AID1551310Selectivity ratio of IC50 for human recombinant GST-tagged SHP2 to IC50 for human recombinant GST-tagged PTP1B2019European journal of medicinal chemistry, Jun-15, Volume: 172Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
AID1651819Cytotoxicity against human BPH1 cells at 62.5 to 1000 uM by MTT assay2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID89401In vitro concentration required to inhibit classical pathway complement induced hemolysis in human2001Bioorganic & medicinal chemistry letters, Jul-09, Volume: 11, Issue:13
Enantioselective synthesis and complement inhibitory assay of A/B-ring partial analogues of oleanolic acid.
AID671764Inhibition of HCV NS3 helicase ATP hydrolysis activity overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of inorganic phosphate release by AM/MG-based colometric analysis in the presence of M13 ssDNA2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID1383852Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID1662676Inhibition of TDP1 (unknown origin) expressed in Escherichia coli BL21 (DE3) at 100 uM using 5'-FAM-AGGATCTAAAAGACTT-BHQ-3' as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay relative to control2020Bioorganic & medicinal chemistry, 06-01, Volume: 28, Issue:11
Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors.
AID1317199Cytotoxicity against MDCK cells assessed as cell death after 2 days by MTT assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors.
AID1067063Cytotoxicity against human PC3 cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Synthesis of novel ring-A fused hybrids of oleanolic acid with capabilities to arrest cell cycle and induce apoptosis in breast cancer cells.
AID1504293Antiproliferative activity in African green monkey Vero cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID1066420Cytotoxicity against human 8505C cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID1386853Cytotoxicity against human MRC5 cells after 24 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID1163423Inhibition of 14-3-3epsilon protein expression in human HT-29 cells at 10 uM incubated for 1 to 4 hrs by Western blotting method2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Identification of 4'-O-β-D-glucosyl-5-O-methylvisamminol as a novel epigenetic suppressor of histone H3 phosphorylation at Ser10 and its interaction with 14-3-3ε.
AID687536Antidiabetic activity in STZ-nicotinamide diabetic Wistar rat T2DM model assessed as decrease in blood glucose level at 50 mg/kg, po after 7 hrs by enzymatic glucose oxidase method relative to control2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID1275391Inhibition of human SHP1 as hydrolysis of pNPP after 2 mins2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity.
AID1565064Selectivity index, ratio of CC50 for MDCK cells to IC50 for influenza A virus A/WSN/332019European journal of medicinal chemistry, Nov-15, Volume: 182Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
AID1617469Antiproliferative activity against human NCI-H1975 cells incubated for 72 hrs by MTS assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1617468Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo ki2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1414763Cytotoxicity activity against human PANC1 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID1243945Cytotoxicity against human 518A2 cells assessed as cell survival after 96 hrs by SRB assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
AID616211Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 10 molar ratio after 48 hrs relative to control2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Conjugates of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) as cancer chemopreventive agents.
AID378967Cytotoxicity against african green monkey Vero cells2006Journal of natural products, Jan, Volume: 69, Issue:1
Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities.
AID1551281Inhibition of human recombinant GST-tagged CDC25B expressed in Escherichia coli BL21 (DE3) using pNPP as substrate measured for 2 mins by colorimetric analysis2019European journal of medicinal chemistry, Jun-15, Volume: 172Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
AID290241Increased phagocytic index in BALB/c mouse at 10 mg/kg2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1504287Antiproliferative activity in human SiHa cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID376698Inhibition of rat DNA polymerase beta at 10 ug/mL1999Journal of natural products, Dec, Volume: 62, Issue:12
DNA polymerase beta inhibitors from Baeckea gunniana.
AID1367376Inhibition of GST-tagged PTP1B (unknown origin) using pNPP as substrate measured for 3 mins by colorimetric assay2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Benzo[c][1,2,5]thiadiazole derivatives: A new class of potent Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.
AID376970Induction of cell differentiation of human HL60 cells after 3 days by NBT reduction method2006Journal of natural products, May, Volume: 69, Issue:5
Triterpenoids from the resin of Styrax tonkinensis and their antiproliferative and differentiation effects in human leukemia HL-60 cells.
AID1383848Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID338353Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 10 mol ratio after 48 hrs relative to TPA
AID232989The compound was tested for its apoptotic activity; no DNA migration observed1999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and evaluation of potential complement inhibitory semisynthetic analogs of oleanolic acid.
AID340845Cytotoxicity against human PC3 cells assessed as cell death by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1846778Inhibition of PTP1B (unknown origin) by SpectraMax 340 microplate reader Analysis2021European journal of medicinal chemistry, Oct-05, Volume: 221Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
AID1666864Inhibition of swarming motility of Escherichia coli PY31 at 16 ug/mL incubated for 16 to 20 hrs relative to control2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
Optimized plant compound with potent anti-biofilm activity across gram-negative species.
AID1651797Toxicity in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia assessed as behavioural changes at 1 to 10 mg/kg, ip2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID402091Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA1998Journal of natural products, Sep, Volume: 61, Issue:9
Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids.
AID444762Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay relative to litocholic acid2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
AID1163424Inhibition of recombinant 14-3-3epsilon protein (unknown origin) expression in Escherichia coli assessed as reduction in 14-3-3epsilon and histone H3 Ser10 interaction using human HT-29 cells lysates at 1 uM incubated for 1 hr by Western blotting based GS2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Identification of 4'-O-β-D-glucosyl-5-O-methylvisamminol as a novel epigenetic suppressor of histone H3 phosphorylation at Ser10 and its interaction with 14-3-3ε.
AID1075587Induction of apoptosis in mouse B16F10 cells assessed as total apoptotic cells at IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 13.7 +/- 2.7%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1666866Inhibition of swarming motility of Pseudomonas aeruginosa clinical isolates incubated for 16 to 20 hrs2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
Optimized plant compound with potent anti-biofilm activity across gram-negative species.
AID664376Induction of Nrf2-mediated CAT mRNA expression in mouse RAW264.7 cells at 100 uM after 4 to 20 hrs by quantitative RT-PCR analysis relative to control2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.
AID1398543Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability after 72 hrs by CellTiter 96 aqueous one solution assay2018Bioorganic & medicinal chemistry, 08-15, Volume: 26, Issue:15
Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives.
AID1163421Inhibition of histone H3 Ser10 phosphorylation in human HT-29 cells at 10 uM incubated for 1 hr by Western blotting method2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Identification of 4'-O-β-D-glucosyl-5-O-methylvisamminol as a novel epigenetic suppressor of histone H3 phosphorylation at Ser10 and its interaction with 14-3-3ε.
AID1628353Cytotoxicity against human HT-29 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID1066418Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID772450Antiinflammatory activity in mouse macrophages assessed as inhibition of IFN-gamma-induced nitric oxide production after 48 hrs by Griess method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Keap calm, and carry on covalently.
AID426248Antiosteoclast activity in ICR mouse osteoblast like cells co-cultured with bone marrow cells assessed as effect on 1-alpha,25(OH)2D3-induced TRAP-positive osteoclast like multinucleated cell formation at 2 uM after 6 days medium replaced every 2 days rel2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.
AID426250Antiosteoclast activity in ICR mouse osteoblast like cells co-cultured with bone marrow cells assessed as recovery of 1-alpha,25(OH)2D3-induced TRAP-positive osteoclast like multinucleated cell formation at 20 uM after 6 days drug removal after 2 days rel2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.
AID467996Cytotoxic activity against human MCF7 cells after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Oleanane-type triterpenoids from Aceriphyllum rossii and their cytotoxic activity.
AID1416503Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay2017MedChemComm, Aug-01, Volume: 8, Issue:8
Extraction of antioxidant and antiproliferative ingredients from fruits of
AID1422363Cytotoxicity against human 8505C cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1074442Cytotoxicity against human A549 cells after 48 hrs by CCK-8 assay2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
AID1651822Inhibition of PCNA-mediated cell cycle progression in human BPH-1 cells assessed as reduction in cyclin D level at 250 to 500 uM after 24 hrs by immunoblot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1391718Cytotoxicity against human HepG2.215 cells assessed as reduction in cell viability after 3 days by MTT assay2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID1651811Downregulation of Cdk4 expression in prostate tissue of Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 to 10 mg/kg, ip by Western blot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID587674Antibacterial activity against Enterococcus faecalis assessed as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID1074443Cytotoxicity against human HCT116 cells after 48 hrs by CCK-8 assay2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
AID1383850Cytotoxicity against human A549 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID750462Antiviral activity against pseudo HCV infected in human 293T cells assessed as inhibition of HCV pseudo particles entry at 10 uM after 72 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
AID1230554Inhibition of human recombinant PTP1B using pNPP as substrate assessed as rate of hydrolysis incubated for 10 mins prior to substrate addition measured after 30 mins by microplate reader analysis2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Structures and Biological Evaluations of Agelasines Isolated from the Okinawan Marine Sponge Agelas nakamurai.
AID1524963Inhibition of TCPTP (unknown origin) using pNPP as substrate2019Bioorganic & medicinal chemistry letters, 05-15, Volume: 29, Issue:10
Discovery of 1,3-diphenyl-1H-pyrazole derivatives containing rhodanine-3-alkanoic acid groups as potential PTP1B inhibitors.
AID402402Inhibition of COX2-catalyzed prostaglandin biosynthesis after 10 mins of preincubation1998Journal of natural products, Oct, Volume: 61, Issue:10
Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1256624Effect on neurite outgrowth in rat PC12 cells at 10 and 20 uM after 48 hrs by inverted microscopic analysis2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells.
AID1439506Antiparasitic activity against Brugia malayi2017European journal of medicinal chemistry, Mar-31, Volume: 129Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
AID1201617Upregulation of hla gene expression in Staphylococcus aureus ATCC 25923 at 0.5 x MIC by Q-RT-PCR analysis relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID1386856Modulation of human ABCB1 expressed in mouse L5178Y cells assessed as fluorescence activity ratio at 20 uM pretreated for 10 mins followed by rhodamine 123 addition and measured after 20 mins by flow cytometry (Rvb = 1.01 No_unit)2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID224258Compound was evaluated for inhibitory activity against production of nitric oxide (NO) induced by interferon-gamma (IFN-gamma) in mouse macrophages1998Bioorganic & medicinal chemistry letters, Oct-06, Volume: 8, Issue:19
Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages.
AID1628351Cytotoxicity against human 518A2 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID1830871Inhibition of human recombinant TCPTP using pNPP as substrate assessed as reduction in p-nitrophenol release incubated for 30 mins by absorbance based analysis2021Bioorganic & medicinal chemistry letters, 12-01, Volume: 53Germacrane sesquiterpenes from leaves of Eupatorium chinense inhibit protein tyrosine phosphatase.
AID1551308Selectivity ratio of IC50 for human recombinant GST-tagged TCPTP to IC50 for human recombinant GST-tagged PTP1B2019European journal of medicinal chemistry, Jun-15, Volume: 172Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
AID1651803Suppression of prostate epithelial thickness in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 mg/kg, ip by hematoxylin and eosin staining-based microscopic analysis relative to control2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID355884Enhancement of neurite outgrowth in rat PC12D cells up to 30 uM in absence of nerve growth factor2003Journal of natural products, May, Volume: 66, Issue:5
Sterol and triterpenoid constituents of Verbena littoralis with NGF-potentiating activity.
AID606484Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Antituberculosis cycloartane triterpenoids from Radermachera boniana.
AID340839Cytotoxicity against human HepG2 cells assessed as cell death at 0.001 uM after 24 hrs by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1651806Downregulation of prostate Bcl-xL expression in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 to 10 mg/kg, ip by Western blot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID377614Cicatrizant activity against mouse measured by wound breaking strength at 12.5 mg/ml administered every 12 hrs measured after 48 hrs relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
In vivo wound-healing activity of oleanolic acid derived from the acid hydrolysis of Anredera diffusa.
AID404873Inhibition of rabbit muscle glycogen phosphorylase A assessed as phosphate release from glucose-1-phosphate2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.
AID1061260Inhibition of topoisomerase 2 (unknown origin)-mediated kinetoplast DNA decatenation assessed as concentration of the compound exhibiting activity of 100 uM etoposide after 30 mins by agarose gel electrophoresis2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.
AID1728767Anti-necroptotic activity in mouse L929 cells assessed as inhibition of TNFalpha/Z-VAD-fmk (TZ)-induced necroptosis by measuring increase in cell viability measured after 12 hrs by celltiter-glo luminescent cell viability assay2021European journal of medicinal chemistry, Feb-15, Volume: 212Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors.
AID697015Competitive inhibition of dehydrogenase activity of N-terminal 6His-tagged human AKR1B10 Q303S mutant expressed in Escherichia coli BL21(DE3) assessed as NADP+-linked geraniol oxidation2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1066419Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID340838Cytotoxicity against human HepG2 cells assessed as cell death at 0.01 uM after 24 hrs by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1504265Cytotoxic activity in human MCF7 cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID1651816Downregulation of PCNA mRNA expression in prostate tissue of Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 mg/kg, ip by qRT-PCR method2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID340842Cytotoxicity against human Hep3B cells assessed as cell death at 0.01 uM after 24 hrs by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID687533Antidiabetic activity in STZ-nicotinamide diabetic Wistar rat T2DM model assessed as decrease in blood glucose level at 50 mg/kg, po after 1 hr by enzymatic glucose oxidase method relative to control2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID409692Selectivity for PTP1B to human recombinant SHP12008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID1697440Selectivity ratio of IC50 for inhibition of CES2A1 in human liver microsomes to IC50 for CES1A1 in human liver microsomes2020Journal of natural products, 10-23, Volume: 83, Issue:10
Bioactivity-Guided Discovery of Human Carboxylesterase Inhibitors from the Roots of
AID1773666Inhibition of human recombinant PTP1B (1 to 322 residues) expressed in Escherichia coli using pNPP as substrate preincubated with substrate for 10 mins followed by enzyme addition and measured for 10 mins by absorbance based analysis2021Journal of natural products, 09-24, Volume: 84, Issue:9
Dual High-Resolution α-Glucosidase and PTP1B Inhibition Profiling Combined with HPLC-PDA-HRMS-SPE-NMR Analysis for the Identification of Potentially Antidiabetic Chromene Meroterpenoids from
AID1172639Inhibition of cell proliferation of human U251 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID687535Antidiabetic activity in STZ-nicotinamide diabetic Wistar rat T2DM model assessed as decrease in blood glucose level at 50 mg/kg, po after 5 hrs by enzymatic glucose oxidase method relative to control2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID1201592Antibacterial activity against Streptomyces scabiei CGMCC4.7610246 assessed as growth inhibition at 100 uM after 36 hrs by turbidimetric analysis2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID549725Increase of GST-tagged full length Vhr activity expressed in Escherichia coli BL21 at 10 uM after 30 mins2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
A novel screening model for the molecular drug for diabetes and obesity based on tyrosine phosphatase Shp2.
AID1662673Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by MTT assay2020Bioorganic & medicinal chemistry, 06-01, Volume: 28, Issue:11
Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors.
AID697011Selectivity ratio of IC50 for human recombinant AKR1B1 to IC50 for human AKR1B102011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1662671Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay2020Bioorganic & medicinal chemistry, 06-01, Volume: 28, Issue:11
Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors.
AID391031Inhibition of human recombinant PTP1B after 30 mins2008Journal of natural products, Oct, Volume: 71, Issue:10
Triterpenoids from the leaves of Diospyros kaki (persimmon) and their inhibitory effects on protein tyrosine phosphatase 1B.
AID1431435Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1166644Inhibition of purified human GST-tagged PTP-1B using p-nitrophenylphosphate as substrate by spectrophotometry2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
AID1172695Cytotoxicity against human KB cells2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and cytotoxic evaluation of novel ester-triazole-linked triterpenoid-AZT conjugates.
AID328030Inhibition of lyase activity of DNA polymerase beta2008Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8
Inhibitors of DNA polymerase beta: activity and mechanism.
AID697019Selectivity ratio of Ki for N-terminal 6His-tagged human AKR1B10 Q303S mutant to Ki for N-terminal 6His-tagged human AKR1B102011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1422357Cytotoxicity against human A2780 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID444761Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
AID1422359Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1414764Cytotoxicity activity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID140447Inhibitory activity against production of nitric oxide induced by interferon gamma in mouse macrophages2002Bioorganic & medicinal chemistry letters, Apr-08, Volume: 12, Issue:7
A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production.
AID587673Antibacterial activity against Staphylococcus aureus assessed as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID1773663Inhibition of Saccharomyces cerevisiae alpha-glucosidase at 100 uM using pNPG as substrate preincubated for 10 mins followed by substrate addition and measured for 35 mins by microplate photometric method2021Journal of natural products, 09-24, Volume: 84, Issue:9
Dual High-Resolution α-Glucosidase and PTP1B Inhibition Profiling Combined with HPLC-PDA-HRMS-SPE-NMR Analysis for the Identification of Potentially Antidiabetic Chromene Meroterpenoids from
AID340837Cytotoxicity against human HepG2 cells assessed as cell death at 0.1 uM after 24 hrs by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1628354Cytotoxicity against human MCF7 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID338356Cytotoxicity against human Raji cells assessed as cell viability at 1000 mol ratio after 48 hrs relative to TPA
AID697024Cytotoxicity against human HT-29 cells at 30 uM after 96 hrs by trypan blue exclusion assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1873251Anti-obesity activity in female C57BL/6 mouse model of high-fat diet induced obesity assessed as body weight change at 0.005 % (w/v) administered orally for 16 weeks relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.
AID697017Selectivity ratio of Ki for N-terminal 6His-tagged human AKR1B10 K125L mutant to Ki for N-terminal 6His-tagged human AKR1B102011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID378286Antiviral activity against HIV1 3B isolate replication in human H9 cells assessed as decrease in viral p24 level after 4 days2000Journal of natural products, Dec, Volume: 63, Issue:12
Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives.
AID1317198Antiviral activity against Influenza A virus A/Thailand/Kan353/2004(H5N1) pseudovirus infected in MDCK cells co-infected with HA/HIV assessed as inhibition of viral replication preincubated with virus for 30 mins followed by viral infection for 48 hrs by 2016European journal of medicinal chemistry, Aug-25, Volume: 119Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors.
AID224269Inhibition of nitric oxide (NO) production induced by interferon-gamma (IFN-gamma) in mouse macrophages2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages.
AID376069Antibacterial activity against Porphyromonas gingivalis after 48 hrs by microtiter plate method1999Journal of natural products, Oct, Volume: 62, Issue:10
Activity of triterpenoid glycosides from the root bark of Mussaenda macrophylla against two oral pathogens.
AID1504288Antiproliferative activity in human MCF7 cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID266474Decrease in adrenaline-induced plasma glucose level in diabetic mouse at 100 mg/kg, po2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase.
AID616212Cytotoxicity against human Raji cells carrying EBV genome assessed as cell viability at 1000 molar ratio by trypan blue staining method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Conjugates of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) as cancer chemopreventive agents.
AID1443716Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by neutral red assay2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Cytotoxic dammarane-type triterpenoids from the leaves of Viburnum sambucinum.
AID1617466Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID235007In vitro therapeutic index (IC50 cytotoxicity/ IC50 complement inhibition) was determined2001Bioorganic & medicinal chemistry letters, Jul-09, Volume: 11, Issue:13
Enantioselective synthesis and complement inhibitory assay of A/B-ring partial analogues of oleanolic acid.
AID1391717Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion after 3 days by ELISA2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID1773665Inhibition of human recombinant PTP1B (1 to 322 residues) expressed in Escherichia coli at 100 uM using pNPP as substrate preincubated with substrate for 10 mins followed by enzyme addition and measured for 10 mins by absorbance based analysis2021Journal of natural products, 09-24, Volume: 84, Issue:9
Dual High-Resolution α-Glucosidase and PTP1B Inhibition Profiling Combined with HPLC-PDA-HRMS-SPE-NMR Analysis for the Identification of Potentially Antidiabetic Chromene Meroterpenoids from
AID739906Cytotoxicity against human A549 cells by MTT assay2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
AID1770392Antiproliferative activity against human DND41 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID378919Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA induction at 10 molar ratio by immunofluorescence assay relative to TPA2000Journal of natural products, Jan, Volume: 63, Issue:1
Bioactive steroids from the whole herb of Euphorbia chamaesyce.
AID311138Antitrypanosomal activity against Trypanosoma brucei brucei bloodstream trypomastigotes by alamar blue assay2007Journal of natural products, Aug, Volume: 70, Issue:8
Antitrypanosomal activity of triterpenoids and sterols from the leaves of Strychnos spinosa and related compounds.
AID549726Increase of GST-tagged full length HePTP activity expressed in Escherichia coli BL21 at 10 uM after 30 mins2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
A novel screening model for the molecular drug for diabetes and obesity based on tyrosine phosphatase Shp2.
AID90585The compound was tested in vitro for its inhibition of the classical pathway activation of human complement1999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and evaluation of potential complement inhibitory semisynthetic analogs of oleanolic acid.
AID486212Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 10 molar ratio after 48 hrs2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Hybrids of 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2) and various anti-oxidants as cancer chemopreventive agents.
AID1434742Inhibition of recombinant human PTP1B catalytic domain expressed in Escherichia coli BL21-CodonPlus (DE3) at 20 ug/ml using pNPP as substrate measured for 2 mins relative to control2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Discovery of core-structurally novel PTP1B inhibitors with specific selectivity containing oxindole-fused spirotetrahydrofurochroman by one-pot reaction.
AID300493Cytotoxicity against human KB cells by sulforhodamine B assay2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID1310455Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay2016European journal of medicinal chemistry, Aug-08, Volume: 118Semi-synthesis and antiproliferative evaluation of PEGylated pentacyclic triterpenes.
AID767556Inhibition of LAR (unknown origin)2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
The first synthesis of natural disulfide bruguiesulfurol and biological evaluation of its derivatives as a novel scaffold for PTP1B inhibitors.
AID1540971Inhibition of HIV1 protease expressed in Escherichia coli using Abz-Ala-Arg-Val-Nle-Tyr(NO2)-Glu-Ala-Nle-NH2 peptide as substrate by FRET assay2019Journal of natural products, 10-25, Volume: 82, Issue:10
Oleanolic Acid Derivatives as Potential Inhibitors of HIV-1 Protease.
AID1770388Antiproliferative activity against human HAP1 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID1250815Antiproliferative activity against human A549 cells after 48 hrs by CCK-8 assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
AID687534Antidiabetic activity in STZ-nicotinamide diabetic Wistar rat T2DM model assessed as decrease in blood glucose level at 50 mg/kg, po after 3 hrs by enzymatic glucose oxidase method relative to control2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID1269249Inhibition of recombinant human PTP1B using pNPP as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by microplate reader analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
A dimeric urea of the bisabolene sesquiterpene from the Okinawan marine sponge Axinyssa sp. inhibits protein tyrosine phosphatase 1B activity in Huh-7 human hepatoma cells.
AID1187407Inhibition of LPS-induced NO production in mouse RAW264.7 cells compound preincubated for 1 hr before LPS treatment by Griess reaction2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: synthesis, biological evaluation and docking studies.
AID377095Cytotoxicity against human A549 cells assessed as cell viability after 24 hrs by MTT assay2005Journal of natural products, Feb, Volume: 68, Issue:2
Three new triterpenes from Nerium oleander and biological activity of the isolated compounds.
AID132692Inhibitory activity against production of nitric oxide induced by interferon-gamma in mouse macrophages1999Bioorganic & medicinal chemistry letters, Dec-20, Volume: 9, Issue:24
Novel synthetic oleanane triterpenoids: a series of highly active inhibitors of nitric oxide production in mouse macrophages.
AID1246451Antiinflammatory activity in IRC mouse assessed as inhibition of TPA-induced IL-6 mRNA expression in epidermis at 2 umol administered topically 30 mins prior to TPA challenge for twice weekly over 2 weeks measured 6 hrs post last TPA challenge by qRT-PCR 2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties.
AID393218Toxicity in sheep erythrocytes assessed as induction of hemolysis2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID1382753Growth inhibition of human HepG2 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Mar-25, Volume: 148Diamine and PEGylated-diamine conjugates of triterpenic acids as potential anticancer agents.
AID623339Induction of apoptosis in human M14 cells assessed as activation of caspase-3 at 50 uM after 8 to 24 hrs by Western blot analysis2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii.
AID1272458Cytotoxicity against human FADU cells after 96 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
AID697013Competitive inhibition of dehydrogenase activity of N-terminal 6His-tagged human AKR1B10 K125L mutant expressed in Escherichia coli BL21(DE3) assessed as NADP+-linked geraniol oxidation2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID396352Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio by trypan blue staining relative to control2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Lanostane-type triterpenoids from the sclerotia of Inonotus obliquus possessing anti-tumor promoting activity.
AID1270874Cytotoxicity against Sprague-Dawley rat cortical neurons at 50 uM by MTT assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity.
AID616209Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 500 molar ratio after 48 hrs relative to control2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Conjugates of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) as cancer chemopreventive agents.
AID697022Cytotoxicity against human HT-29 cells at 10 uM after 96 hrs by trypan blue exclusion assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID687540Inhibition of human recombinant LMW-PTP1 expressed in Escherichia coli TB1 using p-nitrophenyl phosphate as substrate after 1 hr2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID1515726Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID1500869Inhibition of porcine pancreatic lipase using 2,3-dimercaptopropan-1-ol tributyrate as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by colorimetric assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID1067062Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Synthesis of novel ring-A fused hybrids of oleanolic acid with capabilities to arrest cell cycle and induce apoptosis in breast cancer cells.
AID1500890Tmax in normal fed guinea pig at 30 mg/kg administered via oral gavage by LC-MS/MS analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID1414765Cytotoxicity activity against mouse LLC cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID1434744Inhibition of GST-tagged human TCPCP expressed in Escherichia coli at 20 ug/ml using pNPP as substrate relative to control2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Discovery of core-structurally novel PTP1B inhibitors with specific selectivity containing oxindole-fused spirotetrahydrofurochroman by one-pot reaction.
AID340841Cytotoxicity against human Hep3B cells assessed as cell death at 0.1 uM after 24 hrs by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID587676Antibacterial activity against Pseudomonas aeruginosa as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID1465088Inhibition of porcine pancreatic alpha-amylase assessed as Vmax for substrate using starch as substrate at 47.1 uM by Michaelis-Menten plot analysis (Rvb = 28.6 +/- 1.8 microg/ml/min)2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID664375Induction of Nrf2-mediated NQO1 mRNA expression in mouse RAW264.7 cells at 100 uM after 24 hrs by quantitative RT-PCR analysis relative to control2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.
AID1651813Downregulation of Cdk2 expression in prostate tissue of Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 to 10 mg/kg, ip by Western blot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1256603Inhibition of recombinant PTP1B (unknown origin) assessed as hydrolysis of pNPP to pNP after 30 mins2015Bioorganic & medicinal chemistry, Nov-01, Volume: 23, Issue:21
Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (methanesulfonyl-phenyl-amino)-acetic acid methyl ester phosphotyrosine mimetic.
AID616213Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation after 48 hrs2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Conjugates of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) as cancer chemopreventive agents.
AID1382750Growth inhibition of human HT-29 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Mar-25, Volume: 148Diamine and PEGylated-diamine conjugates of triterpenic acids as potential anticancer agents.
AID1158457Enhancement of GLUT4 translocation in rat L6 cells expressing pIRAP-mOrange cDNAs at 10 uM after 10 mins by fluorescence assay relative to control2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Chemical constituents from Eucalyptus citriodora Hook leaves and their glucose transporter 4 translocation activities.
AID1910687Induction of degradation of influenza A Hemagglutinin transfected in HEK293T cells assessed as reduction in hemagglutinin level at 10 uM by immunoblotting analysis2022Journal of medicinal chemistry, 05-26, Volume: 65, Issue:10
Discovery of Pentacyclic Triterpenoid PROTACs as a Class of Effective Hemagglutinin Protein Degraders.
AID1830870Inhibition of human recombinant PTP1B using pNPP as substrate assessed as reduction in p-nitrophenol release incubated for 30 mins by absorbance based analysis2021Bioorganic & medicinal chemistry letters, 12-01, Volume: 53Germacrane sesquiterpenes from leaves of Eupatorium chinense inhibit protein tyrosine phosphatase.
AID486211Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 100 molar ratio after 48 hrs2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Hybrids of 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2) and various anti-oxidants as cancer chemopreventive agents.
AID1398541Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 72 hrs by CellTiter 96 aqueous one solution assay2018Bioorganic & medicinal chemistry, 08-15, Volume: 26, Issue:15
Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives.
AID1728762Anti-necroptotic activity in human HT-29 cells assessed as inhibition of TNFalpha/SM-164/Z-VAD-fmk (TSZ)-induced necroptosis by measuring increase in cell viability measured after 12 hrs by celltiter-glo luminescent cell viability assay2021European journal of medicinal chemistry, Feb-15, Volume: 212Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors.
AID1430417Inhibition of recombinant human PTP1B (1 to 322 residues) expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by substrate addition measured after 30 mins2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Furanoterpenes, new types of protein tyrosine phosphatase 1B inhibitors, from two Indonesian marine sponges, Ircinia and Spongia spp.
AID328037Inhibition of bleomycin-induced unscheduled DNA synthesis in human A549 cells at 25 uM2008Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8
Inhibitors of DNA polymerase beta: activity and mechanism.
AID355135Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 by disk diffusion method1996Journal of natural products, Oct, Volume: 59, Issue:10
Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens.
AID1391719Selectivity index, ratio of CC50 for human HepG2.215 cells to IC50 for Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBsAg secretion2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID377618Cicatrizant activity against mouse measured by wound breaking strength at 50 ug/g administered every 12 hrs measured after 48 hrs relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
In vivo wound-healing activity of oleanolic acid derived from the acid hydrolysis of Anredera diffusa.
AID697014Competitive inhibition of dehydrogenase activity of N-terminal 6His-tagged human AKR1B10 V301L mutant expressed in Escherichia coli BL21(DE3) assessed as NADP+-linked geraniol oxidation2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1465082Inhibition of porcine pancreatic alpha-amylase assessed as Km for substrate using starch as substrate at 47.1 uM by Michaelis-Menten plot analysis (Rvb = 2.48 +/- 0.24 mg/ml)2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID1310454Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay2016European journal of medicinal chemistry, Aug-08, Volume: 118Semi-synthesis and antiproliferative evaluation of PEGylated pentacyclic triterpenes.
AID1166646Inhibition of human LMW-PTP IF1 using p-nitrophenylphosphate as substrate by spectrophotometry2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
AID1310309Inhibition of recombinant PTP1B (unknown origin) using pNPP as substrate incubated for 30 mins2016European journal of medicinal chemistry, Aug-08, Volume: 118Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
AID1190699Inhibition of PTP1B (unknown origin)2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Two new protein tyrosine phosphatase 1B inhibitors, hyattellactones A and B, from the Indonesian marine sponge Hyattella sp.
AID290243Immunostimulatory effect against SRBC-inducing plaque forming cells in BALB/c mouse assessed as antibody secreting B cells at 100 mg/kg, po relative to control2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1238547Inhibition of PTP1B (unknown origin)2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Verruculides A and B, two new protein tyrosine phosphatase 1B inhibitors from an Indonesian ascidian-derived Penicillium verruculosum.
AID284046Suppression of DMBA/TPA-induced papilloma-formation in ICR mouse at 85 nmol within 10 week2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus.
AID1074441Cytotoxicity against human MCF7 cells after 48 hrs by CCK-8 assay2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
AID1515732Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID377097Cytotoxicity against human VA13 cells after 48 hrs by WST-8 assay2005Journal of natural products, Feb, Volume: 68, Issue:2
Three new triterpenes from Nerium oleander and biological activity of the isolated compounds.
AID337152Inhibition of carrageenan-induced edema in Wistar rat paw at 0.04 mg/kg to 0.51 mg/kg, po
AID549723Increase of GST-tagged full length Shp1 activity expressed in Escherichia coli BL21 at 10 uM after 30 mins2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
A novel screening model for the molecular drug for diabetes and obesity based on tyrosine phosphatase Shp2.
AID1401983Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by microplate alamar blue assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis and antimycobacterial activity of triterpeni≿ A-ring azepanes.
AID1551280Inhibition of human recombinant GST-tagged TCPTP (catalytic domain 41 to 1075 residues) expressed in Escherichia coli BL21 (DE3) using pNPP as substrate measured for 2 mins by colorimetric analysis2019European journal of medicinal chemistry, Jun-15, Volume: 172Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
AID1446873Inhibition of wild-type HIV1 RT associated RNA dependent DNA polymerase activity using poly(A) template/oligo(dT) primer after 30 mins by picogreen staining based method2017European journal of medicinal chemistry, Apr-21, Volume: 130Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase.
AID1465083Inhibition of porcine pancreatic alpha-amylase assessed as Km for substrate using starch as substrate at 94.1 uM by Michaelis-Menten plot analysis (Rvb = 2.48 +/- 0.24 mg/ml)2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID1431436Cytotoxicity against human A549 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1634005Inhibition of TCPTP (unknown origin) assessed as reduction in nitrophenol production using pNPP as substrate incubated for 30 mins by EnVisionMultilable plate reader based method2019Bioorganic & medicinal chemistry letters, 08-15, Volume: 29, Issue:16
Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B).
AID403341Inhibition of COX12005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID1666868Inhibition of swarming motility of Burkholderia cepacia clinical isolates incubated for 16 to 20 hrs2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
Optimized plant compound with potent anti-biofilm activity across gram-negative species.
AID772915Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Bioactive oleanane-type saponins from the rhizomes of Anemone taipaiensis.
AID284050Toxicity in ICR mouse with DMBA/TPA-induced papilloma2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus.
AID393222Cell membrane permeabilization in human A549 cells assessed as drug level causing decrease in calcein fluorescence2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID409690Inhibition of human recombinant PTPalpha2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID1250813Antiproliferative activity against human MCF7 cells after 48 hrs by CCK-8 assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
AID1315160Induction of shape change of actin cytoskeleton in human diabetic primary fibroblasts at 10 nM after 2 hrs by rhodamine phalloidin-staining based fluorescence microscopic analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Influence of Birch Bark Triterpenes on Keratinocytes and Fibroblasts from Diabetic and Nondiabetic Donors.
AID697020Selectivity ratio of Ki for N-terminal 6His-tagged human AKR1B10 W220Y mutant to Ki for N-terminal 6His-tagged human AKR1B102011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1515728Cytotoxicity against human Bel7402 cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID1398542Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by CellTiter 96 aqueous one solution assay2018Bioorganic & medicinal chemistry, 08-15, Volume: 26, Issue:15
Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives.
AID1770428Antibacterial activity against Escherichia coli ATCC47076 assessed as growth inhibition after 20 hrs by broth microdilution method2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID1401982Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by microplate alamar blue assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis and antimycobacterial activity of triterpeni≿ A-ring azepanes.
AID1651818Downregulation of PCNA mRNA expression in prostate tissue of Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 to 10 mg/kg, ip by immunohistochemical analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1386848Antiproliferative activity against mouse L5178Y cells after 72 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID1414761Cytotoxicity activity against human A375 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID376695Inhibition of rat DNA polymerase beta in presence of BSA1999Journal of natural products, Dec, Volume: 62, Issue:12
DNA polymerase beta inhibitors from Baeckea gunniana.
AID1347571Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and cytotoxic activity of N-Modified oleanolic saponins bearing A glucosamine.
AID1126806Inhibition of TCPTP (unknown origin) using pNPP as substrate2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Synthesis and biological evaluation of novel bis-aromatic amides as novel PTP1B inhibitors.
AID338350Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 5000 mol ratio after 48 hrs relative to TPA
AID1634004Inhibition of PTP1B (unknown origin) assessed as reduction in nitrophenol production using pNPP as substrate incubated for 30 mins by EnVisionMultilable plate reader based method2019Bioorganic & medicinal chemistry letters, 08-15, Volume: 29, Issue:16
Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B).
AID1664594Cytotoxicity against human PANC1 cells in nutrient-deprived medium2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
Chemical constituents of Callistemon citrinus from Egypt and their antiausterity activity against PANC-1 human pancreatic cancer cell line.
AID1651796Toxicity in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia assessed as effect on body weight at 1 to 10 mg/kg, ip2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID1466839Inhibition of amyloid beta (1 to 42) (unknown origin)-induced cytotoxicity in human SH-SY5Y cells assessed as increase in cell viability at 12.5 uM after 24 hrs by WST8 assay2017Bioorganic & medicinal chemistry, 07-01, Volume: 25, Issue:13
Inhibition of amyloid β aggregation and protective effect on SH-SY5Y cells by triterpenoid saponins from the cactus Polaskia chichipe.
AID437581Increase in glycogen synthesis in human HepG2 cells assessed as incorporation of [14C]glucose in to cellular glycogen pools at 10 uM after 60 mins in presence of 33 mM glucose2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Palbinone and triterpenes from Moutan Cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells.
AID1504286Antiproliferative activity in human HeLa cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID1524958Inhibition of PTP1B (unknown origin) using pNPP as substrate2019Bioorganic & medicinal chemistry letters, 05-15, Volume: 29, Issue:10
Discovery of 1,3-diphenyl-1H-pyrazole derivatives containing rhodanine-3-alkanoic acid groups as potential PTP1B inhibitors.
AID340978Antitumor activity against human Hep3B cells xenografted in non-obese diabetic SCID mouse assessed as reduction in tumor weight at 15 mg/kg, ip after 35 days2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1176106Inhibition of SHP2 (unknown origin) using pNPP as substrate at 20 ug/ml by spectrophotometry2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Bioactive constituents from the green alga Caulerpa racemosa.
AID1424284Cytotoxicity in human HL60/ADR cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1651799Suppression of serum DHT level in Sprague-Dawley rat model of testosterone propionate-induced benign prostatic hyperplasia at 1 to 10 mg/kg, ip by ELISA2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID566012Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 10 molar ratio after 48 hrs relative to positive control2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives.
AID1067064Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Synthesis of novel ring-A fused hybrids of oleanolic acid with capabilities to arrest cell cycle and induce apoptosis in breast cancer cells.
AID1659876Inhibition of GST-tagged TCPTP (unknown origin) using pNPP as substrate measured for 3 mins by colorimetric assay2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Synthesis and biological evaluation of heterocyclic bis-aryl amides as novel Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.
AID1515734Cytotoxicity against human K562/ADR cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID1551309Selectivity ratio of IC50 for human recombinant GST-tagged SHP1 to IC50 for human recombinant GST-tagged PTP1B2019European journal of medicinal chemistry, Jun-15, Volume: 172Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
AID1910673Binding affinity to recombinant influenza A hemagglutinin assessed as dissociation constant by SPR assay2022Journal of medicinal chemistry, 05-26, Volume: 65, Issue:10
Discovery of Pentacyclic Triterpenoid PROTACs as a Class of Effective Hemagglutinin Protein Degraders.
AID1383849Cytotoxicity against human A2780 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID1431434Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1272456Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
AID1628357Cytotoxicity against human SW1736 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID1662672Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay2020Bioorganic & medicinal chemistry, 06-01, Volume: 28, Issue:11
Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors.
AID1074440Cytotoxicity against human HepG2 cells after 48 hrs by CCK-8 assay2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
AID365156Binding affinity to photoactivated rhodopsin in bovine retinal rod outer-segment membranes assessed as induction of extra receptor MII state stabilization at 250 uM by UV/visible difference spectroscopy2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening.
AID444763Agonist activity at human FXR expressed in COS1 cells by luciferase reporter gene assay2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
AID1435530Cytotoxicity against human NCI-N87 cells after 72 hrs by MTT assay2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID750463Antiviral activity against pseudo HCV infected in human 293T cells assessed as inhibition of HCV pseudo particles entry after 72 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
AID1465093Non-competitive inhibition of porcine pancreatic alpha-amylase assessed as inhibitor-enzyme complex using starch as substrate by Lineweaver-Burk plot analysis2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID311141Antitrypanosomal activity against South American Trypanosoma cruzi bloodstream trypomastigotes at 21 uM2007Journal of natural products, Aug, Volume: 70, Issue:8
Antitrypanosomal activity of triterpenoids and sterols from the leaves of Strychnos spinosa and related compounds.
AID1617779Inhibition of ovine recombinant COX1 assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1465050Inhibition of porcine pancreatic alpha-amylase using starch as substrate preincubated for 15 mins followed by substrate addition measured after 10 mins by dinitrosalicylic acid reagent based assay2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID1873254Anti-obesity activity in Swiss male mouse model of high-fat diet induced obesity assessed as body weight change at 10 mg/kg, po administered for 15 weeks relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.
AID79112Antiviral activity against HIV-1(IIIB) infected H9 cell lines.2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Synthesis and anti-HIV activity of oleanolic acid derivatives.
AID364068Inhibition of aromatase at 40.7 uM2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Evaluation of ursolic acid isolated from Ilex paraguariensis and derivatives on aromatase inhibition.
AID774921Inhibition of TPA-induced EBV early antigen activation infected in human Raji cells assessed as antigen activity at 100 mol ratio/TPA after 48 hrs by immunofluorescence method relative to control2013European journal of medicinal chemistry, Nov, Volume: 69Design, synthesis and structure-activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor.
AID1565061Cytotoxicity against dog MDCK cells assessed as reduction in cell viability measured after 40 hrs by Celltiter-Glo assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
AID595754Cytotoxicity against human HCT8 cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID1310313Inhibition of human SHP1 using pNPP as substrate incubated for 30 mins2016European journal of medicinal chemistry, Aug-08, Volume: 118Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
AID1201615Upregulation of fmhB gene expression in Staphylococcus aureus ATCC 25923 at 0.5 x MIC by Q-RT-PCR analysis relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Pentacyclic triterpene derivatives possessing polyhydroxyl ring A inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression.
AID595755Inhibition of yeast alpha-glucosidase assessed as p-nitrophenol release after 20 mins by microplate spectrophotometer2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID235012In vitro therapeutic index was determined. (Therapeutic index = IC50 cytotoxicity/IC50 complement inhibition)1999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and evaluation of potential complement inhibitory semisynthetic analogs of oleanolic acid.
AID378968Cytotoxicity against human PC3 cells2006Journal of natural products, Jan, Volume: 69, Issue:1
Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1504292Antiproliferative activity in human Hep2 cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID1541621Inhibition of Mycobacterium tuberculosis H37Rv ptpB expressed in Escherichia coli BL21 (DH3) cells using 6,8-difluoromethylumbelliferyl phosphate as substrate incubated for 30 mins by fluorescence based assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Polypropionate Derivatives with
AID1488672Hepatoprotective activity against APAP-induced cell injury in human HL-7702 cells assessed as survival rate at 10 uM pre-incubated for 24 hrs before APAP addition and measured 6 hrs post APAP challenge by MTT assay (Rvb = 59.13%)2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Discovery and structure-activity relationship of auriculatone: A potent hepatoprotective agent against acetaminophen-induced liver injury.
AID1846779Inhibition of TCPTP (unknown origin) by SpectraMax 340 microplate reader Analysis2021European journal of medicinal chemistry, Oct-05, Volume: 221Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
AID740218Inhibition of PTP1B (unknown origin)2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Euryspongins A-C, three new unique sesquiterpenes from a marine sponge Euryspongia sp.
AID1540637Inhibition of human DNA ligase 1 using 52-mer DNA/25-mer DNA/27-mer DNA as substrate by fluorescence assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Recent advances in the targeting of human DNA ligase I as a potential new strategy for cancer treatment.
AID1074433Effective permeability in Sprague-Dawley rat single-pass intestinal perfusion model assessed as PepT1-mediated drug transport at 0.1 mM administered in HEPES buffer at pH 7.4 via PVC tubing after 20 to 120 mins by HPLC analysis2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
AID376696Inhibition of rat DNA polymerase beta in absence of BSA1999Journal of natural products, Dec, Volume: 62, Issue:12
DNA polymerase beta inhibitors from Baeckea gunniana.
AID1386858Modulation of ABCB1 (unknown origin) expressed in human COLO320 cells co-expressing LRP assessed as fluorescence activity ratio at 2 uM pretreated for 10 mins followed by rhodamine 123 addition and measured after 20 mins by flow cytometry (Rvb = 0.79 No_u2018Journal of natural products, 09-28, Volume: 81, Issue:9
Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.
AID549724Increase of GST-tagged full length Shp2 activity expressed in Escherichia coli BL21 after 30 mins2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
A novel screening model for the molecular drug for diabetes and obesity based on tyrosine phosphatase Shp2.
AID1515729Cytotoxicity against human K562 cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID767558Inhibition of SHP2 (unknown origin)2013Bioorganic & medicinal chemistry letters, Sep-15, Volume: 23, Issue:18
The first synthesis of natural disulfide bruguiesulfurol and biological evaluation of its derivatives as a novel scaffold for PTP1B inhibitors.
AID772914Cytotoxicity against human HeLa cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Bioactive oleanane-type saponins from the rhizomes of Anemone taipaiensis.
AID437578Cytotoxicity against human HepG2 cells assessed as cell survival at 100 uM after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Palbinone and triterpenes from Moutan Cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells.
AID566013Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio by trypan blue staining method2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives.
AID1187619Inhibition of TCPTP (unknown origin)2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
AID739908Cytotoxicity against human PC3 cells by MTT assay2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
AID1503774Cytotoxicity against human HL cells assessed as cell viability at 50 uM after 72 hrs by resazurin dye based fluorescence assay relative to control2017Journal of natural products, 10-27, Volume: 80, Issue:10
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
AID772917Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Bioactive oleanane-type saponins from the rhizomes of Anemone taipaiensis.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID235232Therapeutic index was determined2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Synthesis and anti-HIV activity of oleanolic acid derivatives.
AID1651821Inhibition of PCNA-mediated cell cycle progression in human BPH-1 cells assessed as reduction in cdk4 level at 125 to 500 uM after 24 hrs by immunoblot analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
Oleanolic Acid Ameliorates Benign Prostatic Hyperplasia by Regulating PCNA-Dependent Cell Cycle Progression
AID772918Cytotoxicity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Bioactive oleanane-type saponins from the rhizomes of Anemone taipaiensis.
AID664372Induction of Nrf2-mediated HO1 mRNA expression in mouse RAW264.7 cells at 100 uM after 24 hrs by quantitative RT-PCR analysis relative to control2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.
AID1504294Antiproliferative activity in HEK293 cells by sulforhodamine B assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Lupane-Type Triterpenes of Phoradendron vernicosum.
AID377616Cicatrizant activity against mouse measured by wound breaking strength at 30 ug/g administered every 12 hrs measured after 48 hrs relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
In vivo wound-healing activity of oleanolic acid derived from the acid hydrolysis of Anredera diffusa.
AID1500888AUC (0 to infinity) in normal fed guinea pig at 30 mg/kg administered via oral gavage by LC-MS/MS analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID1500887AUC (0 to 48 hrs) in normal fed guinea pig at 30 mg/kg administered via oral gavage by LC-MS/MS analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
AID764629Inhibition of human recombinant PTP1B-mediated pNPP hydrolysis2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Cembrane diterpenoids from the soft coral Sarcophyton trocheliophorum Marenzeller as a new class of PTP1B inhibitors.
AID1616190Antiviral activity against HIV-1 3B2019European journal of medicinal chemistry, Nov-15, Volume: 182Design and synthesis of pentacyclic triterpene conjugates and their use in medicinal research.
AID1424278Cytotoxicity in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID697018Selectivity ratio of Ki for N-terminal 6His-tagged human AKR1B10 V301L mutant to Ki for N-terminal 6His-tagged human AKR1B102011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1176098Inhibition of TC-PTP (unknown origin) using pNPP as substrate by spectrophotometry2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Bioactive constituents from the green alga Caulerpa racemosa.
AID687541Inhibition of human recombinant LMW-PTP2 expressed in Escherichia coli TB1 using p-nitrophenyl phosphate as substrate after 1 hr2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID727120Inhibition of human PTP1B2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
Bioactive polyhydroxylated steroids from the Hainan soft coral Sinularia depressa Tixier-Durivault.
AID486210Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 500 molar ratio after 48 hrs2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Hybrids of 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2) and various anti-oxidants as cancer chemopreventive agents.
AID1272459Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
AID616208Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 1000 molar ratio after 48 hrs relative to control2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Conjugates of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) as cancer chemopreventive agents.
AID1770394Antiproliferative activity against human K562 cells assessed as inhibition of cell viability measured after 72 hrs by real-time IncuCyte proliferation analysis2021European journal of medicinal chemistry, Nov-15, Volume: 224Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells.
AID1191564Cytotoxicity against human Jurkat cells after 48 hrs by MTT assay2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Absolute structures and bioactivities of euryspongins and eurydiene obtained from the marine sponge Euryspongia sp. collected at Iriomote Island.
AID739905Cytotoxicity against human BGC823 cells by MTT assay2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
AID355138Antimicrobial activity against Actinomyces viscosus W1053 by disk diffusion method1996Journal of natural products, Oct, Volume: 59, Issue:10
Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens.
AID396348Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 500 molar ratio after 48 hrs relative to TPA2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Lanostane-type triterpenoids from the sclerotia of Inonotus obliquus possessing anti-tumor promoting activity.
AID391032Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate Alamar blue assay2008Journal of natural products, Oct, Volume: 71, Issue:10
Purity-activity relationships of natural products: the case of anti-TB active ursolic acid.
AID402093Therapeutic index, ratio of IC50 for human H9 cells to EC50 for HIV1 3B1998Journal of natural products, Sep, Volume: 61, Issue:9
Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids.
AID1515730Cytotoxicity against human LO2 cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID1628358Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID1430418Inhibition of full length recombinant N-terminal GST-tagged human TCPTP expressed in Escherichia coli using pNPP as substrate preincubated for 10 mins followed by substrate addition measured after 30 mins2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Furanoterpenes, new types of protein tyrosine phosphatase 1B inhibitors, from two Indonesian marine sponges, Ircinia and Spongia spp.
AID486199Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation after 48 hrs2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Hybrids of 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2) and various anti-oxidants as cancer chemopreventive agents.
AID687542Inhibition of yeast LMW-PTP1 expressed in Escherichia coli TB1 using p-nitrophenyl phosphate as substrate after 1 hr2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
AID224273Percent inhibition of nitric oxide production induced by IFN-uM concentration2000Journal of medicinal chemistry, May-04, Volume: 43, Issue:9
Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages.
AID340970Cytotoxicity against human HeLa cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1074445Cytotoxicity against human LO2 cells at 0.02 to 10 uM after 48 hrs by CCK-8 assay2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
AID377619Cicatrizant activity against mouse measured by wound breaking strength at 60 ug/g administered every 12 hrs measured after 48 hrs relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
In vivo wound-healing activity of oleanolic acid derived from the acid hydrolysis of Anredera diffusa.
AID290240Enhancement of ConA-stimulated blastogenic responsiveness in BALB/c mouse splenocytes at 10 mg/kg2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1578453Cytotoxicity against human A2780 cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID1075588Induction of apoptosis in mouse B16F10 cells assessed as late apoptotic cells at 2 X IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 9.8 +/- 2.2%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID697010Inhibition of reductase activity of N-terminal 6His-tagged human recombinant AKR1B1 expressed in Escherichia coli BL21(DE3) assessed as assessed as pyridine-3-aldehyde reduction2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1074446Induction of human LO2 cell growth at 0.02 to 10 uM after 48 hrs by CCK-8 assay2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
AID1424330Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1578451Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID1066417Cytotoxicity against human A549 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID697027Inhibition of DNA polymerase beta2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID340843Cytotoxicity against human Hep3B cells assessed as cell death at 0.001 uM after 24 hrs by lactate dehydrogenase release assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
AID1800516pNPP assay from Article 10.1016/j.bmcl.2014.03.015: \\Synthesis and biological evaluation of novel bis-aromatic amides as novel PTP1B inhibitors.\\2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Synthesis and biological evaluation of novel bis-aromatic amides as novel PTP1B inhibitors.
AID1801408Colorimetric Assay from Article 10.1111/cbdd.12587: \\Synthesis of novel 3-aryl-1-oxa-2,8-diazaspiro[4.5]dec-2-ene derivatives and their biological evaluation against protein tyrosine phosphatase 1B.\\2015Chemical biology & drug design, Nov, Volume: 86, Issue:5
Synthesis of novel 3-aryl-1-oxa-2,8-diazaspiro[4.5]dec-2-ene derivatives and their biological evaluation against protein tyrosine phosphatase 1B.
AID1800199Inhibition Assay from Article 10.1111/cbdd.12241: \\Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents.\\2014Chemical biology & drug design, Mar, Volume: 83, Issue:3
Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents.
AID1745854NCATS anti-infectives library activity on HEK293 viability as a counter-qHTS vs the C. elegans viability qHTS2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1745855NCATS anti-infectives library activity on the primary C. elegans qHTS viability assay2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1346437Human GPBA receptor (Bile acid receptor)2007Biochemical and biophysical research communications, Nov-03, Volume: 362, Issue:4
Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4,061)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990135 (3.32)18.7374
1990's413 (10.17)18.2507
2000's952 (23.44)29.6817
2010's1974 (48.61)24.3611
2020's587 (14.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 57.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index57.63 (24.57)
Research Supply Index8.34 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index99.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (57.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials31 (0.74%)5.53%
Reviews166 (3.98%)6.00%
Case Studies5 (0.12%)4.05%
Observational2 (0.05%)0.25%
Other3,965 (95.11%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]